var title_f2_23_2416="Aspiration radiohumeral joint";
var content_f2_23_2416=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Aspiration of the radiohumeral joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aspiration of the radiohumeral joint is performed to differentiate traumatic hemarthrosis from inflammatory arthritis and the rare case of septic arthritis. The patient is supine with the elbow flexed to 90 degrees. A triangle is made with points at the lateral epicondyle, radial head, and olecranon process. Ethyl chloride or a comparable agent&nbsp;is&nbsp;applied to the skin for anesthesia. A 1 inch (2.5 cm), 21 or 22 gauge needle is inserted in the center of the triangle, perpendicular to the skin and parallel to the radial head, 3/4 to 1 inch (2 to 2.5 cm)&nbsp;deep. 0.5 mL of lidocaine is injected subcutaneously, and 0.5 mL is injected at 3/4 inches (2 cm)&nbsp;or adjacent to the bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2416=[""].join("\n");
var outline_f2_23_2416=null;
var title_f2_23_2417="Manual neck distraction test";
var content_f2_23_2417=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Manual neck distraction test for cervical radiculopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The head and neck are placed in the neutral position. With the examiners hands firmly grasping the angle of the jaw and the base of the skull, traction is applied in the upward vertical direction. A positive result is a diminution of the patient's radicular symptoms.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Bruce Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2417=[""].join("\n");
var outline_f2_23_2417=null;
var title_f2_23_2418="Patient information: Rabies (The Basics)";
var content_f2_23_2418=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/32/28161\">",
"         Patient information: Animal bites (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/44/21187\">",
"         Patient information: Vaccines for travel (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?29/55/30578\">",
"         Patient information: Rabies (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Rabies (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/rabies-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H17587912\">",
"      <span class=\"h1\">",
"       What is rabies?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Rabies is a disease caused by a virus. The virus spreads by bites or scratches from animals that have rabies. It gets into the body from the animal&rsquo;s saliva and spreads to the brain.",
"     </p>",
"     <p>",
"      In the United States, certain wild animals are more likely than other animals to give people rabies. These animals include bats, raccoons, skunks, foxes, and coyotes. Bat bites are especially likely to spread rabies.",
"     </p>",
"     <p>",
"      In countries in Africa and Asia, dogs are the most likely wild animal to spread rabies. That&rsquo;s because in these countries, most dogs do not get a rabies shot. But other animals can also spread rabies in these countries.",
"     </p>",
"     <p>",
"      Rabies is a very serious disease. People infected with rabies almost always die if they do not get treatment right away, before symptoms start.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17587927\">",
"      <span class=\"h1\">",
"       What are the symptoms of rabies?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Rabies symptoms in humans include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Feeling sick, like you have the flu &ndash; A person with rabies might not feel like eating. He or she might have a fever, sore throat, headache, nausea, and vomiting.",
"       </li>",
"       <li>",
"        Acting irritable, excited, or more active than normal",
"       </li>",
"       <li>",
"        Painful or tingling areas on the skin",
"       </li>",
"       <li>",
"        Fear of water or choking on water",
"       </li>",
"       <li>",
"        Weakness in the arms and legs &ndash; A person with this symptom might also leak urine.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Animals with rabies can act strangely. For example, they might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Attack people and other animals",
"       </li>",
"       <li>",
"        Come out in daylight when they are normally out at night &ndash; For example, bats and raccoons are not usually out during the day.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17587942\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. See a doctor or nurse right away if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        You are bitten by a wild animal, especially a bat, raccoon, skunk, fox, or coyote.",
"       </li>",
"       <li>",
"        You were around a bat or woke up in the room with a bat (bat bites can be hard to see). &nbsp;",
"       </li>",
"       <li>",
"        You were bitten by a dog, cat, or ferret you know or think has rabies. You should also see a doctor or nurse if you do not know if the dog, cat, or ferret that bit you had rabies shots. Many pets in the United States get rabies shots, but not all do.",
"       </li>",
"       <li>",
"        You are in a country where rabies is common (for example, an African or Asian country) and an animal bites or scratches you.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17587959\">",
"      <span class=\"h1\">",
"       Can doctors tell if the animal that bit me has rabies?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. If a pet bites you and it seems healthy, it can go to a safe place such as an animal hospital for doctors to watch it. Doctors can watch it for 10 days to see if it gets sick. If it stays healthy, you do not need rabies shots. If the pet gets sick, you need shots right away.",
"     </p>",
"     <p>",
"      If a wild animal bites you, or a strange pet bites you and gets away, you might need rabies shots. See your doctor or nurse right away. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17587976\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some other diseases cause symptoms similar to rabies. A doctor might do tests to look for these diseases.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17587993\">",
"      <span class=\"h1\">",
"       How is rabies treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Once rabies symptoms start, no treatment works well. Most people with rabies symptoms die. That is why preventing rabies is so important. If you think you were exposed to rabies, getting treatment right away can stop the virus from spreading in your body and causing symptoms. &nbsp;",
"     </p>",
"     <p>",
"      If a person has rabies symptoms, doctors can give treatments to make him or her more comfortable. These treatments are given in the hospital. They include treatments to relieve pain and trouble breathing.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17588008\">",
"      <span class=\"h1\">",
"       Can rabies be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If an animal bites you, do these things right away:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wash the wound with lots of soap and water, even if it stings you. You can also use an antiseptic such as povidone-iodine (brand name: Betadine&reg;).",
"       </li>",
"       <li>",
"        Call your doctor or nurse, or go to the emergency room right away.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other ways to prevent rabies:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        If you have pets, make sure they get rabies shots as often as needed.",
"       </li>",
"       <li>",
"        Do not touch wild animals, even if they look dead.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you were bitten by an animal that could have rabies, you need a series of shots to prevent rabies.",
"     </p>",
"     <p>",
"      Some people who work with animals can get shots to help prevent rabies, even if they have never had a scratch or bite. But they still need to see a doctor or nurse and get more shots if an animal that could have rabies bites them. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17588023\">",
"      <span class=\"h1\">",
"       Are rabies shots safe for pregnant women?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Shots to prevent rabies are safe for an unborn baby. If you are pregnant and an animal that could have rabies bites or scratches you, see a doctor or nurse right away. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17588040\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28161?source=see_link\">",
"       Patient information: Animal bites (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"       Patient information: Vaccines for travel (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/55/30578?source=see_link\">",
"       Patient information: Rabies (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/23/2418?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82947 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-F836DB8729-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2418=[""].join("\n");
var outline_f2_23_2418=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587912\">",
"      What is rabies?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587927\">",
"      What are the symptoms of rabies?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587942\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587959\">",
"      Can doctors tell if the animal that bit me has rabies?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587976\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17587993\">",
"      How is rabies treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17588008\">",
"      Can rabies be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17588023\">",
"      Are rabies shots safe for pregnant women?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17588040\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28161?source=related_link\">",
"      Patient information: Animal bites (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/55/30578?source=related_link\">",
"      Patient information: Rabies (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=related_link\">",
"      Patient information: Vaccines for travel (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_23_2419="Disseminated histo bone marrow";
var content_f2_23_2419=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Bone marrow biopsy findings from a patient with disseminated histoplasmosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 190px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A bone marrow biopsy specimen showing numerous oval-shaped intracellular and extracellular microorganisms (A and B).",
"    <br>",
"     (A) Hematoxylin and eosin stain, x1000.",
"     <br>",
"      (B) Periodic acid-Schiff stain, x1000.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced from: Lai, CH, Huang, CK, Chin, C, et al. Indigenous case of disseminated histoplasmosis, Taiwan. Emerg Infect Dis 2007; 13:127.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2419=[""].join("\n");
var outline_f2_23_2419=null;
var title_f2_23_2420="Dibucaine: Patient drug information";
var content_f2_23_2420=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dibucaine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35410?source=see_link\">",
"     see \"Dibucaine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/58/16290?source=see_link\">",
"     see \"Dibucaine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F159194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Nupercainal&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat signs of hemorrhoids or rectal irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease the pain caused by sunburn and skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701934",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dibucaine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697759",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care when a large part of the skin is involved or where there are open wounds.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11937 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-EC2EE36D8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2420=[""].join("\n");
var outline_f2_23_2420=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159194\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015764\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015763\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015768\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015769\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015771\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015766\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015767\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015772\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015773\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35410?source=related_link\">",
"      Dibucaine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/58/16290?source=related_link\">",
"      Dibucaine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_23_2421="ApoE mutations";
var content_f2_23_2421=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F70954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F70954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Structure and mutations of apolipoprotein E (apoE)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 565px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The underlined mutations were detected in patients with LPG.",
"    <div class=\"footnotes\">",
"     Del: deletion of amino acid residues; LDL: low-density lipoprotein.",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Reproduced from: Saito T, et al. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis 2006; 47:199. Copyright &copy; 2006 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2421=[""].join("\n");
var outline_f2_23_2421=null;
var title_f2_23_2422="Infliximab: Patient drug information";
var content_f2_23_2422=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Infliximab: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     see \"Infliximab: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/51/21303?source=see_link\">",
"     see \"Infliximab: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Remicade&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Remicade&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700828",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       TB (tuberculosis) has been seen in patients started on this drug. These patients were exposed to TB in the past, but never got the infection. You will be tested to see if you have been exposed to TB before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may add to your chance of getting lymphoma or other cancers.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have happened in patients who take this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691332",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower drainage from holes in the GI (gastrointestinal) tract called fistulas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692142",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used with methotrexate to stop more problems in patients with moderate to very bad rheumatoid arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Crohn's disease. It may take 1 month to see the full effect.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat very bad psoriasis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691726",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ankylosing spondylitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ulcerative colitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to infliximab or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to mouse proteins, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701381",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a very weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have been reported with use of this drug. If you have any infection, are taking antibiotics now or in the recent past, or have many infections, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-term use may raise your chance of cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have MS (multiple sclerosis) or other nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697352",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you live where there is a high chance of some types of infections, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hepatitis B testing may be done. A hepatitis B infection may get worse during care.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever, chills, itching, hives, chest pain or pressure, or shortness of breath when drug is given. Other drugs may be given to avoid these.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In fistula patients, an abscess may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699069",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of arthritis, fever, weight loss, chest pain or pressure, or shortness of breath if taking this drug for Crohn's disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Night sweats.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424303",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698578",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will need a TB (tuberculosis) test before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027701\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10762 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-4F267068D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2422=[""].join("\n");
var outline_f2_23_2422=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182756\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182757\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027690\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027692\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027691\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027696\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027697\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027699\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027694\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027701\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=related_link\">",
"      Infliximab: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/51/21303?source=related_link\">",
"      Infliximab: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_23_2423="Paget disease of the breast presentation";
var content_f2_23_2423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F60575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F60575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Paget disease of the breast presentation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 449px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHBAf0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD528EeE77xjqs1hps9rDNFA1wzXLMqlQyrgbVJz8w7V2jfA3xGFU/2jovPYSy//G6j/Z23f8JvdhV3ZsHB9h5kfNfS/g3wj4bv/Al34i8StqbvDc6jJcSpq13EqxQ3UyjCJKFACIBgAdKwlKbm4xZuowUFKR8zSfBXxDGQHvtIGRn/AFsv/wAbqP8A4U3r2Af7Q0fn/prL/wDG6+m/hlpXw5+JOiz6loln4hijtpzA8N5rF4sinaGBwtwwwQeDnsa4m3jSxl1C2jaRoINUvrZDNK0jBEupUQb2JY4VQMkk8VnVnVpK7aNKUKdV8qR4vH8INckYquoaRuHJHmS//G6D8H9dHS/0kjOMiSXH/ouvcpXb7PK6ALk43d8UilHQmSQsAuMHgZ9a5/rdQ3+q0zww/CTWvLdxqOkEIcH97L/8bpo+EevF9v2vTP8Av5J/8RXtc6xISJApXooB4P8AjV5WLRDeEKgDp1/Gl9bqD+q0zwg/CLXRKU+3aVkDP+sl/wDjdOf4P68qFvt2lEA4OJJf/jde2sVdpVhVXTPzSNwV9hUFyUKukBbJIBBPU0fW6gvqtM8W/wCFR63x/p+knPpJIefT/V0o+EOuFSft2k59PMkz/wCi69otFTfiMyOxb5mxwD6VPJMEO1EVWPXBztp/W6gvq0NjxL/hUGu7A327Sue3mS5/9F0g+EOuFS39oaRgdf3kv/xuvaLybfEqGd4mbqw4/CoEEcaKVYsV6tnBaj63UH9VgeNr8JdaaXyxf6UD6l5cf+i6P+FSa3nH27Svb95Lz/5Dr2tFYbWRHbudxx+NPMRaQSnDIDnHRqTxdQX1WmeLp8HPEDnAvdK/7+S//G6kX4L+IDIE+36Ru9PMl4/8h17raY2Fo8hxztPJ/CraFPtWAzmVF3Mp7Z/nT+t1CXh4Hgq/A/xGwyNQ0bjr+9l4/wDIdKvwO8RlsHUdFUnsZZf/AI3X0Ojkkg8uB19KnCHdvDfORhR6Gq+szI9hE+dj8B/EwUt/aGikf9dpf/jdOj+Avid8Y1DRBkZBM0v/AMbr6QRSsa7s571cVeGwdoxwPSqWJmS6UUfMg+AniYsVGpaGWHUedN/8apR8AvFBQN/aGic9B50uf/RdfS25YnWOV41nPYdSPWpmwhJViWJzyM/lSeIqAqUT5jHwC8TnpqOh/wDf6X/41Tx+z74qIyNQ0M+3nTf/ABqvpDUdPS9tJbeQOkEyYYKdrD6H1qeC3EFskQDuoUICW5wPX3qXiqiK9jA+Zn+AHileuoaJ/wB/Zuvp/qqT/hQPikE5v9FH/bWb/wCNV9QxghT5ZLDPPtSzB2Zie/AFDxVQFRifLR+AvicHnUNF/wC/s3/xun/8KB8T7gP7R0PJGf8AXTf/ABqvpuWLbmYKWYAK3P8ASmnGzlhwew5FQ8ZURX1eB8zf8KA8UZUf2honzdP303/xqlPwA8UA4Oo6H9fOm/8AjVfR9vcMZXiIAdTkZPUVphFL9cgcgnvSWNqDeGgj5d/4UB4p5xqGiH/ttLz/AOQq8+8G+F73xbqkthp0ttFNHCZibhmVdoZVxwCc5YfrX3DNG3mQsCVwTuHXNfKP7PBx42vPfT3/APRkddNCvOcZN9DKdGKlFLqOPwQ8Sf8AP7o5/wC2sn/xulPwP8SBS327R8Dr+9l/+N179a2XhbSPhXe+MvFkWvXnk393HMLLVblGK/bpIUCoJkQADaMDHA9a3vCmgeC/EWt6xox0jxVpup6WImube91u6PyyruQhorl1PHbOfaui031M26adrHy4/wAGfEKAk3uk/hLJ/wDG6rN8JNeXH+l6YcnHEkn/AMRXvFsn2aLULWN5Xit9TvreNppWldY47qVEUsxLHCqBkknikKiWXg4A/SsHWmm0dCoQaueEj4R6+Vci70s7RkgSv/8AEU5fhBr7ttF3pe7GceZJ/wDEV70YVygwcNwSePpSttiJl52YOD6k9KPbTD2EDwST4Q69GxD3mlAAE7vNkxx2+5Ucfwk154w4utN5OADJJk/+OV7pc5leKJuQgG7Hr6VpWMIBViAVHQU/bSQvYQPBR8FfEhXIu9KJxnHmyZ/9F1YHwL8TnH+m6Pz/ANNZP/jdfQscWQxJBb681ZXdEoJVlweN38RrN4maH9XgfOJ+BfiQZzqGi4Hfzpcf+i6WT4FeJo9u6+0YgnqJpeP/ACHX0WchPmBIHLAdKthD8mAcHkZPQUliJj+rwPmtfgN4ndQVv9FIPT99L/8AG6nX9n7xWYfN+36IqerTSj/2nX0W7Ij/ACnKg9F9fQVZlne8jjLsEYDaB7en1q1XmJ4ePQ+aT8AfFAAzqOhjIzzNL/8AGqryfAvxGnXUtDPOOJpf/jdfSrKshj3PvIyvB/nVa5t1OMhv73PtTdeXQpYaHU+a2+C3iIKSL3SSB/01l/8AjdQL8HvELg7brTCR2EkmT/45X0xLDw5wBkcDbVEWzMoRWIbHTHGKl15lLDUz5xl+Emupkfa9MLAZKiSTP/oFPtfhBrtygaK90rB9ZZP/AIivoa4t40TaozIRjKrWBJu06bzlDCIt+8XHQ+tS8RURUcLSZ5BD8FvEUv3b3SPTmWT/AON1Zb4E+JVXc2oaKBjOfOl/+N17pbSB0Dq2QeQR3q1JcExFTyG61pDESe4PCU+h86yfBnxDHkm80nA9JZP/AIiqc3wp1yL713ph+kkn/wARX0LMqyO0rsfKHH1NZ88cSr5824f3IwKTxEkNYOmz5+X4c6w1z5JnsVc9C0jAH/x2r6/CXXW6Xml/9/JP/iK9m1C1Etk8jptXHyeo9/rWdYXc1s6Q3xHmEfK394UKvPqKWEprY8sPwj17OBd6YT7SSf8AxFH/AAqPXvLZ/temYXr+8k/+Ir2pbjByuSxHQVcglTb5bgEE8Z7VarSZDw0DwJvhZriqGNzp2D/00f8A+IrgK+srpVDKsYLJ3J6k18m1tTk5bnNXpxhax6l+zwpbxnfgZz/Zz9Dj/lpFX0nZeG9Y8X/AR9B0O7tbaW+1S9juZ7hmG2D+0Jy+3apyxwBg4GCeRXzJ8A5ZI/Gs6xKzGWzdDjsN8Zz+le6pYvZ3MtvZ32t26Ss8ywWmr3cMSs7FnIVZAoyzEkAdSa551o0qrbLhRlUppI9F8A/DjUPBHxA1K/0/UlvPDuoWEMM0dzsjnSeL5YyFiiWMqE4zweec4yfKL6WR9S1iJUUFNa1IozDOf9MmzWnNbXXyIuv+I0kLYP8AxPbwj/0bWZDAbLEESu3715GkmkaR2dmLMzMxLEksSST3rHEV41Y2Rth6EqUrskYyi3ljT7/BHPAH0qHMnCygK7jn6VHqCyOyOoZmbglT2qB9olDu5VdvI5JOPSuQ7LGhFBbKUVVzjjGc7atxyIIGjJCxjqcferOg87yIZAVVGzu3dSO1PjliE7q24n02/KT9aLktFmRljJjRsccjPJqi4Gd/lFgpKqTyc+o/xp5jTzMlt5fqx4x7UscEiGPy0BEZIZc5xQK9h0MxQpGXbJGduOPrUiOQAqhcyMTnGdw7ZNV0jCGSMtvkIzn0z2qe3klaHY2xdvHHXFICN1Y4gAWRTkkd1/rilaMQ7Xj3SAsPl4b8atwQhpHkQI0xXaWPGRUixkbiVUMQMD1pk3Et1PnLMU3SbTgZ7VYHmzyBoiygfSm2yL5jAHIJGQDzV4Kocbc7APm2jtVEXEihdFDMCSBkMe1SOqoQ2JWONvy9BnvUrxlYyT9xh9w9anto1yAF+VR+dNIlsjiSRVV8ZHfHU/Q1ZMiKpO4nnHSkJWMHCBCM9TmmI25I/Lm5J42rkmnYm9y7EoKjA3pjkGp4CryhCBvHTaetc3q2k399q9ld2utTWdtERvtEXiQg9zW21tIoZmdARjO09Pxq7EuxpNMhcM0YLA7A5UZUUFfkYMSzK2QcYqOHDh13qGY9+hqIqYZWzkZHY5ApszW9izIxdiSdrA9xx+FEbu8qyM8bQkcrt5z7UxXB2KBlDzk9adF8yFgQMN0I5rNotM0ggITbgc5yOKY6na2Bgg9R3qOLIGxSobORnmrDQrMgXJBHPB7iiwJ2K8ZVnVWG1mznPQ1XuY9hO7AfrwOtTzRESg5POT9DVOZmklUkndjkYrNmq1Oe12Q26pfwkboW+cD+Ja2tDnF7bJJuyuOMHtWZqcauCCNwwQyn0rK+H100E99prAnypN0Z9UbkVna5r9k7yTCH075Jr5J/Z6OPGl6cZ/4l7/8AoyOvrGTMu5QMY5xXyV+z+zDxnebSMmwfr/10jrtwvwz+X6nNU+OB9LR+FL7xz+zrfeH9Jltob271G8KPcsyxjZqcjnJUMeint1rpvh14Ev8Aw/4z1fW5bbSNF0+7tY7ZNH0d2eDepyZmJjjG/qOE6HrXn1rpYt9y22oa3bQvI8pittXu4Yw7sXYhEkCjLMTwOpNWzYOUyus+Jc/9h69/+O12LERtYxlhpXuZ8XN1rAGP+QzqeQf+v2apbGHdyw+8c/hSW1lDZ2zQW4kZTI8jNNI0ru7sWdmdiWYlmJySetWyAhCLnJHX0Fc7d5XOpK0UhpQH3AyVz61Sv5RDD5Q2sp4UZ6n1qfUblYIGAfb9OtY9ujynzpCST0z6U9gLNnGAuOSe5962IF2si4G4jPJqlFtRguBu/rVpm23WVcYIwR71nJgkX45EjY8EtjGAO3rUrTgq4JDE4GMciqqERhQTyec/y/CkXCRFozu6gjqc1BVi3HIPPKLtOBk1YiuVmhIWXBb+Acn8azy7zI3lAo+3jI/WnwWwSJGdmMh5znv60JjsupdjZmlHACKOMkDn/Gp0/dkgR5APLnmoLS1d33bcpn7xPQ/41fS3dDt38Drjk1SdiW0Ftawht7/J6JnBouEEYMiRlh2HYfjVyOxdSSMhPzJp32ZZHKHCk9jWmmzM+bW5lQQmUbmBVcfU/SonjjiJXaMHgYrVmjSFhGv6/wCFQG0Z8tuOcYO4UrLZFqXVmTLGhX5BkD1HNZV/aidiTGMd++a3JIDDywLd8dx71VIEzOI12yA/xDlqTV9GapnHyeZpEoUnNqxyB/c/+tVz7T+7DKeMZq7qdoJlZWUbSOT/ADrmcSWLfZ5SfKY/umP8qzejNou6Ny2ZJIl8xj5ac4Azk9qrzQPPIJJFKqGxHF3Pviq2m3n2ebDAcetbFqUkeS6uZP3pHyj+6PQe9UveHexV1KFZfslohYysd8mBwOelZur6YsyFWH3eQe4P1res4DG7XDIQ54UH+EUlzHuQliQuep4ya0tcg4IXM+nzBLnLRdFk/wAa0FuS5BU5B6egrT1GwWRCGXIIz8wrlbi0ubGQPDuaAjOzuKjVCZvR3ChGBbczdMnpXy1X0bbXMUq5EnzHsK+cq68O73OHFrY9W/ZwUHxxfEjJXTpCB7+bFX0C6eTHiJ3ErPuOeQAewr57/Z3O3xnqBA/5h0n/AKMir6CQysdzhGjx90HkGuTFfxDTDfwzm9b1qxs9TisAsjXE3QRjOPeoyTEWjOcnnOOprRvIEjeOVVRZiCN235h+NVpZXKq4UtgEAkY59a57HQmUmKYDsQTjIBNNkWR0LYUkr8sZ5qxbxoshlO1lboCOo9qEJG8pEA4557ClYbYzCqsca8kj7npinxxRZjk+ZnwQpPb1OKqxeROftCqTIuVVuePXFXEcRsAW4JHQUhMSQD5j2UY3Hp9afDmOPcWUAEZJOOvalydjLEN+48bl4qTy8hlwhfILDqKYrjrkA5YlWA4xUKxERKrSgMxwWAx+FWfs0hT5Auw8VcS3Z0RQmQOp96SVxN2K6x/KOMdgR6VNtImBUAhhyWPP4VdgtmGTvC+vtTpIJDiKRV8z+FiKqzI5isI8kMCBk9yM1b8t8ttLKB70+Ow+Z/MVST1I6mpkixtjQbcHoefzqkiWypFJsygJck84OSBVhHaXOwA91256ehqS106G0mkkiQ+dPkuc9SKvJAZYlEeQRy5AwKaiS5FKWBpYzvwD9aLKEWuUijAXGSQc/gKutA2FHyup4IB6CpPKJKjPy+m4cH3p8oubQiXl8dBjv2qaGXC4LDI4PHNK6dNp5HUdqYpWNF3ksT1B4NUSxQVdfKVAGAyG60ACUKkgw6df8aXOYmeFgGAzk9qh0zVLPV7CK8srhLiFsqJVHGRwRRYlkksZyrFiFHXDY5pjSshVXHLD5SO1STkMh6Ej16Yqtdui+U+Sqnt2pWGmWoLwiRS24HHPHNXFumLgRnBU5DE4/CsiSXc5BOFAALY6Uhu/LD7/AJz2A6sKlotam88yviVM5zzzVOfGWIOOOD3zVaOchgdpCt/DnofepZu/ArJo0WhSmZvL3Ng5Pf1rkpZDpXjGxvQx+zXGYZVHHJ6E/SurupN3GOAea5vxPbC90+WMYEuMhh2Ycg1Cdmao7VpSjZ4+cEV8q/s+jPjO86f8eD/+jI69/sNXa80jT2Zv3wYRSDoQ3Q18/wD7P/8AyON7g4P9nv8A+jI668L8M16GFVWnA+jIxuAyeF7jrUhzsPXHf2pkAyn3tuRn3pJiRIuDxjrmg1YzgD19cDNVp5Qu5s4YfdGe3vViVxtJJGKx72QuCvatESU7hzNKOMgdPepsABeSQDzVZly4+mMVZQbcYAx2pSYIu+arKoAHrvqdMvhQcEHBPqapRL8xwQdx4B/hrShYKo3fMRz71G7HsWF8qJ8uoaRu3XIq0E3fOy4LH5Sei1RgUGUsSzttxk8c+1WocuWGCiLwGoQMtRR5OJCrc44/rV6O2iDbcjpjI7VBZxptZn3Enhc1fs7fywhDAgnr1NPzIbLlhHFBiMqAcZ561bisVM4mEgJx0PHNMiskYiRGO8Hkt2+lai228phgo3ckCrSb6GUpW2ZDIBECSuZW4A6ZNRFBb8z/AOsPRBzj8a0JLWQzeYo3kd89KtfY1ljRplVnAxn3q1ByehnzpGSgScJLJHxgjpULxhJThHORw3atmVdrCNUXj+LHBqnJGXVk8zDFsYHpWlnsJSuYN7b5ZtoAK+/WseSNtxY/jkdK6G6t/s+5Y3Z39COlZd5GVkLSADdWcjqgzF1EHYpC9c8+9c7f20MsRWU5z3Pauvmi3AsANh+7k9axtQtVcc8N3x2rOSZvBnDyRSW8/lSEnPKPnqPStPTX2yfMx47Yov7dZAYSCrjlT6VnQ3DJKY5fllUZ9mHrWa0NUzqDdfw7vfnpRcS4tiS4JGeCOfrWRHdMVG0jPentdD5Q+OOCfWtFIGid28w9WIZRkdqpTRrI+3Az39hUguQJP3eAApAIOagjl2y4Iy7DJ+lVdEMyb2x+yTtdQR5X/loMfqPevmmvrKdRLCxPOM8elfJtdGHVrnDjPsnp/wCz46p4yvtxC509xk/9dI698mdhGMLgj7zDjJ+leCfs9jPjHUOnGnOef+usVe5yQs4cN/Eckg4xXLif4heGfuFW5f5nGyTDEZYn9BVeV2G05AVf1q5dB1DqQDGAMFjzWPeTqLiK23mNpRuChf4R3JrnOhaj3cMpGQvQg+n0pqO+SgJ75Oe9Nmh2EBW+XIJBHSpFZlVpGTKt3Hf2pB6BA6W7Z4Jzz6fWrEcu6T5UHzHg9qrwwLKT8mFJzWxYWm0bhg5GBt7Ciwmx0CuxxjCjgcc5q0sSiJt+3y1PJPrVyxQKqjaVI5OR1/GrEdkrqocBgxz9adiLlezsvPAYjao5HHWtNLbyyAenX8atWVqI8BeD2B9KtxoBKrONyenHNaxpmUplP7Luw6jH4U+O3/uLjdzlhzitrylMxZE2rjOB0FP8vBHA247VryGDmYqWbxPuWNZCM4FTx2W1WLgBsZCitKO3RNwBYbjkiplj4AAwAMAUlATqGULTMkbKAR15GDU8dsGUrtKg/ez3rSWEyqCQR2OOtL5HzDINVyCc7mNHbiYuo3Ko4yRj8RTJraIrhiYzjGW4z71uGAAHOcDvTJoI5FKSRqV/ukZzR7MOc5yS2YjCuVKgZB5zUjxSrgNGztjBccVvPbqAOB8v93vUU0ShcbXO84AA6VLhYancxJIjEQBknGTxmq8CxQAwwQRRRY3KFXABrekhYIVPJUVnXEJG5mCDH6VLVhqRV+cx4Y9vvCs27dn3r0VRnkVozJMsY8uM4HUDjFZ944XB2cngn1pFJlfz9ynfkNgDmo2ZRGVkdc9AKjljZRypQDkgnOaqyEkbxgr/AA56ilI0iaEdycsr7RkYV+341Zt7oH91IwLMME9M1jZJB2cleoJ4quk6Q/eDGNj1/uN2/CsZI1idBKCyEjl17Vk3x2qSDwTnn+VSw3W5zvyjg5JXoarX8glXCltp7Y6GsjRHJJdLZeJbexQvnUJd6L2Vh1/OvMf2fwG8Z3Ybp9hf/wBGR16fcQqPFejyk42yN/I15j+z6obxndg/8+D/APoyOu/D25Jei/Uxq/HH+ux9GR7QMDrnOB0xTJGAzk8jHNLEwCeh9e1VZXCsCenoeeag1IbghQSfvHn6VmSuWbhePWrV62+QbRxVOQDlV4pkjACjuSPlqRGZgOwxmqk8rLhFx159adbNgBScgHnNT1KRpQSFRnd7ZI5q7E4IRQc55IA+Y1nx7dyknnrjsK07JGZ2YryenbA9aALdtbyyyPk+Wrc5/oK07aIR5jwGVR83vUUIdF3YBJ6AGtC3BY7BlTjJOOlS2S2PGMrGM7jjkdhWvZRPA3zIBk8HqaSwtYY5EeUkHoo/rV7KzTYUfOnGWHSrgut9TGcuiJZQ5GMBVA6DjJ96s6ajlHMoTyzzgdTS2a/Kd22RwevY1et7c7mJP3uoHGK0SblcxlJJWIoWUSOocsXbAUDAUfWrTDEW2Nih/MU9YI4wAg2MT+dKY/MkDDDKOAp4/Gt4+7uZtp6lAoMNvYljxgVSnKISUVx2HvWzNFwSAuB045rOvYWcEkLsHt/WiS0LizLYhmIYlO1UL0KcBnHl9DkdKsG43b0lVs54461TuRu5GcnkVlzaHRFamJfgQspVwATgVm3OFHmjOG4x71r3KGRhG4DD6VjXT+XnIwM7SM8VD7nREzrmNJUVmUbvWsDVbMzA4+V0OVYDpXQXBHnKEUeWO4qlKgYs7ng/Lt9aTRaZy8F0ylkk4lXqB0b3FTCfeMflVm/s45Y8AYYHIYdc1hS+ZFIMgbyPwb3FRsUmbtrOVIJxgDA9qt4WSXeOy8Z71ztjdDJD42966S1aN4QoPIXg+3vTjqNtDTIcFCQO2K+Ua+sSv7rzMgNkjOelfJ1deH6nBjfs/P8AQ9R/Z5GfGd8OedPfj1/exV7vdIcOAoBJwRmvB/2eU3+NL0ZIxp7ng4/5aRV71cE7jHgkEZYiufEr94GHdoFKRdjkHDA8DJyD7ms6QKZsyjLngHPGKugDllw6kcZqozAqqtsz0U4rm9DoKU0jKrlvmDPyB1+lWLdWkYIu1dvJ46f/AF6ckabg3G38xmrthApkJJOX7YoG2S2VsGI7H8q3rNFYbWiTcOSF7Cm2tuRjaoJAx0zmtqxs8P0BJPOKcUZSkJaQtvChQVYdhwKvfZ0jdS5O4c9OMVfghSLcCOox9akihWVssO2MGuiMLHO6hUijZ23MpwemKsw2UaqNu7A9a0EiAGCMDFPWNQvC9+K1UDN1CkbTLh9zEgdBwM1Ii4GG7VbKsAOAR3pu3DEnJJ7Z61ViG77kSpkj+dTKBnpn60ZOCen40rOCuTgj0PehWENaZQSgKlhyQvao7i6jhUM+4AkDK81FJJ5kgMEgU5+fA9Oxqe33eWfMYE5zwMUN32LslqTJKGYYyOOuOKZLCH+deMHOR3pyyKc49e9TKw29elVutTO9timq7EAKkkHjHNKUODuY4PP0qDWNOh1Wxktp5J443YEtC5Rsg5HIq0c7QDmlYLlYth/uOcn7wHFV5EZt5kUc+n8qu43J8rZ5qGQjB3c9qzaHcyJvOwoXBLHn6VmTqskjKyYZTnjoa6GRF3jp0yPasy4jA25T5vQdDWbiXGRzU8Ekrjhk4wAOh9Ky5pPm27SAM/L611N1atsZlAXv1zzXL6ksgYMF2vycDp+dZtG8ZXKry+WylAR3Oe4quZxJyMHnr6ikmLrHuyNp64HKmqcjDBwRj0xUSRtEtJdBWAVioA4yeRU0dyp3biRlecVipKshIwPr6VH5nlTFckEjAHasmjdINTm8nWtKKkYM2CSO2K8y/Z+/5HW6/wCvF/8A0ZHXa+I77AgcEq0MqseOnPWuM/Z9GfGd77ae5/8AIkddmHVqcmc9b+JFH0On3RxwOmKoXTsGdVGCOhJ65q4ufLz6DJAqhclgQxI2nvioZqVWyrE5O3pVOdwuWAycVZuHOOOfYVnzOD97J44pkkQdtmCfm659KntfnHzAHB6VVgADEljuJznNW7fI24UHHI96kpGpa2wl2gkkHHSt+CIumMEAfpisiOF3KxJJtPBOOuP6V0FvkRDJGTxnNITZbiZRCI0GScHPoK0LaNwFKqWDHkHtVOyt0WHcWJ+bjNadnKHVpAWJ6KD259Kkzk+xqWjBowGjRWHf0q1EhD57HnJFVLGLdGWztbPTOTitQYaTZ98qM7fb3rSMlZNmElqOtgomAUAhT2961Ivm3YHHrVWFf4iAuOFAFTmcK3l4O89OwreLsrmUldj2gd2YEkKOQaURTK6hCpjA/HNSwFmGSMA9jUh4BC8EVpGktyeZ7FeaSJN2/APTHSqErytlNgVAe3StAlVGZWGe271qmRlyIwrLzkt0q7tjWhjTW6rM4Vcbzyff2qjfxpH8ruFc5CDON30rodRUKgZAGKnC1h3hY7GeJSe25ckH1B7VLilobwbZg3MJ2HZjg9Sa567RXmYYzjr71uXswMxD8DrwcZrJvI3bcpG1jyCeKy0aOlXRk7DvYKQyYqpOm0qAuR1GBVu3Cq2zeCe+D0NRXJIdkZiFIxxUWLuYd2kglXZ8xbkACq95bJc220jDEgg91NaNyxhlBbtjmqzsBcb1+62OD0PrSsO5zF3CYJVEnySdm7MPX61Z069aG4VWb5W6VsXlpHPE8T/N824Edh7VydzDNazmJ+xyjetRKNtUNSOtNyQFBYepr5ar6GjvWe33EYdTyK+ea6sM73OTG7R+Z6j+zyN3jS9Az/yD3/8ARkVe9zDZko+CwPGeorwX9nn/AJHO/wAZ/wCQc/T/AK6xV71egy3OQNqRqAMCscS/fJofCZ7qFiIAIVR0x3qgzb3YDlRw2B0rTmLlW3EMoPIHaqZVFkZAo3cHPpXMdKY+ODfKgJPA4wMcVvWNvkqVjIH+1VfT4fMIViqDjB68109haDesZ+9jqORiqUbmUpWGQIibELBCc7fc1tWVvGsS5G4nk9uawLvwtb3fjDS9XlnuCLFGSK3B/dhj1Y+p5rr4oh5mf5CtowMJzXQjmwDkoSBVm2Qn5jgUpjO8Zxg+lWY1AxxzWyTuYsdsGOelDgKOvPtTwOG7AdzVS4nCHCHdmtGCVxWkGTtYEdDiq804iTOQ2OwqveSzCJm2gdlIrmL7UXa6CtIVOdqhOn41z1KvKbwo8xvTX6PGwLbSTtHzY5rHk154rpYXdWIJC/hWZId5AnLfKc564NZWp3tjDI/2i5VGHICckn0rnlXZ0Qw6eljXudWlFyZPOXeDgqvTNauna8HCefISTncQOD7+1cPbaxpc8iK83kj7xBXhj9a0lhhlKyQTBxzhVbg//WpKrJaplzoJK0lY7y01BJ2Ko6lgMrz1q5BcmQ7lGVHBHoa4G2le2ZcLjaOVQcfnW/BdAOd0shC8c8E8fqK6IVL7nLUo22OqSVWIGQO3NPx1O4Gse1vIpHCBWGOcmtNH4HUg+nat1K5zSjYMDJCrtHXI6VE46Dac9z6VaG1hgMPeoZEyc846A0W0IKbLliMkioZY12kOucdMVbKHnlh6UyVSynn/ABrNoaKM8CspVeMDjiuZ1GyTc5OckcgV1ckYZQACF+tZuqJsTIQMenT+dZtGkHZnAXyG3kYFSA3HArHvUOxmyGFdPrkTAmQHIHGAMmudvCViKnk45BH8ves5I64O5zs0xhfg5Yc9ev1oS6ErAnGF6H0NR3ADiRsd+c1ml152hsLzUWudCI/FyFLMTxnDIwYnqDzWB+z0QvjS9J/6B7/+jI66bUbb7bY72JbCFtmeCa5n9ns48Z3p4/5B79f+ukddVB/u5Iwqr97Fn0HGcAqCelUr1flUg9eoq6pDBegOcfWs+9JZyD6VkaszbolVOenSsyRlchBjjvWheyfL+FZiEgtjgk9TQxIkjZVjG7qTjOOa1tOj3bY9rHjJOM1nWiMT8yg5PHHStWwdVdlMpzINoA7Uhm5YIiliT87E/nV60R48GQ7juLH2HtVSzhVYiBnpWlDGzKY1J2AYqbksktLwPMfLB2r0HT8a6Oz2sIpGHy57Vj2lvHGu35Q3BYDpW4hAEecCIDpipV9kZzaL1rCpnYoTnPWtO3QKGbpWTDMURthye59RWpp8qTcsCCpzya3gouy6nPO+5dXCEE8jHHHWmyFV+d9pcgYH409IwyZDEljkd6qXxijjC7hv6AdCK0bcdehMVcvLOhQNuCkdBVkOARuYFiOAK5YXypP5aNuPXnsK0LW+WScBiACMDHNXGqug3TZqSRrcxgsgLKcrntQ1uhXC/KM5GOKXz41Tdn5V4xTmbKhlHy9Tu9MelbRS67mepianAdzY4Ockk8Vi3jkwtEFJz3z0/Guh1VwkLNIAY1PJ56fhWHehcNu46gD+lKUddDopvQ5y6hU4V1HDcMfaqFy7OjJwQnfvita48tVCldxPOc1m3AByXUqehI9KzcbaHSncwWiQB3XCsT0qhcvIrspQZz0zwBWncLGHOOO4J68Vi3rvvGPmHBznrn1rLZFlK8kklVi8TNk9/Sq8+GtyC/zKOAasXkotWVZNx38FlGQp681Wu2TOU247nFFguLaESI3mMQR8hH8jTbuyS6hlikHzLghgOnvUUcwyQTxk5P5VPDcESkMc5Urz70aCOXKNaXMiz5wCVfHY9jXgVfRusx+ZIzqM+YMHjvXzlWmHVm0c2L1UT1b9nBQ/ji9DEgf2c/Qf9NIq97uYyHfzM7CO3QV4P+zYceOb/jP/ABLZP/RsVe93SM0gIbg8Y7VhivjCh8Jm3GUTCEI2cjvketMgtWuZSpBznlhVh7ZmkUR5OSCcnpWzZWaLKjAZkYc+3tXOo6mzkTabaJG20ncDgbcdCK6KyjWOPkgNjt2qrYRFQgjReSc+vvWlcWu+HyoxtV+Tjrmt4pnPJ3diWwZXjyo/CtJBgE4rL0PTxZR7CzPjkM55rY2np2remnbUxqJJ2RHGoMoPcDgVZTGBgc0xFHc9O9PUYz71qtCWLIvBFZs4XzMAjI45rRlxtIqhcHy03KmT3PeomzSmYOv3ElvAw3jK9OeelcpaK88Ub5jBJPzdOfxrS8RSSvcFsMFYccZxXE+J9Zk02GGzhIN3Nzuxwo9frXnTfNI9GlDSyNnXZBbWItLW6X7TJwFzlsn0qkNBXTliXUoZJ710807BkKO2/jjNcTaJqH9uWrbEvrKKJ3nO7DqQMsB716bpVxoUmk28OlXLpcOmbiN9zrg87S5rWFFddzaM3HRbGPdRqJjJLDHCqgK6tHkbT6ehqneNHaRfaNNm8uJD8me4Paur1OOOeb7NcwS2NokRleebO2UjjC1zOg2ctxfNcXVlv0gymNbqM5VTn0PsRWc6bvY6IuLjzf1/w5reE9Ua/SWRgFkT5Np/rW3MpE37wMykjJPQfSuduNNPh3xGRGVZJTjYp655Brfad5oHVfmfg8dqS00ZxVYpvmjsyWCAGc3EcziUKU3ZyoH0ro9LupZQY3ILAAgjuK5O1WeMu8KsqMcEEcfWuh06PcVZDIkgYZI4B9vpXTSd9jlqxOgRv72ATxxT36YGPwpmAwBBIP0p+DtyBg5/OumxxMiPKnJHHpULgAZGSexqyRu7AdxUeQEAI+lS0IoS/I208nP51XukMuV7H8DU8sY+0oXzkE7RSTD5wevBrJos5jU7XEirtIJfOe3SuQ1CAiVlYgc5BxXoN+uVLOD9K4rWFIkbC8L0OeR7VnJXOimzi9ZiCEvkBe+O9YEki4ZcEvnjFdTqiJJEFkB3H8q5UqwkZCTuPHFQkdUWXFO2MfLgFSPpXJfs9f8AI6Xvp/Z7/wDoyOuxjQywYJI7c9a4/wDZ5GfGd97ae/8A6Nirah8MyK3xwPoNhjDKeAeRis25JcsxB6VpOuGI68VlXUo2kj86ktmNfnIIY/X1xVOKMt8p2lR6VLdE5J6mi2A3HLAEHpjrSYkaFiAJUGS2OCT0NaSRBT55QblBx6nNZ0Cs4QqeBn5SOTW1aJuZRkrwSMdh60hmjazMIlcna0nGzv8AjWtZlZRuhztTvjvWUjW4eNN26TGVPcfjWrb4jK4OARuwPWoZLNATK9vsO3zCewqSKR0RUGcZGSDVKIeXOpZe4PB7e9adsqGfDEOjDINNJtmTaRciLAkjaAf4s5xWpaybAOFye56ZrJeQR7doLDoVIz/n61HfXW2RljbYVAwQcUT9wmK59DTmvthLQuQ/IJJ5z6D2rNnuGlB8wsSFyQxrPjkaQMzON44Iz+tAlQlUlf5XyAT1zWCu3qbqCQ1ZSSxHQ9M9atWM0kEiglmOev1qqV8lCHxns1XrWPfCck449Olbx03CVrG7pl4y3H7xsqDwjdq3GnKj5iC/t0ri2n2SFQR5wGRk847VrWV+Xj2ySZbJ7d666E+hy1Kd9TQv7gNGFiwxZsfL1Nc1fQMzZi+Xc3Q+tacZZpmIUBeg96r3cgWRt3Y8nHTiuluLV2KF4uyMKeJUJJGew9qy9Vkw77Rk/dOPSta92onmOc5OQD3rCvJFkRnDEjmsZPodUTDuw2w4XDep+tUJwxXqFGASevSrryu6kkfIeAexrHvpAzBckBRjjvWJoZklw8ks8T5Cg8P61Du2xHceTgknsabOha5ZQpAPOc1UudyyJknYCcj1qb2GTxMHJLcEEVJbSkSZbOcjk1QkkIz0HQZ9qRJdvzPjHJOKLiLOqyFGjUDKk184V9E3cweyLHJIOf8A61fO1b0OpyYrp8z1n9msE+Or7bt406TO7/rrFX0PJH98t90HrXz3+zOhfx1qAXr/AGZJj2/exV9Fzxkny15APJrnxK98dB+6R21uZHdufWti1tMBcjBPQZqlo0N68sgv4Y4UR8RFTkunYmumtIRwSOMdu9TGIqkrOxLbRLGuE7jrVsKeM4zSRqMDNTouO1dKic7dxyLj8vSpMDHvRGuSeakVDg8ZPTFaWJuMC5/CpBnbSmMDrk05egGKoRVZcsS3NVJ13jk5bsK0ZE6+tZd1uViSDx6dqzmrLU2p6nD6+JxcON2Tuww9K4fxfZONRtL5whj2iNi3Kp716Frts7TyS7towOT3Nc3d27XNlLayKSjdDj7p9K8qV4yPWpOyTMbT/N1OHUbbTJ8RQx7fOYFec8tg8c9KydIhn0qdpbjzIIjlBnPzn+8B6V0ngHT5brWDZXrR3Yil/wBVna2McZ9QK7zV7JrxBLDFh4UaKKJYhJvII/I12cjlHniwp1VTk6clocbpV5r+sRQWSXEd5ZfM21+qpnnjrn0ru9Ka5k01YniivU+ZduwqYsfwk+vA5qrZaG0kcdnPbtBbHaUuIZVWdMDLLIe/PpVbU/F58O6rdWNzpUy2M4DrKp3CQnjOR36VrH3V7zMa0ud8tNHNfEW6tby8sL62uY/7QSREkgjcHg9iAf1rRS08lT94uRkBWxisK40eG78VRXlpYW9jC7tLHtfflMZLE9iT27V1MsyKm0KrOx3hu5yK45tOTbLtaEYobpxkE3lozNE642jkev510FpGflKhuOgNYejQkS70G0nPCnpXV2qHg5IO3j61vQTaOSs0mTqGfZggZ6ipyAIxxlqZErRwqsjK7gZLAYz+FSDHljPauxbHHIqzShFXcVQL1JPSl27wMHntVfUbP7XbywkgCVSrH2NSQw/ZrOGBSxWJAoJOTx6nvWZTtbR6kM6Aup/iU8ZqOVTt77qmbf5Zwcn0xTJmIRWwSTxx2qJIk5/UW+fHPmdDXJ6ipE5AU5P3ueldvqYAQt1Pc+lchqSfebBBJx9ayZ0QZx2pjbM6MfkIyPrXLXDATAk8E9h3rp9dTdiVHIC8YI6iucmVWfIBIOTWZ0xLFuw243EqecmuP/Z1/wCR1vQBknTn/wDRkVddbxfu1wAoB6VyP7OzbfG17zjOnv8A+jYq1w+0xV/jgfQLyCS3WQBkUgMAVwx/DtWBeNhGbHAOcVuahN8oG4nPGe9c5ft8mB0qHuWzLlcmU88ZpI28wfMNwHcHrUMrEJnJOeMinWLDKtjcUO7HrSYkb1m6GZOSAPmLHpj0z/StbTwkyY+faSQSW4A7VkWkLsrOI90Z4x6cdK1LV2SVBHESw5YH7oHpSGa1uqoYyoIdencDNaSxll8zO4t1OOBUVmVcLwAH65HAq9AsauwxuY9FUVDIbHx48tgxG4jvx+tTWIZWwpXAGRuNVZt8biMHj3H9afJM0cg/dAKR94HAPtWiSepD1VizJcMp4QZUdOVqjdzkyf6pTIw67+v/ANei4umUGTaEOOhG4GqVtKtxAyXEbLOfmV0+6fwqWtTSCsrliCRSyukUu9cg+x9/WrHnqflkIRz2bjkdhWKZpBI6pIQehJb9DVuESPArSxtwOCeaXs77Gtu5fZhK+eT7GtC1If5WfAHvyKwXl2uqIDuGCc8YqzbTtt+fg5596LW3E43RrzyqJW3HnGOtS6VKQWZicH7q/wB6sTzef3hJ53YatPS2j3Bpc4OMD0FVF+8ZyjaJ0qNIybSuE7Gs/UY9/KuNq8Y9ferf2nleioOBVC6ckMSwOT931ru3VjmitTI1GTcXUjAUBeawLyRUi8sDBxlfetLVJXDbIgd3eue1bChWUkOOvesZS3OpIo3hbyy46A/MPSsW5kD8kjkirdxc/uZFyct15rMndeNy5HXipuUVXkG98nnP51lXE3BU5OD+lT3DqZVHdcn2rIvrv963IHTpUtgLcTAugGcZx1pr3SqxXOccVmPdgtn+6R+VQNP5krKScbgTmpsxm3Ldny4kGPnbJ9hXhler3d0qqW6gccHGK8orqw/U48V0PYf2YDjx5qPY/wBlyY/7+w19OrZtJKGLfL1X2r5n/ZViEvxDvwc8aXIf/I0NfWUdv+8Dd+ntUVo3mZwlaJBDa58tgB8g71pRRjbj1pVi429xU8a4WrhAzcriBflxjNPVT+NKPpzTxWiRIoAB56VOAVBxxiok6irCYK4NMRETkjPrUwGCCvH1pmzB3Yxz3qYLkc0A2RMoIO/r61m6h8jLgcg8/StYj16fSq1wgK5IB9KTV1oXB2Zzt7aC4DZYqCM8dK5mW0mDnYJc5xnHy4967q4geQKyqBt/I1lajZSSRkRMwfuB0NcdalfVHbSq20POdU0i7tdRGsaLIIr0Y3AH74HrXRW/j+1tlUarY3Gnylg00mzfGfRk7/hUr2bwFkO4SYJG4dRWhY3Sm2EdxaxTJj7pA5x79qxpVZQ929jeajJXauPPie2kjWG2iW/vrnLosRxGc9N/dcDBrI1rRdc1mC1tZVs4rBCstxcqpXLL2TJ4AH8q6KzvbO2L3FvZQ2V2w2mSJQd314qDUNSe7Yq08krlTG6qPl54zWs6qlHV39DKCcZXivv1KUtj9l8PwRuifaU3Rhh0bvk/UVVjt2nhiijjACjlvQZz/WtOSNntyoVwoUcH1FS2uLeFRuDA88DvWajzPyKcml5jLOzS3JJVVYjse1bEK5xtGR61WdU3qdpdj2FaEAAX0wOldlOFtDkqNvUkxgcnpxj1qN+VI7ilMm442kD1NOBBPGDxW3QxtYrrluMfSmucHBGRU7AA5qrPjYcfhWb0FuxjnaTzwaqysRwueOtSk565HpUcvC5I+b3qGIyryQbWIHtj1rmtQVxE7EYBPQHpXRX8sUURlLKQeprm9RkzHlsDrgA9axbOiBxmrEq7AlfmHORmudgiYHIHQdM9K6LU8mXoD79qzEjCyK5CqvOAB/Os5M6YEcKhQMEnn0rgv2fQD4yvc/8AQPf/ANGR16LCpDZDMzbj8oHBH1rzf4Att8Y3nvYOP/IkdaYf4Z/IVb44HvN7JuU44B7AYx+FY19yCfboa0rly68Y3HvWZfsB8oGMDvUrVmktjHnBBBOMZ5zU1unAcEgKuSBzUDrhw3brnParEJMRxGgIzjJPWkxI3rBWlmUwybAcZ9634owrpiRmbOCB1NYOngGZE3YPBx2Y10sWw+WwUc8ZHakwbLSOcIoAUYOQO9WF3RsXMYztGAD1qrCrK0h3BGfOO+D7VsW9pJsR1kOCv3T1+tRZt3JbSIonMaASxs5J3MQcYHoDVfUNgA3RuqdSq88e/wD9atK9hDwq4DiMY+ccc/nVP5oyqmVApUsMx7mI/rVKb2JS6mDcXUQw0UqspIBQNjH4GqNzNHsdwvyA8Ohxj6Yq9qVs/n/aJGLPyVcIoJ/Csl7xd0q3TwqAMmNQAT/n2qoq7NtkJb3hlikmgRggGWLZ5x7Vri6TTtMiur4shlP+rkP3M9K46+vr3U7+Cz0kmJRl3Mbc7V7mmXHn3jj7dcvcMuAGY8D2xV1Kqp6W1N6ND2mreh02n6taXnzrJhyTjPStsTxtbnBJb9cV5psn03W/sUiFCpBZScY712NpfI8a72AI4JWoUnJaoKkFGVkzZBMzKWIwP1q/bl5GG3O0cD2rI8xikZGACea0Yc7Vxu2jqBxWfUiWx0ltcLHEIx82Op9apXNxsjbacGiN3jAG0bT/AA1QuplUEjrXVzOxzKOpXublQhxjzO+R0rn9QbdGcnliavXFwHkCkj1OfSsTVZsSDbwo96L3RolYxrrgEA81lzykZ3kDoBV66YCU4PSsPUSTIhLcbicelS9B7lOe53OzMvGduTXPTttllLHA65zWpdzAqyBsY61zM85LvuI29qmKuNEktwoPByMCqLXg+Vs+3tk1l6heAI2DycgEd6bZpJcFccRjueO1bKIXNKeV590anA6k+lcNXrXg7Q11aQzyIf7PjPXGPOYdvpXktbUepyYvoe3fskDd8R9SH/UJl/8AR0NfXKRFTgjivkv9kAZ+Jepf9giX/wBHQ19fbc9qqUbs5LkQU9sZpRxwKkxg4PFIQQfanYQg/lQvBGckUo6YFOXj2FSA9Qfxp4zgdh6UxTx0P0p/GB+WTVASg468jFSochuarByMKMEVMG2kelAmPVPMyc4pkkPOMg/0px5+vrSkZYg9MdaY07FUrgEOePfvVZ4FIYJwDwa0Gj45A49qVY8J0xipaT3LU7bHPXdj5iBIyAy8A+lUBYCDImBOergV1UkOBleCevvTCgHDKMYxWMqEZO5tGs0rHMyachQNIQcchala2iyHjjCv0yK2ntBKApOPekS2Cj5EBI7E1Kw6vsV7Yx1POCMDP50eRvJ2kIO3tWh5JeXaMAZ7CrSw+Wx+XJPGaqNK+4nUtsZ1tCEOFwxHrVs/u0HYetTBRkkDrTJEBAB5rZRsjJyuzOKGdipZwB6cVZjKhSqdqkdAp3ryMYwKrE8gIrZIyam1ht8xIxwpGazry5eJ4o0haQOcEjonuauMfk+bgnnms68cs3yA7gODUTehEVrqPYk8DBqC7mAQZ+lLAzn5GAO0D5h0NV78AxNnOMdBWLY7a2Me9wlvy2EH8IFcvqt2GAQgkDoe+K2r6RQc7mIFc5f4aYssfz9+eKhm8EY92A54IGOw9KreSCSSmPQ5q67jJUDkd+1RnB3FgMYyBUM2TKgG0nexDema8s+Bm7/hLbsKcZsXH/kSOvV7gYdcjcT2ryr4EjPi67BJH+gvjH/XSOtKHwz+QVX78D3gKRDgD5uprH1PHBIGDwa21ULGwGR2FY2qL+6kx2/SoWjNpamS4w6sOnpU8ZQlA+cAg4HODVeYhWTJPXNWLaTYMgAgDnPSqMzYtJAJVaQEY6kDrW3p1yIm2BHCkbsk459K5aCSZcnfnB4B9DWzazlX4O4txg1LGdFJP8qqoO7JOc9vpWtaoQ0eZC3OVy39KwoJEL4Y7cAHn0zW3Z7GdSSEJxjA/WsmrkvQ6BYDLYmFo8Y529mNVJrNo4QkE/2fePuLz+hp771Ta+5h6qwU5PbFV5CgZGUz7v4izc8dqqXumcNTn72wuQSUneQgfKzgDGevauW1PQ5zbySQQMrryTKwYtXoguI0ZpJPKLHjy3bLdKzbm4TaS5Ea9MDpUweqOnc8y0l20q7S6lcrbOGgm2rhowTng9xxVa0vYI5dqSFx5mQ5+tdT4jRHaOW3MbKeHO3tjriuKNtYrd7YvtCyMfkK4ADdeQeMfStqsFUSNaNR020zq/E377UBcFYTcTIAC7dselQ6ZceYTFNhdv61kW9/cazfgag8IkiUfNsxW7bwxuoVFjyv8Xr71tNX95GUZa2ZuJNm3ChdxJxuHat3TDiPLDnGF5rntPBERAfaoOcmt3T2Y2+WwpHNYJe8VJ+6aiSAY6kgHOfWszUFAGcc9jUizFUJdSSfeqN/ccHaM1tujBaMyLzPmlweFHNYmqT5wB1zzWjdykIzP0xXK3920Zzkk5wB61Pwml7i3EpySep965+/Y43M2fSr91IWjJY4yK5/Ubj5Wbd8vYE1MtRIz9RnEasw5JPSuR1a+2yYB6g8Vo6lfKscjMc84A9K465naaQsTW9KFyKtRQRMr+a/zH5Qc5Nb/h20m17UYbC2yltu+dvUd65hQXIjXv1969s+FuhrY6cbydPnk+7kVdS0UTRbmd5p+nW9lZRWsCgRRptQAV8o19YPcAL6Ac18n0UHe5GMVuX5nuv7Hn/JTNT/AOwPL/6Ohr7EVc4wPoa+Pf2OePibqf8A2B5f/R0FfYm5SARjp1rc4Rkig49ahfA4q0DnqRmmPGCTjk0nqCKwGDxTxgj5uKRlxkNwaQMO9QyiZTz2HpT8Bsn0qHIHSnhu5BppiBBk9Of5VMF+Xjt3pi9fUZqVWBPTigTHKpYnnmnNu+Xg4zgkUkZGCc06Nh93JOaaESj5jxz604qMdKYoC9D1p44oAjZOOwHtUMkYJIUZx1qywVl6kU0IuSeeadh3Kvl46HoPWlMLRjOM7vep1RSGBGcU+QAw7R0/lTSHzFGOEgktxn07VK0AUHbkt156VLEu1tpPH86JcBi4GR6k8UCbKbgAgY5A7CoGUMfm4qw75z7jtVdnO0jI/KpbGiOROoGKpSs0bA469farUj4XGDnuapzESB1yazkzSJDO2ELZ3HNUZnQDcG564zxSXlysC+Wm5ie2aoY7l8qedo7VhKSNEtNTSSdBHwQccGszVZgiyEcgD5R6n0p88scEY24yTxnisfUZi7tg4BPJzzUNkqOpk39wTuzwT1A6CsO6l3I6gnp1q3qUgZ3Rc9OTngn0qggDqUyeT+lSzeJSRHJIycZq0IsY3jI7U+K3ZpDtYgelTfZt7AgHj9azkzVIo3CruOFOOua8f+BP/I33X/Xk/wD6Mjr2+7h2QkgDpnmvD/gVn/hLrvH/AD4v/wCjI61w3wz+RNT4oHvuSAcnjtVC8iJLI3JbvVsFj97giq0z7vvDGOTSkbnPTKCTGcgr296hjkJ+UHBzxir9+v7wvjqcHmsucFZN3OD6HpTZn1L3mvGN6EHn0rTtJssCpxIfT0PWseGTA+XHbnk/pVqKTZtyApz0qRnX2mBhpSS2MjnqK3rS43bQzlTt/hIrkLGUKqKW346KR2+tbdpcOJ0LbFBGAVGePf3pENXOohlCkhDJhgNxA56/SqlzKxfywiKc53FsGqpeRAWW5kkLclVHH0OKdNLNJFugijQFctvPJ9+KUm2EYpaldykKkAwMzOPvNggZ5Oe9QyybpXJTdGBtDYwB9Kltk2DZCVLseXYdPcn+lPEXlBi8qNzyd+CaheR0XSMB7a2RirowVssuOtYV8kVncSyRMoOQyA84/wDr10OuRrdhI4y8coB2seQfrVW+tFm09opIFaTH8P8AMGt4S0CSuYFstu+JrdSk0gxIuPlPuPStlbQ24UxhgrjJH1qhDokhAZpGULwBnH51qQJLAmJpQkI44OWNW5aEJWZo6TBkYJxCjZYN6+la4uA8QMYxznPrWHp0jOxUbVXPC9SPc1oFwE4yAP1qIhJlszF8jAI9TWDqdwyzKFwQfSpjcGI4LYBHJrC1CfZMzs3X7orXoQnZjNVugibRnnrXOSyKz57r3xS6hdNNIUDHbnkisu+uRGhVMYxnrUtgRX14MmJevrXJ6zeKilQ3Q1av7/bG7lwH/lXC6ve+bIyqSQOKcIOTCUlFXZX1K7898Kfl9Ko0UldqVlZHnzm5u7NjwxZG91WGPBI3DNfQNu629rDFGAqooUCvJ/hfbos8ly67tg4Fd9dantRmhILDgoe1cdaXvHo0I8sEadzeI2cOOK+ba9b1fXoUXLN86glsHDCvJK0w99bmGM6Huv7Hhx8TNTP/AFCJf/R0NfYYlBbHBPtXxr+yOSvxH1Ig4/4lMmf+/wBDX1qLh1zkZHaqqVeV2OaMOZXNXcpBBBzUbyhJAo3fNzVBbpzjj8qSW7cJmNA7k8DOKzddWKVJ3NXdkdARUZjRhjpVRZxtHOPUYqQTHglhin7aL3F7Noe0boQQSQaAx6ZxQs3oDg0pZG5cY9wKanHoxOLHI7DGOlS+YBjaePSqskL9YHV+OjcZqtJd+S2LmN4uM7iMr+dDnbcShfY0w/HbFSLIAMgn15rNguElXMUiOp7qc1Mrg4wapTuDjYttdEDOGP0qSO4VlGGx9RVQP+lI8gX7x696fN1DlReMpI/nT0fggfzrPM4RsNuOeOKkDsB7DtTUiXEthmwAh/HFKXXJHUiqrSfKME+wFN3k5/hJ6Gq5ibFwyA8H059aikYkHGMDtUJdWzkknPWmFwM4NJsLDXb8/Sq+4Kx9TTpXXBwetV3kCgEiolJItIGcHcPSs+eYxh2IAX2p91cLEBlgqk85NY9/fxFGAIIPoO1c8qhrGDKs8xP+rXgnJb0pYEAYu7Dbnmsw3yoOM7eT71FJeTSxbVHlDOcnrWSmjVxZPq+oRxA7MHnnjpXMTXTTBlBypPXPFWrhcvgqzE9W96atsrR/MoCg9uKnmKUUjLZXkJXHyDv61LDaM/KqSfXpWulop2koeByRVlbdZAABt560XHcy1gdD6HvUmAiZcgMenvU90ywszHkr268Vn3cyOiO5+YdDjpWdzRIjuFDjqOB+teE/AkkeLrsj/nxf/wBDjr2u4keRcIPl7mvFPgTj/hL7v/rxf/0ZHXThvhn8jOr8UT3ndvjO3PHU1Xky/wAyrhxwferDcjYTwRjcKiKng53EDHSlI3TM29jHkn3/AENYcig7lPDZ5PvXTSKDEcY5PINY9/bHcZYx8w4xjgioT6CkupkRvsk25AIOVJ71fSRZ+G49Pc1nzLuXIAPv/KkSXgZbJ6E0XJOms7lYgMACTr061s213uKMpVWRsnIzn6Vxq3PKHIZhkEZrUs7omPIJzn5s8CmtQO8tZnjiDQhMM3zbRkir989tLEEhjVpFUHrg/jXHWGoShSjybIz6jpW5pl2hRm80l16KBSaZPmDSPuYyEMU+92VagkV5sSCLIYY5bAX3xWmQtxHt8rY23BUtgk+tReWqkBzkngHrgVPKaKaKEpYK+H5HJBbI/Dis9ZGhZ23xkZ+VeeK218kIRuiGeMVXexibeiqCF/ix/KqSuDkZTT3V1GUJt4I2/iZsn64ojt7VEDK8lxcMfvP0x/erSNsm2PyIFQesmDzTQhKjLAqGznsauNNsl1EKUQRL5Y2qvBqC5uhjGSAoyear39w7k+USSO4HasW9nAA85zxzgHrWlrbEXuWru5U5cMFUDqT0rl9R1IzSHyySx4BqHVtT3bo0wM/wj+tZZufKy748z1P8IqXLoUh8shX5VycDk9s1garf4dlVuB94mmarqqKuFYBR0GeprjtSvzscbjl+Rg9qcIXYOSWrHazqQLFUPPtXPk5PNKxLEk9TTa7YRUUcNSo5sKKKUVRmb+i+IpNJsXigTMhOc9qWTxDqtwWKHGeThateDfDDa1dosmVQnrivY7Hwho+mxJE9uJH7lu9c8uW7sjsjz2V3Y+f5heX85kkDSOeM4qjX0fc6Pp9ryltGoHzcKM/SvnCtKcr6GNaNrPue1/smsF+IupE/9AqT/wBHQ19WrMOTjmvk39lZgvxC1DPQ6XIP/IsNfVG8k5VvkxjpzXBi5WnY1oxvEt7y5BHTPQVKdoIK8LjketUo5A2CAc+lTB8DAHTrmubnNWiwsm4dcfWpk24AOSapq3zYPSpFfKvsZfriqUyXEtNyCo6YpwGUAYkY9Oaq5IPLDnsakTJO4sOPSjnFYnKDHzD9cUgUlCFaRR0wfmFAcMRwSBU8TruxjAB6Gtoz7MlmJdacFLPGsYlIwGjzH/8AWqo761ZgOJUmHGUkjzj6Ef4V1q+XyWHBpBCrE/LlevvT5HumNT6NHLtrssUhW5tmAzjcp4J/HFTDxBYkDddLCScAS/Ln25rbk09JflYDBPIaqN54Z0+4IFxbpIRyCwpfvFsO9PqSQ3qSKGjlRwf7rA1bEucZ/PpXJ3fw70SeUv5U8Lk5LQSlDTIvAzW42Wuu6xEozsUzbsfnVKpNdBOnB9TrzMB7AnjFKZAOc49ya4y48P8AiSLAtfEuUwOLi2BIP1pk1l4viX91e6XclR/GhXNHt2uhPsV0kdi04IyCOtR+cgx84rjrePxgV2zJpQY9SjE0pt/FjKQ39lxA9GbdzR7Z9h+xXc6me5TgAjnvms64vyoIyOP1rnJ7HxU5xHLopXsXLA1E+geKpAhe+0dCM5CAnA9qhzk9UUqcVuy7e3AfLc89mNZVzcBVJY4wM4FSSeEtWdv9I1uDZ3KL0pU8HWwy9zq00y8cKcD6isXe+pquVbMzjNGp3uQox61Gbu3LrhzIfROSK3B4b0iBlZYRMT0aeXP6VZSwAdhbmC1CjgIuDipuVoYAaeclYLWTBHUjipFtDvQ3boGTnbux+lbb2kYJLzsS395zj8Kp3mm2jXaPKu9kGUOKTkxWK5yqERskaAdSf6VTluYlUAzgkDIPTFXrhLVGLfKMD7xXPNY1xcQlWcZkHoFqeYpRKtzc24hYNKx3cEjrWdPqKJEFSF5GHTPeluWVjnY+M5xnHFZd3cwxdIQzhcYZqpFqKGape3Ulqyx+XGzcBd2cfWvLfgUobxbeAjI+wv8A+jI67nUNUkQMy+WhHGAK4b4Fc+LrvJwDYv8A+jI678OrQkc9Z+/E92ETBVKv8vcEUxpSjZAP4VJKuIiAcrUEkgVsn07dKiRqg3bs+nXNRTIrg4IBpwRWJO7aSaaQ8ak4BHTIrJlHPatZuj+dFyp+8o7+9ZD5DkjnPFdz5CTJweDzXP6rprRsZIFO7uB3oZJirKY5COmf73Y1cjujkEvyehFU3Ifgj5xxg96jV9u7bkeoPNNMR0lte4I+bDAZytalhqRDhlZlb1XqRXEC5aN9p+X365qwuohfvjB/vDj9Kq4rHpdvrCMP4g4746irSXYZDl/lz90DgfWvN4tWZArI+T3INW4tZK8ykgNz8pJoTRNj0SK5UE7h2wFC8VXluyJuCEGOi/xfWuKh19lLEOMDqATSz687qTvXA64NWmibM6ua4Uks8v0X1/Gqc98ETcGVlHqf5VxlxrUgyFKkd1U81jXurSFyAWXjGOv6U+dBynUan4hJRkBAXOfQmuWu9Vlm3DdjPp2rJluQctKxPPTPJqlcanGiMowgPXPQVLbkVZI1WuI4oi4bc38Rrn9W1YIpJYAdeT1rJ1TVdqnD7m/hAb9cVzM0zysS5JJ7mtqdHm1ZE6iiXL7UDOSQDk9T/SqDMXbLHJplFdUYqOxyTm5bhRRRVEBWho1k97eJGi55qrbQSXEojiUsx9K9U8FeHBZxrNNGC/ctwKyqz5VZbm9GF3zM6/wjpcem6ehZQGPcVqXd0S20EZ5xu5IqpLcKibe1Zl1epgDaCRwCeMVyOVtDqsWJ7l1ZdznvnmvnivaLm+2PkjaSDz1zXi9b4d7nPiOh7J+y1/yUDUf+wXJ/6Nhr6lWQFWBJAA4wK+XP2Vm2fELUD/1C5P8A0bDX1GzjcQwwG6Ed64sZ/FNcP8A23YMd+Rgjrmns7K+EB2gevJqsx25XaFx0xT1ffF6j6c1w3OhovRHnLMcHnFPjkKkdQM9MVnbhwMvjOM1JbymQExSh1BxkdBTUtdCXE0BP8/OAackitnkE9CQappKcBhz7mpImXGdqgscnHrVqV2JxNCJyEG4Y/GpBneSS2M1UR+xAOPWrCZYYzzWsXczaLasSenAqdAQRhuRzg96px/Ngc5HPWrSNnnbya3g7mbROgJHzYBPQZoQfxbm4Hc00ZY8AHpk1IGUAnHNaokaWbad4288HrkVH907iwOeRmllbIGSQB29aryN1Zf8A9VRKVhpE7MMdVzmq7svtz7VWkkYqfmWoDc7lGMnHWsJVi1Bk8iKQSoP4VC8QcZaRxkcAnmqck+0sVJHGM+tRLcNt+YnI43E1zuaZqoMsmB1bPmfL7imSRyADaVbnnPFMkusJ8xyR6VALtyCNoIzwPapclsUoslaGTOMLtPpVaW3lGQFUk+1JdS+bG8JLhXGMocED2rKutLiuLa2glursJA4dWWTDMfc9xUc6LjHuXSlyJmGIVUY2460/ErSMpCE45weaVnQhlYkqwIPrimxPFCFEQwoAGG6gUJobuVr9ZSSxCDpgnmqtyJvKY+Z8zDr6VdnuotjE8jNZV1fBF4OFPFDaBJlG88/yJBhXwPu45asa485ImCtCMgFVx0q5fXOR8rnBHXNYd1chs7shT2xTizRIpXEkg3s86qoOOBnIrCuXXzWYSMex9qsXs5aMgkHvg1jXD7vM38dMAdq6aaCWhm6oVePdudgOxNY3wJOPF15nvYuP/IkdaF6wdX4rL+CJx4ruz6WTn/yJHXoUvgZw1P4kT3ZSXGMEY45pjqu0BjxnAHpTEuCDlQCGHPtUitvQHHOeKyZuRPvQnaMg96WN9rEsOp6//Wp21iBnAPemhWV+cY6HFZtDTJ1RGOVYpzzSTo4OJFDIfxFNU7SvXHX8avRspPz9RzUgcvqmjxzgvEQrrxxXO3VtLbt+/Q/7616VLbRSn5RsdRmsu6shKjh13bTzRYR560nOzPydj61C+OSQCa6W+0Qbi9vlDmsa6tLiE/PESv8AeAp3CxlSNIOY2BB7dDUBvJY+hKn2NaDpuYYAyPWq1xbuwyFX+VUiWVm1V0I4bJ71BLqjSE5XHp2ouYJ1O4ImOoBOay7k3a5byQO+atRQi3JqPyttd1x1Y9/pWbcatcf8s0cenIAFUZTOwy0Tgd/aqNxcS7SCj4xgGtIwEXZdRZRhncHHVWzj86ybq535ClwD1yetV3dj1BqIhiehreNNLUwnU6IGbcc0yniNzwFP5VPFY3MpwkEhz7VrdIw5ZS6FWitm18O6hcdItv1rc0/wVI5BuHbGe3AqHViupcaE2cWAScCtTTNEu75xhCidyRXoVh4VtbUBvKyc5JxmtmG1hhjOxcsTt47VjLEfym0cOlrIxPDXh+GyUFhl+57k11qzCKNVA2kdcdM1lNMUcFSc+ntVFryUyAt83U+1c/M3qdFjXuLksD87E55A4rKnny5OeAc9ar3N5kE/xdPpWTe3pWMkngDnnt2oSuBNfXqD/exkk+9ebVr6vqLzSmNGOwD9ayK7KMOVHHXkm7Loey/ssAH4gajkcf2XJ/6Nhr6jZBGSUYnuQa+FvBmv674c1SW78LzSQ3rwmJ2jgWUmMspIwykdVXnFdoPij8UWORfXh/7hkX/xusq2CqVpc8Vp8xU8RGmuVn1kx3kCQD1BxzmgoCRtJ2jrg18oD4kfFZiGFxfnHcaVF/8AGqRviR8VFBZri/UDqTpUQ/8AaVYPK67/AKZr9cpn1exXKkfh709EOQcZDH+HtXyTH8TPihncl5eHHGRpkR/9p1KnxO+Kqrhbu+x/2C4v/jVZ/UJrdov6zHomfW0MSZIY8dMVaRVXvn0zXyAPiX8V8jF1f/8Agqi/+NU//hZvxaAP+lagM/8AUKi/+NULBSXVEuun0Z9iojSbTgDHepxCjKNwbJ6818ZD4mfFsYAvNU+n9mR//G6k/wCFm/F7/n71X/wVx/8AxutVhWt2iHV8mfakaqDjHbrinKhHpk9Sa+K/+FofGE/8vmq/+CuP/wCNU4fFD4xZz9s1b/wVR/8AxqtVR80Tz+R9rhdvB/Omuw3fKcZ4ya+Kj8UPjHzm81bn/qFR/wDxqkPxN+MLrg3WrEdf+QVH/wDGqHSfdC5/I+0WcbsDnaMZqBjhsZ+X1r41PxL+MTcm51Y/9wqP/wCNU3/hZPxgJ/4+NW/8FUf/AMaqJYeUuqKU0uh9fXDI0hHI29aou7KzMPu+tfJzfEb4vn70+rf+CqP/AONUw/EH4uMP9bqxH/YKT/41XPLAzf2kaKul0Z9VzPkfe+ppm4MANxBz3r5VHjz4tf39W/8ABUn/AMbpD47+LJGS+rY9f7KT/wCN1H9n1P5kX9Zj2Z9Vg4DDIZvWmKTvAThO+RXywfHvxaJ5fVs/9gpP/jdKvj34uN0fVj9NKT/41R/Z0/5kH1mPZn1Wyg4dfofWq0hCL85zjPHpXy0PH3xY5Ak1X/wVp/8AG6YfHnxULHMuqE/9gxP/AI3S/s6p/MgWJj2Z9PeYAoEeTzyTVWeZiwK5r5pXxt8Uzna2qH/uGJ/8bpreNPijyC2qcdf+JYn/AMbpLLan8yK+tR7M+hbi7cOEX5gc546VlXMzFhuyR2BNeE/8Jf8AEv72dS+v9mr/APG6ik8U/EZjlxqXT/oHKP8A2nTWXT/mRX1uPZntszK77skqO1ULlgBuHODgZ6ivHj4n+IagEjUQO2dPX/4iopPEvj4/fF/zzzYKP/ZKtYCa6oPrkOzPQ71UVmfnf0x7VizSsxYZIT09a5Ftc8cuRujvyT/04Dn/AMcqsdS8YbiphvsnqPsQ/wDiK6IYaS3aJliovozoNRkCxkHg54zxVH4KsV8U3ZHU2Tgf9/I6yprrxZMMS2t6wx/z5D/4mqfg0eITqcv/AAiVpeXV95J3paWpuGEe5ckrtOBnbzjuPWumNNqLVzllUTmpWPo1WG3gYJ6VYCHgJwT05rx3PxaX/mC+IR/3BW/+N05ZPi4v3dG8RAf9gU//ABusvYvujb6xHsz2GNic4UkepqZMFcZ59uorxfz/AItKSf7I8QDP/UGP/wAboFx8WsnGkeIOev8AxJj/APG6XsH3Qvbx7M9nZTsJU5x1NJudRyc+ntXjJu/i1g50nxBjv/xJj/8AG6Q3nxY4zpWv+3/EnP8A8bpPDvuh/WI9me1RylQSCfrmphNljk/Ma8P+2/FhRj+y9eAPH/IG/wDtdAvfiyBgaXr2P+wN/wDa6n6tLuh/WI9me1SQGZGKLg5wAay5YkOVlU7unSvKxqPxaUYGm6+B/wBgf/7XTW1D4sHIbTNcP10b/wC1U/q0u6D6xHszv77S0flUDZ6ZFZ1xpDDlQcdSBziuKFx8UecaXrvPXGkH/wCN0jTfFAj5tK1zn10g/wDxul9Wl3QfWI9mdYdNkBb5Rn0NQtYyMcCJD+tcqX+JmDnStc5/6hJ/+N1GR8SDn/iU630wf+JUf/jdP6vPuhe3j2Z07ab5hI8lfckU19AjfloowOlc35fxK6/2PrnPf+ym5/8AIdA/4WSOf7J1v8dKP/xumqE+6D28ezOjXwvATjykz/u5qeDwvZgZaJQ3bIrl/O+JSqc6XrQX/sFHH/oumG5+JHfTtZ4/6hf/ANrp+xl3QvrEezOzTw9aoQViQ9sY71ZTRoYyV2L+FcAJ/iITxp+sZHHGmH/4ig3fxEHWw1cf9wz/AOwpexfdD+sR7M9GFpBEpAxkD/Jpo2DgDO0de1ebtd+P/wCKx1XPTnTf/sKja78dHhrPU+OP+Qf/APYUexfdC+sR7M9DuHCoSp2r6CqDy8qOBnk4rhGl8aAfNZ6mB72J/wDiagaXxaOWtdQH1sz/APE0ewfdD+sR7M7e4uVztz17Zqk0wJydvJ6Vx7zeJc5e3vemObXH/stV3uNcBw8VyD6G3/8ArVSoPuhOuuzOivrwKHbcF2g4z9K5bUNRMyGOP7uevrStaaxfMB9kvZiOAFgY/oBViPwh4lkGY/D2sOPVbKU/+y1rCEY7sznWbVooxCc8mm1sX/hnXtPtXur/AETVLW2jxvmntJERckAZJGByQPxrHrZNPY535nU/DwZ1i4/69j/6Gle8eBPhv4o8S6FDrelpon2KeSVI1ub2WOT93K0ZJCwsBkoT1PBrwf4ec6xc9v8ARj/6GlfTYh1WX9k+NNEW5eQXk7T/AGUEy+QuoSlyuOcgDJx2zXrRxFShhIum7XbON041Kz5l0LEXwm8apkGLw2Qe39pT8f8AktXn+tySLBcQ3kMUN3a3M9pL5UhdN8UrxnaxVSQSmeQOtfR/w9bwC93K/gD+yg7WyGYaUMR7M/L5gT5BJ1+98+Pavl7xPI9z408QWoJEUes6gzf+BctGGzCpeUqstEvLfQqeHi7Rgt2OtI1SFEUZIGT9auRJngjAzk0y0j2Dcfy9qnDbiT1r56TuezEnRU4weRTwjA8sDnpTIV43AYzVqMIFy2cnoayZaFClXB71IpZz8oG0dzSgHgjn2qcq7AKoVT1pAOEeQCwwKmhjGct0qOJti4d8kdqem9lDEY54Bp2Ad5abs5+WpfKVgCp4PWiQqnzSctj5QKc+4RxuqjJ42+nvQIjdCvB4HYVIykoPmAUdjRKpJ3DJz37Co5EJyAxz0z70AO4k+R8Beu6nt5aKpBwuce9JBGQwxhiPWnshlLLGBhj0P9KAFJUKSNtV0DFycfKO3rUolQqAoEa5wC3ep4ivAR1aRuvHAo3DYhdWwpwB0IPqKjIeNmZZAuelStGVJUsGwCPlpnJgUunPfd1FICKQBlLGMb8dRUWzciSxRqVU8gdTVtZdqhCHJY4+QZqwI1hgOwKCPvbu1MRTlJMbsHCDoqqO9QLAfNAcMSeuB1q88fSRMMp549amLpOgKsysccnimmBlmDy43VSiqDxxk/lVbhZGOVYgZOR1q/JEFmBXc75+Ur3FQXHmLGz2y5lPVCM5oAztSty0arG3zEZC+n41AU2wJujDEDqwrXgM6pvaMRyE4KvzUd1bud23grgunqPagDJZQQDIFQDkMOoqgY1aVskueoato2mY2LS9uOP0xUFwESFJCAGbt60xGG8SsWwzAHjJ6VB+x4xX4l6njGTpEo/8jwVpzIZOJANr/wB3pWZ+x4u74maoMj/kES9f+u0FaQ+GRjV3ifS+maj4p1u3uLnStD0Q2aXlzaxvc6xLHI3kzvCWKrbMFyYycBjwRVkQeOR00bw3t9P7bn/+RK84+KYx+zD4pz1/tm8/9PL1q+ABp/8AwuCE/Dv7P/wjH9jj+1/7Ox9hNzn93jb8nm467ecZz3rZUoNbGLqSR2nhvVZdZ0tri8s4rS6jurmzkihmMqBoZ3iYq5VSQTGSMqOtaDZHHYcA/wBKwfBOTpt+CMj+2dV59P8AiYXFbsgdX+UEqfauSWkmjdapCE7jll+Y9sU1owWxgZ64pCNrg78VIGVAC5JJ70r9x2KtzCRkjt7U1dxxxgdDmrzsDgYw3T61A7ldwIUc9u9VcVysQFBABGPSoXIyD1PrTppcZIyPaqzSZ4H0PtS5h2GyMpbcG5FUtWu2tbF54ozPKg3KifxfWpyAC/ylieDTZtktu0AX7wwR7UKRSSuc5pPi2zvpVhu43s7hjjbLwufQGt0H5sNwM54PSuOufBLytcIJyYH+dC/LA9ga2fDFpPplmttd3BmZW4J5x7D2oUm17yLnGG8Ga/mEOQGx2BPSlOQ2NueOtOMKTfMR04yKayhAI3O5fU9ah6GW5FOA+QenRhWXeZh4bOB3B7etarHaCxGR71mXsqu+1yBkcBh19qlslozhMXYkHJ45A602Uhl3ICCOvFMuGURHysKFPQ9RTUnV0HJ5FSBXuCZFYFsEfd96zZgcH7wbvWhcGOQgKcOp4xVe8XADH8aLiRk3GcEg/KD1rLuskbg34GtSUBpMKfl7+lZtyFKkAHK8GmijDu48bs559q5/U1+UOOo4rqrsKfm5x0xXPXkYZHUDrzn2rWDKRS067MEgKHByDmvYfBWufaIEQsScAda8QwVcE84NdT4U1M29yoB4NOrG6uios9B+Ns/mfC7Wxkc+T/6Pjr5Rr6W+Kl2Ln4Xauc5OIfx/fR1801thPgfqc9f4jrfhqivrs6scD7Oen++lfSvw4+IureFvC1volv4fsb2K3luJFuH1N4SwkmeUZQQNgjfjqelfN/wsj8zxDMB2tif/AB9K9wtQvlgKNrZPHYmvpsLQhXwyU+jZ5VWbhVbR3158ctWtIHll8KadtX01l8n6f6NXi0EkmoanqmqzwpBJqN9cXhiV94jEkrPt3YGcbsZwPpVjxNOZrhbSMcAjf7UyJeFRF4AxXm5lTp0JKnT36/od2CcppzkW49zucH/9VXUAU5IGTUEaokYZiM9DT4k3OTnljjntXkM9FFhAd2Rz6CrUa7hmRcHsPWorVVUbhyV4GfWrEL9C33x1rMoniwdzIMKo5zTY1y/Ulj1z2oUGSNjnnqPQU0eaSuCoA6n1FAixEqByAFGfWpiMHO4EjpVBYYp3bMjeoIOBmrESM3COGIGSaBkyOfOBdd6noMVJKzq21X+bH3fao4fMGDkcHp3qTbyHICvnjPXFJsCxbK7wkKQqg5yahiG3eNoUA/efv9KkudpaNEcKTgHnpSyqobzndEjjOCX/AJ1Si2TchjdllL5KgnB3DrVtUUyll+QHqrDpVGa+s2iP2SSa7C8yOFwin0z3p7zXX9lyTRxs0kuEjD/Px7Y4B+taRpt6oTGXJQOY0TzBu4y3IHtWiunzzJssoJXOeMDke1VvDFtFHd3D6srhwny7xjB9a6Hw/e3FhcyOLkR2mMruHJP1NV7JkynbYwvJntyC8TowzkN1FHmNcDE4O/jDYwK7nRbiLVEuLnUo2DByFVsYC+tYF/Jo10bho7gIVOwDIAY+30rP2UgVS72MmBjKwEA+cDGPU0zzl2ssgBkJ5HrVHSruz/tWe1uLi3IjBOUJBOPY1ZjtJLpzLueGP7yBhy/+fWqdFoakmWJpo7eMfIXJBDD0qvOGMKSsoK4/L8KrBJFfMowwJAkU8f8A66kEv7rZGd7dSG6j3JrJl8pNbT4dUVQ8ZGWxxioEt5JZhhjGknQY6/jSLCyHMkmFPIxxkVOYyw2FlTbyNxxSTBopOZpS9q/zYydo6g+xoCwR+TGzS+aDywGT9KlZv3ixsPnBOWHWnQwvLKWiiZtoywHGPcmnzA0Z1wrBpN8yS5JC7RhuveqjiUBlZUkP8vateRZLdyUUOzZUqvXn0rOkSSK73XG3fgA7eox60XBIzrqLy2jjjBQAZc9SfasH9j44+Jepkf8AQIk/H99BXV7o2mmWOQFivJIzz61y37Hf/JTNU/7A8v8A6OgrWLvCRhV0lE+mNA/4S3w/Z3Vla6PoN5bG/vLqOaTV5YXKz3MkwDILZgCBIAcMelX317xkgyfDfh/8Ndm/+Q62mUlQVOD3pzY7jms/rE7WI9nE5jwlYXenaTIuqLbx3k15eXciW8rSInnXMkwUMyqTgSAZ2jp0raWQOmRnb03U6dGVgwIB75pnktsLDAHtWfM27mllYglKnaSMgGkbGexHakkLIp3DA+n61CHVtzH5W6UirFkMGHI6dDVS7zhiv5Zp6yb+AOnXioJZQQ3PA4OTV9BJakEjBE3AZ9T7VUz5hbaChHTIomvbIHyzOmTxgnvVWXU7WIZ89c9CB1zU83maKD7FwBiTvHI79zUMqsvzKCD6ZrA1PxA0EjrDh0PRyMCsd/E93G/yiMBeCp44qHVitDWOHm9Tt4d/PzZz1FMePcwO0Bh1NcZF4qlSTLIpzz7gUy68V3TOhgKrH3JGcmj20bai+rzuduj7F2549f61DcOQu5uq9DmuRtvFgMgW5TCkgeYnb6iulSeOaFGSQMhOQw/ioUuZWRnKm4vUej4y2cr1qpfBZAdoOVOc4qwQsiEj7o7elV2JMLE5PBGB0+tFmtCGjGuVKZDgHI6iqsSOylAxGT1xzVyQjcVU5b0qpudZRKv4j1oIIyrBjG2Cy98VXucLgZJU5HSrmQ7bx8ynoelVZcANxxRuLYy5lKhxjH9Ky7+MqpcA4HBzWvN8zMT93GKz5W+Uq3X07GhFGLcKoYEHgjisS9ysnsK3rpFwwbJYdO1Yt/yMhfrWkRnP3Q2zNx8uadZTiOQE5AFJqI+YEfj3qtGRg4zjOR7V0WugWjOq8XX5n+HGqR7hkrFxnk/vUrxSvQ9euv8AimL+Echgnb/poprzytMPHli15mNf4jvPg0N3imcE8G0bP/faV7NNILeylkPUdB+PUV438GlLeJ7oBc/6G2fYb05r0rxfdEW6wRPknCjHWvp8vko4fmlsrnk4hN1LIxkmNxdyySH754NalrGFH3uaz7K3U7S5wqj860ECsmzIHPBr5vEVXWqOb6ntUaahFRXQktx5r7ccA1egGJAcbgD+dQQxqhCHOW4NWA2xTjop4rlepsWAcOXOAvoKliLSMNy7Q354rHa9eSQxWqbwrcsa2owYkDOpJAxzUvQoRwWyFyBnjB7U9o9ioIg3zH5snoKiRi8g2AYPUZwcVPbt+8kVk35PSouOwrozkDaF2n161OiuFYx7WiHGV459KdH8pBIAyODRcXkFnGA5VVUcA9GPqaa1EyVo2KDDGNieSehptxJHEoZz07g9azLy7aSATSnamdsOD/rD9PSui0rSLwacj6lblhKhxsj3OD2Cr/U1pGm3qJsp3Yt7K0junuYnuMZjgDcj3an28Wn6xamW5nkl2EDyE4Bf09xVjT/CyWln/aGpgWzlsiOXDSSf7IrKuHh1W7A0mK4gt0yCIkwzP3LN6fStowitxJSfwsdFfy6arMNNtp1EmyO0kbETN2Jx1/lV7QjdatqN0ut3UVrA6/6i0wRDj0PQVk6To2pS38p1LVmuIkjO6KFPlx/dB7fhW5p+mW2rab9m0608mONsFXY5lx6+1aOaWolSlqdDeta3Nox0OdHWGHarsQxJ/wBpj2+lcRNoyuqtNrhaVJdyKspbee6gDjArrp9PfSdOlE0Vu1y4HlwJwfpt9KwbfS7u9llefS4kkRGkJztKj2FTGab2L9jZX5i7GYrywXS5Gls2T55G8zcJG7ZP932qtHDDcMsVpEuI/wB2ZfLxtbuyr0IrIsvDGsrPbRWekzizb52nZiWkJ9j2HpXU6b4SvW1RbWG4EFtb4KkyYZm9PxrRa7kO0b2Kun+F9DeVJ9Zkhkukk3LcO5DE+hArpJLS0vW2W6ObiM5Mm4lCvYVzqaBqqazOzoJ08zcsO0sFH91Setaeqx3iXs13ZRy28IABtk+YoQOcnoBWU02CiriXtreJKbZrJJt43GVNoVfai38P2jbhuRZZBhmL5APtWTP4j0QmOG1YXV8h+cSS4Ge+Sf5Voab4p060nnl1K5sbeEx5hiRixc+nHvWHJbU0cZW0M7U7CSANC7+YXPygKAQPpUFvDKVJZlAPTzDgN7A1fl1OLU5Y3+wiGP73mIOT+ZpJbOPzHFtOZrdV3Mr8FD7eprKSa1HZpalG5kCQjcH8zOAR/CfY96gGXDSxTOGXgDb8rfhUvmISAHZ2GdwXsfpTlePYFhUoW5JxWfMHKQFW2lJV+ZeVIGMfnVUxuA7kq7er9x6GrU0RaQHDFunzHgj+lQTKqIWYnk4I7Yo5mFirNGsan7RHtG3qo65rjP2Ohn4m6kAM/wDEol/9HQ12t0GlUFnbyR0APb6VxX7HRx8TdTOf+YRL/wCjoK3pO8JHPXWsT7AfKxlU5ApsThoz1IpzsASB0qMbQpUADn161zp6h0CVBkkc0mcKCTznGKe7IoxnnFQNN6ckjpiruK1yK6ky2O4457isy8u4LJA9ydkZPyn+lXby6hWF5JiM4rzLxVq63U42E7UG0ZqJ1OVXOihR535G7qHicI223Teo5B6EVz+p6/duyyxybRj9K5v7d85Mnyq3HHU/WpzOHhRSQAex6iud1Jvqd6oxhsiSWfcC5x83zYz/AFqBroKRkncOVI6GqF4yxMFBDnsoqo03lM4I3AdGzx9KXKaJo1rm5M8YBdduMqe4FZk0zCICQPkHHrS212HYZRQ45xjpVe6ucs+W+82MdhTS6EsbHKJX2M+OynPapDcKp5bJGeBVISKfuFdwGCD6U9HjAxkEn161VibjmnXzeQxyRxnpWtYancWykQS/KP4O35Vzk7kP1AKH5c9av2435wQOOcVTViWrncaV4ihunVH/AHcuOQTgGtiW5DIz2zDaTg9wa8xcCOJgwOT0PerWiahPasxD7lxymavm0OWdFbo7kqJvmiA3DkZGPwqpIG5JGSe4HSodN1SKdHAbD5+6e1TSOGYKG2hs/MBT3RyNNMgUbE2r8xOcDpUExLRMI+MZHNE4x905wc+9RsT0BG3H3TQgZmTB1Gw5C+o/rWfcOGTcuRitORmWE5PQkZ9KzZzsXHUnoPWqQIzJHJjY5496yLo5Ug/lWxOgZiF44zise7wpbJ4HvVxKMK95UjByOlUB14PWtG65VyM5HfNZaE9O5roiSytrr/8AElul56L/AOhCuLrr9eOdLn9cLn/voVyFb09jCrud98G3VPEl9uJGbFxkdv3kdddey/atUYDlYiRx61wXw0uDa6tfyA4P2NgPf50ruLRAqCRurHca9Kdf2eDVNbyb+456VPmr8z6Gigwdq9K0Iol2qxwfp61RiZRg/MB/OpYpAX+zoTvHzV40j04ovZbgbwG6DHWrX2dWjIYk+nuarRKo5f7386mZmAGWwVGcelZNlE9siQk8Yde2OnvUiyltznJycYFVo2kkQ+WDkjknoatKGDLlgMdVUcmpbuUiVERdj9FPBJ61ajKlflOw9CfWqYCfPLI2GbopqOe4t4YwJmZjuBAUcH1/KiMXJ2BuyuXJJWMYCwktg5JP3R7VlXsAvQ8cP7wbRslP3R659xVn7C99pbSQ3ZiMrDyiqnPXGM/Snabq8Ph+Sa0ghhkeBGBS4G4u/wDeB712wpKmry3MHNy0ibWm6RZNJbSzI17NaRFwX+VAQO9dR4PnvruzOpyXCRQPlBPI33T3wO2KpaLqEN54fUavE9xf5WQW9mnIB6BgK6jUdDur60tYjpssWmOQ32WMYAOOrelNt9irLZs5y58OW2oWxkjvxdzrNukvJZCdq5ziMDgH1rqbSaH+zJ7S2ijVwg2lE2sT/XNc9q2kahZaXJ/ZQQLE2TGV2qnPRfU1oeHZ71XDXcUUFuq/61z80n+HPas23v0N+RcujuXkgtNNswWtWY43NF3apdHtbu4gnbTbJbOJxkSSDJA9Qas6dcxrN5wYXEmSFJ4yfQZ7Umry3UNzE2q3kQOMxwQ9Wz/DxU7ibbfL1/roPttEVFSa9vDcFCC78DYe3ufpUKQ2LXIZrcZLkrMfl3EnvTtNhhmuZbiCGVRu5hlP3vr6UzVrfEguCUluQflUEhYx/KnsTduVmzYu5Ifs62YnLu38KZO0DtntUlrbWUCGK2Usz8EhTkHuc1iaLDKbwXHmHfyFGMge9aty84DBbqeBCcBUUfN+Pai5lKFvdTLot0RdhhebtuJwSfauV8W6CmoWM5Se/spG42xuNrH3qd4p5Z2QPOydyW6Hvis681TXm/0bRbJXSJc/vm7eoz1NMpU3HVM8xtvBtj9saOQCWaTO9nlwc+4qa10qHTJLiR9Liuk3bY7jeFVPZQRyRXodto97fmHU76NYLyJf9STtY88t6YqjrM8Ol27f6Ct4xmJikkGUGeavmQrt6bmHoV+oVJhJM6b+IDCDtx357VrXlw1xY3CTLFb5y6uvBJ7fnVSxm0rWLnyAcXiAOBFuiCE/56Vt+ICkFmkN1BGZ1wyMvf8AGsazsmUpJtKxyVqiH5kUmQj5s8fUmkWASSNhwiDJZj6+1OaNiJGbgdcKckZ9aRBIsis+0JjCqR2rhNiuZA85EiyAY+WRWxz7iorhWjO52DbgcY6flVmYMZfnO8Y+7jv60xU8pHw6sD/30TRcCm6gpl9wQjIIPP41wv7HeP8AhZmqZGf+JPL/AOj4K7+OOSLfJI8bnP8ACuMD09zXn37HzFfiZqRGD/xKJf8A0dDXRS+CZzV/iifX8saksdxAHPWgD9390HA705wGznkjmnu6qgGKxQmyjIwMpwBjHPPWngRiDc38I4qC4BDkx/hgVzXi3UZI7dLeJtjE/Mw6UOXKrs0hTdRpIq+LdUgktJIrchs/p6151dEllxISx4z6VsTsVjbJZy3OccVi3cbcHA+UZZfb1Fckpc7uz1acFTXKjMaGQlmGSoPpUEgMLKxJYA8c8CrrwuqKS3yE8c9BVW7Y4bJBXGMY/lQje1ySS6Vo03Kq/N948k1nzzpC23jyz074prSFVwi/J3z2qpdXAfKkDkHt0rWKM5QXQf8AagzYXhScDmmXMoz5YcNz2HWqKgA43NuPQY6+3/16WcSRIHbDA9D3rXlVzFxLkcY27h2zk9cU2YukYbcu3261VSbashO5n4ACdSD6UI/zKpbk9Nw/mKdjOSaZZcDcrFtwxk8dqtWoKh2XJUDv0NUkUqcbhkHp/wDXoE2YtoGdvO7B4pNXJ5mjUndmDH1xUEMzRtkdOgIpnW3XLHoDnPSoA+MDOT2560JC5ro0Fmb7QskTkAc5Fb2m6pFMBDKcS4yuTwfpXM20iYZSR7U2Unzg6H5+o9jQjKpFSR3DMXjPqehqlIXQjnbn07etVtOvxPaK4/1qnawqeWRXVwM+w9adjmasVw3DowGCceuaoSBSCGYhkPSrZBBZvzFZl0AZwU79c9qEG5XlOJC2Qf6VkXhAZ9uK1Jfv4z2zWRd4ZjzitIiMe5B5HUmsl1O88Y9K2LjIkwpHFZMpJl4xgH0roiJmdrgxpc4PB+X/ANCFclXWa5/yDZ84J45z/tCuTrop7HPU3Ok8CnGqXAxndbkf+PrXo8CE4DZx2rznwGCdXmx18g/+hLXpNuSRkEDb60VJaJMuitC/EPkG7GR29KnWEp84XB/iaobeMtICf4ufwq8GCIR94Hr7VyyOpCvtWQgqVGOp/nQ0rMFZFUIThs0yNdysZCeenPSrIAwjNyM9h0rNsolZSvSQ4PYdhTwyrtADqB1/2qYA/mHcvVeCOalt4syxl5MgA7ieai5VguDhg3lPuI4Gc5ptnbX93PJaLstyUP7xuhHfI7f1q5aJ58iB5CImJIbGKtG7aJJJ7ZAZB+7BPNa0J2kTON1YoLpISK+8qW9uIoyFQytsL9AcAdAT+OK3tP022sJ0uNVtJr24iXMUTDESMekYHVqr6TdaBYXlu93q2Zt3m7IDuIY/0Hauh1Dx1p0d5B51qLQTNssmH7y5lfpuA7Cuxy1I5Wki5oemx6TIszTf2ZFeKZ9ityW/U57c1lRal4i1bxDavJc6hY6PBId3lvnzB6EdTV/QE1LRL2axt7K3vNQvP3ha5fzpoW7F1H3R7VY8BQ6yJtQj1iUG4aUyv8wJBB/h7Ae1TLbUcHrJ2VjprzSbiSOJ/tgls0JLqWJKj1psa6RFAFgU3SjgSM3Kv64ptvpDX873F5fyyxYIMaS8L/vHoT7VpafptpYQSJDAGkccPuxx6VmiudJWb+7QzpQ5eOG1iDcbiFzyT/e9qSIQedKZbdZwn3ZJAfkI/u1cu45ZQmCIlU4/dDAx9adDaNMojTMC9SWHBx7+lUl3HzKxFaXLYeZ43MsuduB97/ClhguZX8nymkh6kMcKv19amnY2Onki6jQOdzhOcL6VJpNyt0EDS+YI8sAqHOO2e1JkN6OSRoQxI0iyGRQAMZiHGPT3olRVuWYwF4cZDHn9Kl09y0mz5Yl3blG3p71bnEdvGxTczNySWz+lNbXOZys7HM+LtUutK083NotsxbAWMrzjucVgaR4hvNQ04SreRRRhwsicF/ouOfxrp1kg1FJEu9PMUinak4+YMDXM6lHBo2vIy2a2ccKZaSMZ357bqV3c3UY25XuvQ63VbqS10dZLVFuEz83lxbiMjqwPIrA1GyfUdMSe5W3hnjO4BUyGHbPoK6TRJ2mslnjuoZZWBO4IQ23/AHa5jxLqUg1AwtMYLKQgBkVWMpI4XHUDrk0GMd7HEX/9sJdYmudLeZX3OLOEJgDsWPUjNb1hqK6lZNDcTxyjJwz5w7f3QfUVkaxfwmONrSW3Dbim+aQQ54HDr1JPQV0WmRCx8OGG3ezheRvMMcIznj36VFRJI2b02OUUErIscSgBtu4Dn6GmujnAMrKgG1WAyf8A9VX2jO1JmdmuM9jw4+lRS7cbrhkVO20Y2t+HauE2uVXj2BgkgkbALfJgA/WqwT5iscauyDLgjgZ6c1akxt/1sZTqTg/MB2+tJuCwb1YKwYjGME/jRYLmc+WEkJk2qfvHuPpXm/7IjFfiRqeO+kyD/wAjQ16bdRt5TFVK8Y3Ic8+5rzb9j4A/EzUgTgf2RL/6Ohroo/BIwrfFE+uY5CrFWHyk1ZALYzwvaoHDAjAyopzyhF3Ena3b0rnQ3rsVdTk8iAyM52qD09a811nUpbu6YP8AuwoyvGQT610fibWvODW8a5GeWrgLqX9++7eWPKjPFY1Z3dkejhaPKuaW4SuiMxZ8q68sOi/hUc2ZE27/AJRzwMbh70+V4WgcHcHxkYHes3MvPLA46HuKzR1WuyrOh80Rs2c8jJ61WlctuJC4A2471bkbzCybQHHOR1qg8W9gWO1wM89KaNEU7rzfJOzOR0x2rHdvkO5QSO/t3rfVyz+XgAnPOeKrXNkQgcqNp+8MVrGVhtGUmWJycFenFWJ4y0W/zPnPP5VbCRRZAOMjgelZ9yQWVQx29elXe7OeWjHWYDmZ2Cuw+bg7eaqyPIbtyYg0svOE4BPsP1oLbHwMqp9+tDOGMID7XRc7s9D2rRLUzcbu4kVw+4Ku1sHIOOQfSlS6YzyhmKhhhgvQ+gxSQqBEy7RkHtzTYo99yFXC5YDP44zVWRNrmjGWMZJHC8jFQPIsjOoUqxxyeAKSTdFvj3EbHZcH09TVYqXJH3QD0HNJIzlHsXlKxuS3XGDg5welEcoy4yAAOfoaqzGFShx/COPenxmN+OCcetFjFsvQXH2dhKp/d7hn3FdPFLHNbRSwAnPXFcTG5Y/NnKjmuj8PXANuYe6n17Gk0Z1FpctTKFYxqxUkg81UuEBG4AEjgir12A+c4DDvVCaQLkdCR2NJGKM67ADIV4NZF0w+YgVqTPlOmD0rFu929l6D0rWI7GdP98Hp61kz8SMT+laswzIAQNtZVyf3xweR3reJLM3XVH9mTHgNheP+BCuTrq9bP/Esnz7fj8wrlK6Kexz1Nzqfh4ca1P8A9e7f+hLXowyQoxjPJrzf4f8A/IYnIOCLcn/x9a9JiO47icCoqG1HY0Vfa2QCcDpUuWlGEIUN1xVSLzFlBDgcdKlTGNoJBc9R3rmkdKLo+eJQBygyeetPXeHjQk47mmxMixsHzuPAJ6GnwxSFjtkBPRfSs2yki0gWMMWkG88AdwKmCL5ZiVhluSwPT2qvIpAVX+83VqkhjMg/dsQVGAOmKzbLSJJbpkBt7Py3uDxtd8K49M9qoXNlfXVzuvpALFQFKrxvY/wgdx71YtdNEciKNxIYs2eNxNdULU6NptvIGF3qU4IQMPlh9CBXTTlBRuhcupQ03S9E0/Q4xtFncKzSzyquWKj7qD0rN16C3Glw3OhxH7TK/wAkpwHHrtJ5H4Vbv9J1TUI4o5ZRI0jq0hgT5UGe9bupWEOjWg1eOYSW8LJDsJwbcf31HcZ710Rk21cmUUk9b3F8JaLqum2h1SWS+nglmWHyoF2zSkjgluu0HqTXQ+G3u7PxXd2bXCXghBkdo4CwLHqhJ9PWtKLxALrSreSFZhNMu/zB8oRR/s+9aWkWrWNq8l0xt47twxcD5yO+D70+a92kZpSjH3n5WJ7y5jhMH2G0tw2com84JPU46ZFW4o/tB1GKWaR7jYCuBhYwBnaKlt3tt8MccEFyIn3hs4ES/wBTU2oWbPeNLBNutJAfNRAM5x13dh9KhRZlKaWhlaXDI0OIEnkj+8yMdseO3PWtWCC4MKItzFux8xYZUZ7CofD+mS6bZzSahqFzdrkkhlwoHYAUJr9pqF9JpljL5Uqx78mM7MezdKHJLcJNyb5dUgWGGzWRI5IZZ342qOB7kmpnmNpKJEureO1ZOXA3EH29/as+We3WSW3sjI08SESMVyDnqazLiZbO2S7vJSbWE52suFJ9hSTKUHLc7O2kjuYsAF1RMmQLglvTHrVS+Z5Zle2VvMXBKFPn+orP069vr5C+mSxeTIAwwuNv1qhe6rZ6LrFqdUvubs7BtXLE+mOoX3oclbUiNJ81lv2NPW9Q0vQrW4vtVu1tIC/LKCck8FcVnaB400HxBdy2ti7P9kX5orgKC3pgd/rWnrGoaZHAbe5WO9aTKCFgFUKf72f51yZ8L6Xpl1LqunaFGkkkewNE5VU9xn+dJuSfu2saU4U3B+0Tv07E/ijxElrJLb6HDbC6IBUBgWKnqwQc8e9cnbRatfXCy2n7qXqLqe3Dk+uQf0rO0qW5vNeu47ySxFyH/cyqhE6kHhQ44II65rrbtbwTWk1wnkxuxBjUk4UnliOm6tmrGSly+7Yr2NhvuDPfwadezRygLMYysuMckjofY1BrQE+ouY4ym0eWFQ4K10unaVDptzd3sNyGMicEZG4dfu9qw/Nju70vcxNHycMnGfcmuOu76GkHrdGSWkiiNqsYD5GwgjBHue1Qr58ca4RZJScrGV6+pzWqkcMJlO3zA/I39j+FQGVn4QbQcliRk4/pXOa3MzytyglGjy/7xWOKkmiXAKSBieMEYUfT/GrYbKkThJGxwW7VXDJErStGAr4xg5wf8KSQ7laaSKFBCsiGRepA/wAivK/2OQD8TdUB/wCgPL/6Ogr1Kd8IUDoM8k7eR/8AXry39jolfiZqhH/QHl/9HQV0Ufgmc9beJ9hmNSD2xWdqodYXIAAVc5NaQUMoJ4J5rM1edIbGZpPmHK4rBrQqn8SseV6izeYSFYk5z83ArId8MwfBDcjA/Ste/kCys5ZBnkKfT0rAu3XewXKpnOR0BrhPdWxakcJbSDKl2AAGe5qkm0xESPmTHGO9U7m/BdAFzhcHjn600Sl44124bOQasIrqS3BjARWXBDbtw/iqsfLZnDMWbquB0qw8KRpzIzE9dvUfj6VA2YY955UcKfWhFozT88hwArDp7mngM6FZCQB/OoHuY0ywRqjku5R5exG2scH2rSw5Mr3RIODnC9CO9UAxeUrtw2fWtC4dFmVJNvGc1VkjVfnUjaOg74raJhIjZS0THtnp3qDyCXRSWGBkVaQgrkrgjoDUsLs+F+9jhQOtVexLK0qNCkbs3XKjPBbHeoVlO7IGAPm3eldHeWdrc2dvFFB5d1GC00quSpA6gjoD3zWC8BSOMEDdIP8AvkZ4z9apMi5BPKzyYD5QdDjBNEYcnGKsxwpJIA7AHuSucY+lQTugndY5Mov3SRgk9+KpPoiJDtu4r1IHBPrSKjRpwT7YFWbNWeXaeTgEUyYbX8vkHPFK/Qwa1GKTu4OG6c961NJnKTdNpb09RWaQgZec469qcJCpV1b5s5FJohrSx1UkitGG3dSSRiqFywMmew/nVmSVNsTYyGA/WqEz/PIFPI5GalIwRSnycYH1zWbesHx8vINXZZAuQeo5rMuuDzkg1rEGUpcMxJyfp61jzAGVgctWq559AOayJG+dhwATnit4ksz9cx/Zc2Rg8cf8CFcnXWa7gabOAOOP/QhXJ10U9jmqbnT+AAP7WuM/8+5/9DWvRoxkAyHjsK85+H5xrE//AF7n/wBCWvQ4QPMR2JIFZ1dzej8JooCJEPCgDn6VYUBImY/dBzgDmqkXzuDuzgZxVxOQSTtI6VyyZ0pFjzA4iVUzkgFcdKsCTEmxuDj7vrVeGMqnmK2enWnI5mYOSqjJG4d/as2Ui/GC+0lS23qvTmrrxoCskbOpUDlqr20jvINobzAnQ9CasQo4Zixdx02npWMmaJEjn5Du4IbdnGcV0NrKl5p5jQbJ4xl5H9PascFBtEbAFW3Yxkip5Czq0sZO4feZTkUozcWNq5iXWqXS6zPBY3QEeFYJETlmHbFdLfWOo6rDcXNnERFaRrEXIwHOMkYPU1iadNY6QRLcpANVublWM8w/dQoOg9yT1rQ8Qa9q2o6h9nnvIjgt5AtU/dE+3ufU16dNqUU73MpNqVloXdI8URyalKk1v5Mqoob7Qu5lK9Aijp9DXUWPiaHU7CSGdne+bLMhBz5Y689PyrhfB/h2GPX7cPI8d02ZHEjb2m55LDsPQ1r+Kpp7PUXjitJEbp5v3Rj+gHtRLmjZRepUfZ1FqjotI1ix0XV7DSbCyuZ7O9kDTzSKSQT2GeTjvXVabrkFmbi2gtWfZKYwC2TjPf2rzC1F/Fpy3LMW1FVIjnkfmJSM8Y6n2rP+H/iKbR7iRI5n1C8dx50bKCIz1HPr600pdSZU4TXdns/iq8ntdPkkMgigjjMjlhhduOceteX6Xquox2tteTX7wrNclUhcA7lPQqo6LXp17dadqWjySahPHHKYyH80fcBHOB/KvPPCuhaDPevaxG8a9BLW8rZjWMDoOfX6U1G7bOeDUI+8tj0q0sAtsZHDxtIgy7fK+76elc3428Falr8Fu9rf/ZJ43MnynMZPbK1Jca02j6ZFbmXz71mKSzyOFye3Xv8ASuc8QRaprUumiASuArTTW8c5i4HRc9yetSknsVFSi+Zs19Cu73wv4di03XYlu9QnkdhFanD7B3J9avNq+k32g2+pPbRQag7GC0a9Tp1wc9lJ7151DYanFr1he6xqN5HcRRZS34MR25Khj3PQVaEur2WoCa6Iv4tSUPOZFZvs4P3VUdAoPbvV8ikrkyTjO7/A7ezuJdR00PekWN1GNskpCyRq+eCD3GKy9f8AFOsRbNFs4H1KdiHbUSAsSx55bHTArOl1TVJL7+xkj8mxt4w8t1OgWN07DjofatGC/R7G3mudTmihRDGlvaEBpRnupH/16I0+XVic77I5vU4JWvr211LUPtc5VZYht/d7M8kqoyPr1rpNO0jTtPK3RuLkmbDGBJmaLd64bkGum0uOCS3t7pYr0Mg2EyRgGT8xWLrF8LvUN7KY4oztyeuc+lZ1arSsiFG8g1LUTLMolHkrnG8dvY1RLCcn/SAHXIYDgsPYUPco+7zikgQ/IB94+4qm4iAYkbpMfgv0PeuJu7NlGws6xbGVcjb0LDn9OtRyuo2A/M23bleR9KYTGZVbc/zcFV9e2M01ZoUb5IyGHBLgnJ/z3pFWBo4dxdnJVuoZcGqVxtMqPGxIKgk4+79RWiZA8TSNtLlfqM/Ssa51Zbdc4818+WVXruPatKVGdaSjBXZMqiguaTsiaSYOMSDdx8pIHHvXlP7HX/JTdT9f7Il/9HQV29z9o1G2kgniQvvwY2fyxGOxYnqfauG/Y8OPiZqfqdIl/wDR0NenXwEsJSvN6y/C3/DnEsTGvO0Voj7KbKrznPrXG+NJCtvGFbkucgngccV13LHljgjFcN4xRlKlRuizzXj1fhPQwi/eI861FpWkI3HGflGP0rJuXfywqqNx6Cte/wACUsVHlr0GaxnTdktkDdlQDwa5Eew3oVCoVkk+bfnJz2qwj4jZioAx1BqeG2MlysbuNrEfMVzimXYETtGvAQkcDrTvcuJURmcAODjpwelRSOqBlYjb0wTnmmuV8vJJGeAazZHZ+jHk4wO1UkUPVg5JXPDdKku0EnLcHrj/AAoCItuWcnqMmkEiyOYyNoUjJPHWqEzOaISt87DA9RUxjUFSG3FepxxU9zEgnJj3HBwoI4pqAOcOeOvH8q0uZyRWNvJ/rGJJJHuB7CpbYJHdKd/lkBjgjv2AqSWfYPIYhY1OTgc596puDLIqRDdk8Y71a13MGjdtTa3TyxRZEcyiIOww6dPm4P8A+uufvWZJngWVJFikKh4/unHcGlgZGnH2k+SoBXp8wPanTSW8kVwxjCrAFVnU8ZPcD+lUlZkvQjQlXjwzI+4EMAeh9T61GIAt1Ijg7wTu4z+FWtZsLuzv2tnk8yDKSRyL8ocOu5TjtkVW01/n+YHLcc9KrZEN3NTSbUxOxO4dQc1X1gCO6TGcAfjWtk4GBxnJPc1Q1EJIJJVBHYHH86hPUyvqYk0jfezk5+lNaXcwHtkc9Kincqxx2P5CmW4O8StGHQe/BrZIlm7YXbPGI2GSoyB61LO3zv78cVn2oaO6HmBgw4IIxgVbZtwYnOB39aixhLcr3RBUYOO9Zl0csT2zzVqdvvdSM96oSk4IYdq0iIrT5Cs3tWOeWP1rVvGPkMeM1mKPlzke4raJnJmfrmDps/Y8fj8wrlK6rWyP7Nmwew4/4EK5Wt4bHPU3Ol8Bf8hibHXyD/6EtehRbgrAd/yxXnvgMkatMR2gP/oS16EmNu7njgAVnV3N6HwmjbqSvXaO57mriYMS45HbjrVG3YtGQ5APb3q5vZRiNR26dq45HUixCrxxE4yc7RnoafCHfaVCqM46feqBTv8AmBKkHgdqmgkI+X5SM/MO/wD+us5MuKNCLEeQ+FOcgE1qQsNis275jncD1rPgym2ZlG8HaGzkH3NW45lSTDKcMONvP4isWyzSiRdxEn7sjkgg9PXNObdFGNpQxkE7Qcf/AK6gVjOVBkOAQCWODUzmNFeQ7WERKnI5x7VAylcaSt+A3yqqkNhjWvGqahq6T2irp8MIBjWJcncByxz61SWTzLeMgPGh+YBwAR9aspGtuvmosm8MNy9dprWFZw06A1cbNNqsF1HN5S2uxjvkhjLNKD32+3YVC2o3fiDX9NMpmS0iBOWXJkC8/vOwHc12N+1trkdjNJqCxTwqEMIO0t6ZNZ0+nLa6xLLc2hW0MO11Vt2Rjrx39vzrvhPmd2zFuNrJamTrJtxaXUmo3c9wQR9ihtoiFkUnnA6/jWboGtyzahBamC2sLd5SHUY3pH6E9dxruNJisNW1eKG0SCLKqMxybpIFUZ5/2j6DiudTQrSTxZdNBJJczrP5k0hUKwjA9uME4966le+pg5pNnUiCbTYXguTvEsZZZfMVht9/euV0vUkg+IFkLR2vgGVLh5G4LEZwc9gOam8S6npcVoZJbi4unJaBLdW/dhx6MORt9TVDQtJLaNa6hFHby3ZkIDuzA5PZTwrYqJOzVjaCTpty66HpPxM07Tr/AE2PVpII5Wgkwgicfv8AP8J/nXmWm641grziK7VTuUKCHZR6Ant9K3r8O17ZxRXEV5NCpjWxXOwZ+87MeCfxqbUNMjutHkW7sXf5cw21unls5H+11PNKzs2upEJwiuSWtjlY3HiNfJF1fNcvKJEaWDy4oV+pPr6V6Lb332Rkdrm1uyUWFvMBiUkcYAH86xPCNlpsemmKd/LMbkfZSpbY3fk84q5deGgu+XTrg3DLguvv7AdKznLl0QpWm9djP1jXvEktzPJaJa6bZblWREj8x+ONwJ4I9xRp7Xeo3cb3U8pkV8obGAEhv7zk9K0IrgWMUsT2mXYbSPMzj2APbvSHWmmg+zofs7h/lkTgN9eKj2t0PbZG9qV+1jbiIyXMk7JgyzN830ArlVkluJwHkzI4O4s3NPnlDuxFwZ3X78kufnJ649BTIdiFl3KCfxP1H0rnqS5mKEeVFqAfuGTEbOnJbPP6dKjKB0BG5ApzJ2/Ko4wsMf7pAODuGfmf3qrcXUdrCktxNGiEbWyOV9sVEYuTUYq7B2WrY+dj5e3Db+SCp+7VS9v4odhkkUuAAzMM5PsPWs241WW6dUixbhm2h2YA47YX39Kz1hK+XHc+Tbzx3BkJkjYhP9pj6+le9hMknO0q7su3X/gHBWzCMdKer/AsXGoNcgqbhLZTKEbDbHVT3IPf2qsiIZEVWKlJt6mWM4Uf3i397p/KrARz8+9kzMXjVtrqNo5kc9cH0pnzMkksADKZtpEJMgkkPUsD2FfRUaFOhHlpqyPKqVZ1XebuQ3hItZSUlAM3+qbad4HV2PbPeuI/Y+APxL1PP/QIl/8AR0NdpfNGtpcbJAzNKPMlt0CeYf7oz2H61xX7IGf+Flanjr/ZEuP+/wBDXlZ1/Dj8/wBDpwPxP5H1688sYKlWOOeKxdatzd2x8w7RgnOK0/nIbcdx7e1VbhS0bozfWvl7XWp7UJcrujyjUI2DbXwTnuOoqimnlLgNIVUDkD0Fb+p24hvndo3XnI9KytQn4DLGuTznPXFee9ND2I6ox5QDKzQBo0ByQfX1FUrhWmc7mzuOST3q/PcFwxULubgjoKzXSZmPd++PammWtCRLdAWWQDIGQOuKo3IjjJKRkk9j2qwVKAiRizeo6VSeA7GJZnJPH0q1YtFW4Lr8rAYPOP7tRxys4GTubOADVq6RRkKfnAyTUdnG0eGfjd1PpWi2BssyAtHg49mNZjs8TFVkxk5z2xWxcr/o4JbIHUD3rLmeNjHsTfg8p6+wogRcqSEtEcEAE8mn2trI0HnCNpI5HMQUA8dMn2HIqN0GCJDg9gOlT6fK0aXdt51xDAwDMVJUs4U4XH5itkYT0QXUi3NzcM+DlsA+w4A/ICk+zqsa+W0YIBXAHBJ6k1nzugndYMpGH4JOR7AD+tailigQkAgYAIwfqfWqehncz55pYd4Y7967WzyeOmPpipbb920ccb7kXDYzkBqW9tzFErvIN+clRzVeHzViLoo27jzT3RDZvmVvLwMAd8d6hlkV4yvIQH86xVv2V/nfkDirEdz5iBFxluScdKnlaIsZt8EErjkqegB71DCx3huCPQ9M/Si4wZmKN1NCR9Gz16/41stiZGhDJI00byOXkf5nJPPHQVZmbEeA2SefpVS13GUbgAF6EDqT61LcMd5x0AqTCW5XkyWLA5IFVJehGcnpg1YkIIJBz+HFV25kx2HFWhGbqZwEQcg8ms8cdM1Y1GTdc/LjjjIqsM9/yraK0MpPUo60P+JfP9F/9CFctXUa0V+wTADHTj/gQrl62hsc9Tc6PwMcarOfSA/+hLXoEZyAVB2jk5rzzwUcapNjvAR/48td3C24feIHf3rOsb0djbtnTJLLhSOM1YKjzAqNkgcAetZlo275nO0LwD2q+GGwqPlOPlYd645HUie2BkEgU8Ec57tV20UGRjnLLgr71RjkJClY8qD175q7C+3asYGPQ8Z/GsJGqNA7w4DR7Q2PMBP3R2p1o0sl7ceV/qoiAkhH3h3pIy64ldsMeCDyoHpViEPK4aMKADgbDgGs2y0aEYZpG4+cgYJ5X/69XLZWlXDtEW242qOOKpWyu+JCmFB7OP0FWJXy/wC78sMTkOOn0NQwLXDyYYZX+JcfMD7H0qW3RAqxsxkUDhsfOtVg+2UPM7BiMgRjn/8AVVrcZlbM21TyCVwSfrSuIj+ylVDeWwB4dhxk9q0dIkt4bt11OeaS38sj92eQT0P0qrbzeWp2TMFbqQdxA9CKVGiwTOjYz8nlp3rSEnF3RMrtWY1tO017gRR33kKXDyMi4Y4ORg+tdHp8ekW8ssjTeXIG3rCnQEtksx/iJ/SuZdMxu+1ST2PGBSRW4R3CTM27DYZevtmuqOKcVaxlOkpu7ZJ4r0R4LmCbT4xLE8pmdDHmMFueg9auLpUd1aQz3Uskf2fAjt9jFAO+xegpV1PULVPKimAQjKpIuR+FTyavqEaR5+zAjkmIk5J9c1Srp6sfvJJIItP0CLVIlWGZTdBXmlaTAVR6AcBj0qzczwSPHDbpvSOT/RkldvMjP+1/s/zrFGtOrJHdwvJGMgIiD880yPUhJCyxW8jkEgFjt+X0zW3t00R7KzudFJeWtrO8ku5rhxuzI3yr6jI5yapXmuXEjvNaRG3DnC7OM+h+lZ0NtNcp+/CRblypOen9atOEReS+7hAsY5PqfauadRspJIoiMNPG0jMHQ7mcknn1NW2RCz+UVGfQcE/40qsDIwX5T0PfP1qY3EMcYLBQXGOF6n1qbg2NhjUoGkZAWzkkcg00yx26BhIvkkfNLKu0YrMutRig/wBSBNMreWCGwCx7e5qgwkuVEl6J7mNZyfJUfIcdF9wK9TB5TVr+9P3Y/i/kcWIxsKei1Zcm1l5WzaKAnLLIyjJA6nH8qzSvmGH7QY/MdjJifJfnv6ZqWG3EbOjNAZYG8+RSp+dscKp6YxjH0xV0hEtw8pkjtZBvl+0YGSfugHtk9u1fS4fC0cMrU18+p5FWvOq/eZRWD7KkDBWSRXLxxuo2t/t7qikWNIgW/exi4JMJcyB5PVsVYlMMIEUrCzlLBgu4yBoz2yegPeopZRCDMqzxDI2JEAVVRxlv89K6jAdcM6SyKgMamVXlezi4HPCH1x39ap3DMHkPmEMHAkaGTbsHULgdz6UXEg2MVIKFgVaJyQvcs49e9LCrSoFRkll83fHJGmw8dXOevtTSsBXd2YyFRF8r4U7cGJPQZ4J964j9kYgfEfU85GdIl5Hb99DXdgC5BSWI3Uck3yeZIFYv/ex/KuD/AGSJPL+I+ot/1CZB/wCRoa8bOvgj8/0O7A/E/kfXAcou3GD/ADqNgmzncT7etRyyNkkngn86iaddww2NwzgV8vc9hROT8ZEbwqA7MHpxiuEvrne2373YHoDXoviiIXCJKIjIU449+9cDqkCoeAocdAK4qqtNnq4aS5EYzrIzKuCWOSc01J9h2bdxPJJ6CpwzvMoQYIPaq020SNvXYD0x61KOgZIVGGySOp4705I2m+dMKvTNSWzM7FWG6MDr3rQhtDJ8jHCfeO3v9aZLdjJESPcBHUgD8qZeRBp0+VUHVR15q1foIWbymYnPNZNzdyqAXU429T1qkrkOYoI3GPILEHPNVI4IxIUkdl7ggdDVQTws5Bi3SueMnCqfU+tWYVkVMmMs2fvVraxLmSpAyxM20FVHP0rMljkeXzVLSjpjk5q3f3tybbysFUzlkU/f9M1nvcSW+3GY5c/wtjFaRTM5SuWLi2e5uBEsH75gAIgcMFP3eB1p8KhIMS3Y3J0j3fdx2PvVPzGM4nBbAHIBwxz15poVg5EX7sBsqM7iM9uetXbQzJb6cvIA5KuB8xB61FPdYhWOMhY8Y2kY/H61eaztI7QSzXMbXTKX8ocKuP7x7sfQVlzLukwW3JngLxk47e1NWEVXJUgsADjOalS6Pzdgw57VGyAhSzDZ065qI/cxjg1puSxUO9znJ54FWhztUdarQqF6+uRV+GMtIFBHPrSbIZNEVDfLye4NQzORnJ/CpCAkKk4yTVSdw8oHYc0kYvcaxO3ggZqF5Akbt021JIwztUD345qhqUu2EIOp6/SrSuyW7amW+WYsx5Jzg0nqOB3pVwQc9uppD146dya2MChrJzp82O+P/QhXMV02sf8AIPn+g/8AQhXM1rDYyqbm74QbbqUp9YiP/HlrtUflQAeODXD+Fcfb5c9PKP8A6EtdnA+eh6DtU1Ea0noasU37pgATn17VfWUbVwPmP8OayIpiyfMeCevpVyJgq/f4NcM0dcWbECszkg7kxyM9KtwuxXCuBGOQD1FZEMuCZMEKeCR2NaCzM0ilpAsgT5cjgj0rCRsjVhcIqRO3DH5XQZz9RVqIuY3/AHhwpx8o7+tZNo5YF2wm3sp6H1q55s/lJgxjdncy9T9KyZoadmRFCDv255XcOSatQMPLDgb8EsSBzn6VUt33qu7YzDnfjBH4VJ5hDMwdlx/EvT86hga0Ux80PhhnlcrkVMZCw3zKxQH+HgMfeqVq4KlQ0sbEc55H1zUis6TrEZHDnkhlGDRYku2xhUSlwULDkbcflUyk7o/JkDAc/KcD/wDXVJpSr7TEcY5Pb8u1SrKRApZMYPOR/UVSE0WBGWZmLBgeNp7f/Xq3MPLgG113Lx04HsDWe5NwVcRqMZII5P4VO88kKbtp2NyB1JNNMlondmaDLFTEOQSRu+mapSzfu2Y8soy2W6HtgU6OVJWItyzY+Z1Zck+o+tVXZMHy1IOc5A7emKoEhwLuQ8Cv5qjJPr9ania5ePDqwDdCMAfjVIzyIT5jnHGcj9KtRIQSzrjd0IPNUmEiWKRkkRZWCSBSMhs4HtUm9ljBAGV6HP3vrVC42DbuMYXOc5OF+tUn1U5uTZMECDDXEiHaf9pfpXXhcHVxLtTXz6HPWrwoq8mad1dxQxbmLxzBjhI+prO8+5v0KZSKIEMo3YJ9SzGobeA+cqXHnzmcDy5Ij85PXk9B7VYfBK7pYo7twwhM8WflHUlen1Br6fB5XSw3vS96Xf8AyR41fGzq6R0QsQS1i85d/lBmVf3fmA9iSe31qVoUCAEKIhj7LJ5vJb+W7OcDuKbBctt8+GCRpEH2d4omwh9l7Y7g9+lRv9mHkoDH/ZqIUS6XljITwMdARztPrxXpnEWnke4lNvC0M97aoJGhXgF+ybj/AAnk57GqrSRktM7LF5qFriK7JZVI4yM9P8mo5GYxxq5e68pdzTRnYWQ/wEnjPHI7GqUkr5SQqjMyZuILghpXX+EE+o6YFNRAkuZ1KPBFPJFJJGG8zy90ezsAT3qgbhd0rlPsbjakp3mQSegK/wCeKYZTBmGJmaXb+7hueEDenuAO1JZp5M2+OUo0g+75e5WPds+nWtErCLKk72xEQu4Za1XAJ7A+opjsoiSWRklWOQGSVXOT22gD06VIcukTrGIm3EwlpM7v9o47npTBcxrAsxRVlUFRJAu5Rzyz/wAqACZhMUkMgddxLukeGQdkArg/2URn4i6gOf8AkFydP+u0NdkXnSNPmEmc7ZgcEA9yK5D9kxVb4i6kHxj+yZOv/XaGvEzxfu4/P9DvwHxv5H1bNtCkBSWXkfWoXG4Fio5HpU6hVlG5hj3qWbY3cA9BXydrntXsc/dM3lyBFK5yAPevNtS+a5kQ7+M7h0xXpurjybaR415GTxXnM5jO9nOWJ59/rWFd2sd2GejZjhhbP8y4yQCc8+1Vp7ly+BH1PG+pL7ykZmXlc8A+lZ807KSEIJI3c84HtWUVc67ly3ZYGMiBT3xT1v5o5JGkUlD0A45qnFOIU34V19T696swAX8wkDAEEKIxwAKqxDY+Sa42F1hQxnJOR3rHdJr0SDYQvPXiummDRxtgEjOdv07Csq+uVjUyL8hB78VcTF6so6doqoVaVVY9cZzx71rSwwpGyllVfyrMt9UaZthJOehFaMgHksDgOBgADP41d+5EkzI1UxlR5S8nrxyaxYURpm2wvMcAlT29a17qznZooyMzTcxJuwducZPpmql3p97paCRi0SufLLK3qM4/KtYu2hJRFy0hTzFVlRSqjHAPr7mmCQ43Bgp7ZHT6VYawNvLJbzl90SlpPLAbAHPHrV6x0qI6YdTurq1+ysQgZn/iP8IA5yO/arugbSM+MC4mVJpI0UjO5hx6k/WqUsvmQruQHYSqsOpHvUszxMQkXKoSqv0LDsary8t8pyCRjjA/KqRNxmcpsIAHXp3qMKMlurY4Ap4DiRwMZU4/yaQZyQykDNUS2ORxuJbDYPORxViJg0wGPlHPHf2qudqKNuDgfNnip7XqzBsjHX0pMzexJcsSwwBj27VQlkKkrznFWHfIOPu9qr4J+tNGQ2IAct25JrGvJfNmZj05rQ1Kby4hGCMmskjIGa1gupnN9BRyDk4PTNJjA+YAZ6UnBA9R3pSMYbgZ960MyhrRBsJiPYfT5hXMV0+sY/s6bHfH/oQrmK0hsZT3NjwwcX0v/XI/+hLXWQvkkevXFcf4eO27k/65/wDswrqYXxnP50TWhVNmlA+FGOo/Wr4ZjDwQdvGOhNZVu4xux83vVxJMzKR+FcdRHXFmvE5fGzAHc5/pVmJt7iXIO3jg4x7fSsyMkoCuM5xg8GrCuoPKgY6/4VyyN0zYSaUPtT7m7vVy3D4O1yvPDDp9MVlWc6oSUGcnLRnpirrTbdsscTHnBKt2rJmiZppIjxKvmkt03dGHt7irwk2W6q0rkjoNuMVl2kgEbeZLlum5lGTVyCXMbNkeXkcHt9Khoq5cinkVFEW7BPIJzkf57VYt5FMZJjIAPDMetZMmFkWUqxIO457HtVt5N5YMCiMQQo7UAawuw8SQI8nOcgnJH0qKKYYJjcqDx7VWhdz8oYMF/jPWnrdFcgKFz2HGaYvQ0HndShZlV8dv4vxqU3crkbmMe7ghTnNZTyEoGKKo7fLnPr9KkjkCLjapUjnI4/P2pisjQDtEHCKoLdW35/WmRkhXKvGOMc4yf8Kqm4jUcbWZxjDd/pUctzHCMOQFUYPO7Jq4RcmlFXJbSV2WJhGduXUkHgK3T1znrUEmpLaP5cYklZR8vl9F+prJluHv1cCQQKp+dD8rMPQehNWLeAWcEMksbyQyODJIH+SFCOhXqfc9q+lwWR7TxP3f5/5HkYnMUvdo/eI5N/OYppIvPkUssQyGIHb0Geme1aNqWIgmtt8bo3lSCQ5CqPQdAc+3zVEXjlDWs97hGYSwXRQKdg5wccA9h2aqdzcSmWTyYRFdMwCKW3LJEPQnoM8+or6GFOMIqEFZHkym5O8ndl17qFITMixvayt5A2grsH8R/vEE/lSNJ5Vui3Tjy43EdoXIYk/X27N+dV4zITcz24zcFSkMW755XHBP19D3pglEMMWwRNbxRbJLdx8sch6+5JP5GrsSWbiZorgPcB0nsBvUL924LeoHABP5Gi6uVtWzOkSoHDyInKbz0G1eAPUHocGqPmskkNuGY3MURdmuOInfsPcgcVTa5e3ZypW1lK/v4ymVkfjj8uDTUbiuWrq4aRj9qaae4WTzlmVQFDN/CcHHoD9KrvLi732sEcxkJDSwD5i3c5PT06VTaUM4iiRkRSWSTPyse7kdvpUjbRCGlhlKzAt56Hgn0wPzrRKwrkzbQ7+WkUrRJ80cqlmRP8TVhfLkjkLGZ4SoZ1lfbtHZR/hUYkaSNjKq3EkK/vBBy7e2f1piRpKrRhPOgUiXdK/zq/YCkA9pggYqY7eXdmS2f5wR/dz29frQI1jIadpg0vLBBtjAP8J781Xa5YZlBSRklAnjC5bd2wfY02IJ80A8ySJpMqr/AHmb+7n1Bp2AmnSV2UsYIbhG+V1HybPTHXNcb+yqSPiHqGDg/wBlyf8Ao2Guu3+QC4KRyR586EtuH0B9RXJfspjd8RNQBGR/ZcnX/rtDXg57/Dj8/wBD0Mv+N/I+omuhuKEkOBweuafDIx+6QCBjnmmzOvmAAbuPSo4wTIcADvmvkk9T3baGJ4wv5ra1WNSp8zOecEYrzO9nmwW3e2B3r0LxxAgiR/8AlocjpxivP7xAkRw3zEbWAGM/jWFV3nqd2HS5NDKeYs+2QDIHXNZl1OUjcRr82cZJq5cREf3fYjqKptgZBUE9BkZA96qNja5YsQ9zGyvlJTyRmr+nWUqDJk2gHqD0+tZli0scmZF4GAOAMitVtSaPCQw5boSTxQ1qZtli9nkjRTA29ieSRwKyb7z5tvmZ+gHU1sRQTNCXlKhySVTHAqrJOFYb1DH+7jNCZBBpdssTJI+A5zkAdqs3NxGpdlYHGAQe1Vri9SKNUUMoYZGeprHuJpZW3BT5a8kgVSjcTLU0yvc+cTuHQ5yM5qO8vbm6tooJGCwQZ8qJRhVz1+pOByahBXAXkE9D60yVgFxu3uvfPFax0IklcousjZQMQg+9zxiqkilJCVHKng/56VrPbmaIuGUHuWYAAfSqowuwkDHYEdfetVITHOxWMuCM4+8ec1TQK3rg+9X7lzOrO5DMf51GnKIkYOf60JkEcYKEiP8AiBHIyBUipwxJJKDJBP8AKrUKKEYyEZHPFQonnNtUErnOT1FK5LIZwk7r5AKoq/Nn1oOQgQZ4H51POBEAseD61XctwW4JpoybIWO5MkfhTTIsMTSMBtHP1qQKSCTjjt6VjalcGZtiH92D+dXFXIk7K5Wnl82VmY8E5HtUR6gg+xpeeh5z+lDYGDitzneoj/MBuPI7+1A+bOelKxPNA4bH5UDKGtAjT5vTAx/30K5euo1sg2E3vjp/vCuXrWGxjU3LulOEuTk43Lj9RXURvkDniuNjJXLDqOf1rorC58xAR6c1b1QouzNy1Kl8OTg1cikAUjGMdKyYZM9DV2Fzt28c1zTidMGa6z7sFgWwABjtVu18m45uZGCgH5k4bPbNZEMpCDPyjGOO9WkbaQUGV65J61xzjY6IyNRGwygu6gdCBWhG6wqNsysOvHBNYiTEuGyVDD04FXIZAEZNyknkAntWLRqmaa4cFi5GTnIPT8KvRXCou1jliOGHesWJ1OCI9hxnIPFTxz7pFZ/mH8LdazaLubfmnzHC7VYHrnjFWS8bRZzlwvX1+lY4lIYHzVK4wRjqKVbhY5I1kbKZ4I9fSkBptdiG3VSmGJ2qV5yfcVP5smVJQhvXr+lZTXUWN0yc8jcpyB78UJcR7MoxHfcQc/nTsFzb85vLcMY2BP3T6+tK0m/aAMQDoOmT71iy3MUZkZyGJA4XknPpVeW5knTLSm3tkIRYnJ3SE/yr0cDllbGP3VaPd7f8E5cRjKdBa79jWm1EPLsi2u6/xqOEA65NNgtvtKkMouUuFYo8bbdu3qc1BF5kLs1pALZ4HCI4bcrKepPY/wBKj87MVyLcrIgIiaMjaD6kD1NfYYPLaOEV4K8u7/rQ8HEYupX0louxoyXGWEYMcc06jaWTcrRjsD6n8xUf2iK4lzFEYxdN5bQM2ORwWPufyrNln8i3KxqXiiCrEpJYxH+L/wDXTrl286SRmRhEipBL0KOegPv+hrv5TluXjOpLny8283+jvaSp/qwOh9ulNWaNI0ebMi5MEcykExHHJYdB2we9Mt5njmmSCRUu4osb5OY5Sfvc9x2HpSvNFbQSz+WsERiDXESrkCUn+JfQj/GlYCbKfaYxMrSPZkQiZPl8zPIHsM9+1Elwto8dwzK9vFIWudvzSMx46+vb9aqXjqqosiO0GBPb3e7kP3Vh6Z4qld3ZDC43RkFx5kkOSrMR39MVSjcV7FpwqKyeWbiCNy0W98SbyOh9cd6pCZ5fLEcxIVCDERjy/Ug9yagMhkgLlWZoXJ8/dlgp9R3zQxe4Uqq+bGHBQk7WDevuBVqNibly3VkmNvGywzeZh4/vbvbP5GrlrutLjZGiwTbSMztmMvnk/WqUd0NyEDz40Yo0bDa2SMcnr7U+0kESqkLI0igmOO4+bAI5P4dKTQ0WZp/LD3bBonA2fuR1b+9+FR3BG7blJYQoeFxyS/ctVeObznTyXIJjw6PwgHqKSJ/LnlFsBbOAABJ8wYDqR6cUWC5YeVXuDK5DOcKJYvu7vf8AlVfzwQftIkeSInyZ84JPqTVVZQodFZkEpJMR4GP/ANdV5p8SgcR5HKMcqPbFUok8xZe42hf3anILb0GWY/3jWP8AsrsU+IOokf8AQLk/9HQ1ZeWXyyDlE3YwOF//AFVB+yoVHxC1EsAR/ZcnX/rtDXg8QK1OPz/Q9DLX77+X6n0+3Abj5vX1psILAENgng4qeRo1HzDg8YpSA2DGNuBjivjUfQXMnxFaNdWTDaSy8gY615jqMJOQflA7n1r1263KGIO5T2Ncjr2neaWmjX5gPmVVz+NZ1o3fMjow9S2jPOniLBwOGA6f1qi8UcVwFdiwA+bPf6V0F1GYS26MqcdW4zWRdw72DBCcHGF7+5qIs6nqU5Zt5Zmwp/2elTWShnBBAA/hHNRvHIDv+Xb0245NNDvFLtiQAk42k/zrQydzUnujHtXy/mPC4Pasy4umkbdlkHcqO3pUVxI8pzsG7GDj1qm0kj/KW+UHtVRiCGm8kyHDlWUbVB5H4VXXzGRj5mF/jA5xzUsgxjHIHc/yp0BUHARsnO7PQ/StVoS2JIzOCFTauACo6+1NjhZU/efKMcc04o8hLKqjnt0pqCRycAsMj5j0oIZG4/c7kLBy2cD0qIqXYgLjHArQhtiWLNhuDjB6H1qwtiAFXDBupyev/wBejmSEUY4XUcDI9fSniCNSWGSfatSK0dgFQHHc561aSxSNVZgSR096nnM5SSMo2zu2CNowDj2pk6LarsH3jz6VrzhI1YkrnAyKxrld7fvOcdKcXczcrlCXON2cZ6YqIAv05xU0qgtkHmsrUb8QKYomzJ0J9K2im9CG0hmsXZjUQRkHI+bFZByenSkzuyScnrmlxzgcV0RVlYwk+Z3FHHHUY/I0MCQCT1poHBJOKMErnNMkU9KaBlvWn8be+fek68nr3oGUdZ406cHrxn/voVy9dTrX/IOm5B6dP94Vy1aw2Mam5d02ETi7U9oSw+oZaXTrgxSbCflNQ2lx9nZztLB12kZx3B/pUUjBpCwG3JzjNatqyIOpgkUDAPFXoZATxkeprlLfUDCuNhYf72P6VaTWyo/1BP8AwP8A+tWUo3NIzsdQH+UDJB61bglJxlSB6jtXJDxBz/x7cenmf/WqSLxL5YwLTj/rr/8AWrGVJs1jVSO0tZm6gkkHt3/CrHmDA3YXHfHSuGXxSQf+PTP/AG0/+tUo8XYYEWR+nnf/AGNYSw8+iNVXj3PQIZ12dgM8bTTg5jjOZGzno3avPz4xJ62Iznr5v/2NSnxtIVw1mSfXzv8A7Gs/qtTsWsRDud55gkZGOVK4/GpwzFWCcAcNzXnsvjhpMZsmB9fP6/8AjtIvjZl/5c3z2P2jp/47R9Vqdh/WIdz0rzQsaAZIPVh1478Ui3qsqkDdFnBfgAe/vXm6+N3C4NkSPXzufz21Zj+IAWMKdLBbyxGSJ8ZGc5xt616mAwWGT58VL5a/i7fkceJxVT4aK+f+R6AkKpMszn7RgEo0T7MH+HqK0Eu/3ajzi6CE+bBIgBEvXjHJ55x1HavLn+IBlidJdO3Oz7w/n4Kn2+X/APXSy+P1YEppjJI23c32nOce22vpljsLFKKlZLyf+R5Do1W7tHoZkMQiBfzIo0Jdw3zK57kf1/OiKcReSZWO9FOGXoS3TPr9Pyrz0fEBN8jNpWfMbJH2jj/0Dr703/hP9zSb9OJEmN4+0YBA7D5eKf8AaOG/m/B/5C+r1Ox6TbTFJod0ipNChdnX5gwPt/Xt3pIZFiuAyEyfZyZJ4WOT83XHavO3+IKSxvHLpRaMnIxc4I9OdnOKk/4WPkhm0oGQAJu8/GU7qRs5+p6Uf2hh/wCb8H/kH1ep2PRI/s26MMwWCJ/MUu3CBvuqSeWB6/SljuGhUeZLsvI5CZIx80cqH7q+uemPavO4viOqG7jk0gS21woBie4zsx0KnZxUL/ER22j+zztByQZ8k8YHO3tR/aGG/m/B/wCQewqdj0K4c20vlEMLnBcea25N3YY7EDiqMTYlCzsIpGGc4+QntuArhV8ebeBp2QOm6bOB6fdpI/HYQY/s3cPRp8jnr/DVrMcMvtfg/wDIn6vV7fkeiKssZjmbdAezIoKk9z9KWYAhRKiRKrBklQ5JXvn3NefyfEEu5/4lzeWQBsa4zgDsPl4pD4/Izs04qCckC44Psflpf2jhv5vwf+QfV6nb8j0KaXzYMu/mq5OXztIA6cep96jVkMe+XDKi8eXy6+xrgm8fRgAxaSEcEnJuMj2429jTW8ftv3x6cI3K4Yib7x9cbaf9o4b+b8H/AJC+rVex6ESZVKT5kiZQ2QR+7PaoXuFWVCzCfsZE6hh0x7CuC/4T0jbs08hl7m4yPy21H/wnOCxSwKZ64nx/7LR/aOF/m/B/5B9Wq9vyO4mfeCzP5o6jefmH4UzPygsDj+63Gfoa4oeOB1bTst6ifBz/AN80p8cgnLacW9N1xnH/AI7Vf2nhf5vwf+RP1Wr2/I7cneDGW8rnJ2DIJ9Krfssgn4gajtGT/Zcn/o2KuP8A+E5ccJYlV9PO/wDsaT4VeNv+EC8Q3Gqf2eb/AM21a28rz/Kxl0bdna39zGMd68XOcRTxMIqk72v+nc7sDTlSk3PQ+1d+7CkAH6UxgyksOCK8AP7R6548Kf8AlR/+1UjftH5HHhXB9f7R/wDtVfM/VqnY9f28O57+HJT5/wAhUcq8AhQD1NeBH9o7p/xSv/lR/wDtVI/7Ru/GfC3T/qI//aqr6vU7C9tHueyatosN+gyRCc8kL1ri9X0xrWVoyDsHP1rjh+0WAP8AkVjn1/tH/wC1VVu/j7BdLibwpn0/4mH/ANqrKWDqPVI3hjIx0b0Ny6jdhsSPnG0bhyTVS2s5CMSKGkA/g4FcxJ8YrN2JPhg89P8AiYdP/IdMf4v2bAhfDBUnuL//AO10lhqyWxp9cpdzqbu1CqDsxu6H39arvaKkrHB29B3rlpvi1HITjQcZGObzOB/37qqfihGf+YIf/Av/AOwqlh63b8g+t0u/5nWzQEkiMEJgc4pHglVQpUDPHBrkv+Fnx/8AQFPv/pf/ANhSN8TY2z/xJjg/9Pf/ANhVewq9vyF9apd/zOt8uRCNvXH4CpoYXZRwcmuLT4mxqwP9ig4/6ef/ALCrVt8VbeEf8i+W5z/x+f8A2ul7Cr2JeKp9zv7bTXJAWMgevatKLR1U7pSWY9q87/4XLHu58PZA6D7bx/6Lob4zKwOdAPPre/8A2uj6tV7GcsTF7M9KS23blRRkDgYqGW3IU8EsPxxXnS/GVFGD4fJX/r9/+11YX41wBs/8Izn1H27r/wCQ6Pq1Tt+Rn7aPc6e8iwpJ6VhXkgYEA4/pXO6r8VFvc+VovkA9hdbv/ZKxT45BBzpx5/6b/wD2Naxw8+qD20e51zZxgGqU+kLKGdWIY8jNc23jVS2f7OPT/nv/APY04eOAAB/Z5/7/AP8A9jWipTWxLqxe5Ynt5IGZXUnjHtUJzzgnbjoetNfxrE4w+lBvcz//AGNZ9x4jhkbMdgU/7bZ/9lrVRl1RDlHozSA98fj1p3RehzWL/b6/8+p/7+//AFqX+31A4tD/AN/f/rU+Rk86NnHHOOmaQL3259gaxhr6gf8AHqT/ANtP/rUf2+P+fU+/73/61HKw50WdZX/iXTHnt/6EK5ita+1YXVs8Qtym7HO/PQ59Kya0gmlqRNpvQKKKKogKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Various presentations of Paget disease of the breast are represented here. Paget disease is typified by erythematous, scaly, and weeping \"eczema\" that involves the nipple. Discoloration, depigmentation and desquamation of the nipple and areola are sometimes seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     (A) Weber J, Kelley J. Health Assessment in Nursing, Second Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003.",
"     <br>",
"      (B) Rubin E, Farber JL. Pathology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999.",
"      <br>",
"       (C) Mulholland MW, Maier RV, et al. Greenfield's Surgery: Scientific Principles And Practice, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2006.",
"       <br>",
"        (D) Stedman's Medical Dictionary. Philadelphia: Lippincott Williams &amp; Wilkins, 2008.",
"        <br>",
"         All figures reproduced with permission. Copyright &copy; Lippincott Williams &amp; Wilkins.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2423=[""].join("\n");
var outline_f2_23_2423=null;
var title_f2_23_2424="Approach to the patient with myalgia";
var content_f2_23_2424=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with myalgia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Robert H Shmerling, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2424/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/23/2424/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myalgia, or muscle pain, is a common complaint among adults presenting for medical care. In fact, nearly everyone will experience muscle soreness at some point in their life. Unusually excessive exertion, trauma, and viral infections are among the most common causes. While many causes are benign and self-limited, myalgia may be the harbinger of disorders associated with significant morbidity.",
"   </p>",
"   <p>",
"    A thorough review of the patient's history and a complete physical examination can usually narrow the list of potential causes of myalgia to a manageable few. For persistent or severe myalgia without a known cause, selected testing may be necessary to identify or exclude specific diagnoses and to direct treatment.",
"   </p>",
"   <p>",
"    It is important to differentiate myalgia from myopathy (muscle disease) and myositis (muscle inflammation). Although myopathy and myositis may cause myalgia, most individuals with myalgia have neither. It is also useful to separate diffuse from localized symptoms. This review will discuss the approach to myalgia as a presenting symptom to a primary care clinician, focusing on etiology, history, physical examination, laboratory studies, and management. Specific disorders characterized by prominent myalgia are covered elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link\">",
"     \"Differential diagnosis of fibromyalgia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14137?source=see_link\">",
"     \"Myopathies of systemic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6856?source=see_link\">",
"     \"Drug-induced myopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiologies of myalgias can be divided based upon diffuse versus focal symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diffuse myalgias",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of diffuse myalgia are (",
"    <a class=\"graphic graphic_table graphicRef60716 \" href=\"UTD.htm?6/54/7021\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic infection, including viral, bacterial, and spirochetal diseases [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/1-6\">",
"       1-6",
"      </a>",
"      ]. As a prominent example, dengue fever is sometimes called &ldquo;break bone fever&rdquo; due to the severe muscle and joint pain associated with this virus.",
"     </li>",
"     <li>",
"      Rheumatic disease, especially polymyalgia rheumatica (PMR) and inflammatory myopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=see_link\">",
"       \"Clinical manifestations and diagnosis of polymyalgia rheumatica\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"       \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Non-inflammatory conditions, such as fibromyalgia and chronic fatigue syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link\">",
"       \"Differential diagnosis of fibromyalgia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=see_link\">",
"       \"Clinical features and diagnosis of chronic fatigue syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Medications, particularly the use of statins (with or without creatine kinase elevation) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/10,11\">",
"       10,11",
"      </a>",
"      ], ciprofloxacin [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/12\">",
"       12",
"      </a>",
"      ], bisphosphonates [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/13\">",
"       13",
"      </a>",
"      ], aromatase inhibitors [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/14,15\">",
"       14,15",
"      </a>",
"      ], or withdrawal from antidepressant therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6856?source=see_link\">",
"       \"Drug-induced myopathies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic disorders, such as mitochondrial myopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/17,18\">",
"       17,18",
"      </a>",
"      ], vitamin D deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/19,20\">",
"       19,20",
"      </a>",
"      ], and scurvy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/21\">",
"       21",
"      </a>",
"      ], can lead to myalgias, although these are much rarer causes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=see_link\">",
"       \"Approach to the metabolic myopathies\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link\">",
"       \"Mitochondrial myopathies: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Liver disease, such as chronic infection and autoimmune disease [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/2,3,22\">",
"       2,3,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Endocrine disorders, such as thyroid disease [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/23,24\">",
"       23,24",
"      </a>",
"      ] and adrenal insufficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/25\">",
"       25",
"      </a>",
"      ] can lead to myopathic pain. Of note, glucocorticoid-induced myopathy often leads to muscle weakness and wasting without pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29093?source=see_link\">",
"       \"Hypothyroid myopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=see_link\">",
"       \"Glucocorticoid-induced myopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psychiatric, as with somatic manifestations of depression [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/26,27\">",
"       26,27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Localized myalgias",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of localized myalgia are (",
"    <a class=\"graphic graphic_table graphicRef61398 \" href=\"UTD.htm?9/21/9563\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unusually strenuous exercise or overuse",
"     </li>",
"     <li>",
"      Soft tissue disease (such as bursitis, trauma, or infection)",
"     </li>",
"     <li>",
"      Pyomyositis",
"     </li>",
"     <li>",
"      Myofascial pain syndrome",
"     </li>",
"     <li>",
"      Muscle infarction or compartment syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these causes, myalgia may be multifactorial. For example, a patient may have concomitant rheumatoid arthritis, fibromyalgia, and anserine bursitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14041?source=see_link\">",
"     \"Bursitis: An overview of clinical manifestations, diagnosis, and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=see_link\">",
"     \"Pyomyositis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42472?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of soft tissue rheumatic disorders\", section on 'Regional myofascial pain'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"     \"Clinical features of rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=see_link\">",
"     \"Diabetic muscle infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients presenting with myalgia, it is common that the diagnosis cannot be established at the initial visit. This may relate in part to the need to follow symptoms over time and to obtain laboratory or other diagnostic studies. In fact, the course of symptoms and signs over time may be particularly helpful. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Muscle symptoms'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The list of conditions associated with myalgia is long (",
"    <a class=\"graphic graphic_table graphicRef60716 \" href=\"UTD.htm?6/54/7021\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef61398 \" href=\"UTD.htm?9/21/9563\">",
"     table 2",
"    </a>",
"    ). In patients with a characteristic pattern of symptoms, the diagnosis may be established promptly. However, considerable uncertainty is common after initial evaluation. Selective testing and vigilant follow-up may be necessary for several months to narrow the list of potential explanations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Serious conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early in the evaluation of patients with myalgia, the clinician should attempt to identify those patients with a serious or life-threatening condition. Conditions causing myalgia may cause significant suffering, but true medical emergencies presenting with myalgia are rare. Prompt diagnosis and treatment are required for bacterial infections, especially endocarditis and impending sepsis, which may present with diffuse myalgia, fever, chills, arthralgia, fatigue and back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/5\">",
"     5",
"    </a>",
"    ]. Rhabdomyolysis can present with diffuse myalgias, as well as renal failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    compartment syndrome in severe cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's history provides a useful starting point in narrowing down the long list of potential causes for myalgia. Particular attention should be given to mode of onset, location of pain, and associated symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Muscle symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in sorting out the cause of myalgia is to understand the specific nature of the patient's muscle pain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Did the muscle pain begin suddenly or gradually? If sudden in onset, did it follow trauma or an unusually strenuous activity? Is the muscle pain worse in the morning?",
"      <br/>",
"      <br/>",
"      As an example, acute onset with prominent constitutional symptoms suggests infection (such as bacterial sepsis, pyomyositis, influenza or acute hepatitis B). Acute onset of myalgia in the neck, shoulders, upper arms, buttocks, and thighs in an older adult is characteristic of polymyalgia rheumatica (PMR).",
"      <br/>",
"      <br/>",
"      Subacute myalgia is typical of a medication-induced cause (such as statin-induced myalgia), and can occur weeks to months after initiating therapy.",
"      <br/>",
"      <br/>",
"      Insidious onset and chronic symptoms are typical of infection with chronic hepatitis C, hypothyroidism, hypercalcemia, and vitamin D deficiency. This is also the typical pattern for patients with fibromyalgia, chronic fatigue syndrome, myofascial pain syndrome, and a somatization disorder. (See individual topic cards for detailed review).",
"      <br/>",
"      <br/>",
"      In addition, muscle pain in the morning is highly suggestive of PMR or other inflammatory arthritis.",
"     </li>",
"     <li>",
"      Is the muscle pain associated with pain elsewhere? Is it near joints? If so, are they axial joints, such as the shoulder and hips? Shoulder and hip pathology, in particular, tend to cause referred pain to proximal muscles. Referred pain accounts for the prominent myalgia described by patients with PMR and rheumatoid arthritis involving the shoulders.",
"     </li>",
"     <li>",
"      Is there a particular distribution of muscle pain? Statin-induced myalgia typically presents as proximal, symmetric muscle weakness and soreness. In contrast, diffuse myalgia, fever, headache, malaise, and a nonproductive cough are typical of a viral infection, such as influenza. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=see_link\">",
"       \"Statin myopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link\">",
"       \"Clinical manifestations of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Is there redness, swelling or warmth in the area of the muscle pain? Is the muscle painful to touch? Pyomyositis, abscess, muscle infarction, or compartment syndrome may cause focal muscle tenderness. Pyomyositis and abscess may cause localized inflammatory findings as well.",
"     </li>",
"     <li>",
"      Is the myalgia associated with muscle weakness? Is it difficult to arise from a chair or reach above the head? Objective muscle weakness is not expected with fibromyalgia, myofascial pain syndrome, or PMR; these common causes of muscle pain can be placed lower on the list of possibilities in the face of demonstrable muscle weakness. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26694?source=see_link\">",
"       \"Approach to the patient with muscle weakness\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Have there been muscle cramps? The etiology of muscle cramps is often not found, but can be caused by several conditions:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Structural disorders such as flat feet",
"     </li>",
"     <li>",
"      Unusual positioning during work or sleep",
"     </li>",
"     <li>",
"      Neurologic disorders such as Parkinson disease",
"     </li>",
"     <li>",
"      Muscle injury such as trauma or fall",
"     </li>",
"     <li>",
"      Dehydration",
"     </li>",
"     <li>",
"      Exercise-associated muscle cramping",
"     </li>",
"     <li>",
"      Electrolyte abnormalities",
"     </li>",
"     <li>",
"      Medications such as diuretics, statins, and beta agonists.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Leg cramps occurring at night are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4711?source=see_link\">",
"     \"Nocturnal leg cramps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Associated symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence or absence of associated symptoms can be quite helpful in pointing toward or against a particular cause. The clinician should undertake a detailed review of systems with particular attention paid to:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Constipation",
"     </li>",
"     <li>",
"      Depression",
"     </li>",
"     <li>",
"      Fatigue",
"     </li>",
"     <li>",
"      Fever",
"     </li>",
"     <li>",
"      Joint pain or swelling",
"     </li>",
"     <li>",
"      Paresthesias",
"     </li>",
"     <li>",
"      Rash or hyperpigmentation",
"     </li>",
"     <li>",
"      Weight change",
"     </li>",
"     <li>",
"      Nausea, vomiting or diarrhea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Constipation, fatigue, and weight gain are common symptoms of hypothyroidism, whereas rash or hyperpigmentation are suggestive of infection or adrenal insufficiency, respectively. Fever raises the possibility of infection or systemic rheumatic disease (such as systemic lupus erythematosus) while joint swelling suggests inflammatory arthritis. Paresthesias suggest a neuropathic condition which may cause myalgia due to referred pain or indicate the presence of a vasculitic process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of myalgia may not be apparent until additional details of the patient's medical history are revealed. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient demographics, such as age and gender. For example, newly diagnosed systemic lupus erythematosus and rheumatoid arthritis are most common among young adult women, while PMR is seen exclusively among adults over the age of 55.",
"     </li>",
"     <li>",
"      Past medical history, such as a prior diagnosis of thyroid disease, hepatitis C, diabetes, or hyperparathyroidism.",
"     </li>",
"     <li>",
"      Medication use, especially statin administration, can lead to myalgias.",
"      <br/>",
"      <br/>",
"      Myalgia due to statin or fibrate medications may be associated with weakness and an elevation in creatine kinase (CK), but these features are often absent [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/33\">",
"       33",
"      </a>",
"      ]. A number of other common medications may be associated with myalgia, including bisphosphonates and aromatase inhibitors, as well as inhibitors of CYP3A4 (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"       table 3",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      In addition, abrupt discontinuation of serotonin-reuptake inhibitors with short half-lives (such as venlafaxine or paroxetine) may cause significant myalgia [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. Muscle symptoms that follow the administration of a new medication should prompt the clinician to consider drug-induced muscle pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=see_link\">",
"       \"Statin myopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6856?source=see_link\">",
"       \"Drug-induced myopathies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trauma, a change in activity or function, recent injury, or unusually strenuous exercise may trigger muscle pain, which is typically localized.",
"      <br/>",
"      <br/>",
"      Understanding the functional status of the patient or a recent change in function can help determine the pace and direction of the evaluation. For example, the possibility of myopathy is raised by a patient with myalgia who has difficulty arising from a chair or with activities of daily living. For individuals with longstanding myalgia without alteration in function, fibromyalgia should be a prime consideration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link\">",
"       \"Differential diagnosis of fibromyalgia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A psychological assessment may aid in the diagnosis of depression or a somatization disorder as a cause of myalgia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the history can provide important clues to the cause of myalgia, the physical examination can provide compelling, objective evidence for myopathy (muscle disease) or an alternative explanation for the symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Muscle examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it can be difficult for a patient with myalgia to cooperate fully with a muscle examination, the finding of weakness can be particularly helpful in narrowing down the list of possible causes of symptoms by excluding many. For example, the finding of proximal muscle weakness in all four extremities in a patient with myalgia should turn the focus of diagnostic considerations to inflammatory myopathy (such as polymyositis), hypothyroidism, drug-induced myopathy, or hypercalcemia.",
"   </p>",
"   <p>",
"    Even patients with significant pain can usually give maximum effort at least briefly to provide the examiner with a sense of whether muscle strength is normal. Besides assessing muscle strength in the usual proximal and distal muscle groups (including deltoids, wrist extensors, grip, thigh flexors, and ankle flexors and extensors), assessment of neck flexor strength may be useful as these muscles are a powerful and often overlooked proximal muscle group.",
"   </p>",
"   <p>",
"    Besides the assessment of weakness, helpful findings on muscle examination may include focal swelling or erythema, which should raise the possibility of pyomyositis or other localized infection. Severe, localized tenderness without inflammatory features should increase the suspicion of muscle infarction or compartment syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=see_link\">",
"     \"Diabetic muscle infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It should be noted that muscle weakness without pain includes a much broader differential diagnosis discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26694?source=see_link\">",
"     \"Approach to the patient with muscle weakness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     General physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The source of myalgia may lie far from the muscles. For this reason, as well as the fact that diseases causing myalgia may affect other organ systems, a thorough physical examination should follow, with particular attention to the presence of the following physical findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever (which may suggest viral infection, pyomyositis, endocarditis, or impending sepsis)",
"     </li>",
"     <li>",
"      Hypotension (as may be found in patients with sepsis)",
"     </li>",
"     <li>",
"      Hyperpigmentation and postural hypotension (as may be present in adrenal insufficiency)",
"     </li>",
"     <li>",
"      Cutaneous lesions (such as those found in systemic lupus erythematosus, vasculitis, Lyme disease, psoriasis, or endocarditis)",
"     </li>",
"     <li>",
"      Ecchymoses (suggestive of recent trauma)",
"     </li>",
"     <li>",
"      Limited shoulder and hip range of motion (consistent with PMR) or spinal disease (as may be noted in patients with spondyloarthropathy)",
"     </li>",
"     <li>",
"      Joint inflammation (swelling, heat, warmth,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      limited motion) in the peripheral joints (as is typical of rheumatoid arthritis, psoriatic arthritis, or systemic lupus erythematosus)",
"     </li>",
"     <li>",
"      Bursal or tendon tenderness with more limitation of active motion than passive motion (compatible with bursitis or tendonitis)",
"     </li>",
"     <li>",
"      Tender points (as with fibromyalgia) or trigger points (suggestive of myofascial pain syndrome), although the ability to distinguish tender and trigger points is controversial. While the presence of multiple tender points in characteristic locations is highly suggestive of fibromyalgia, their absence does not exclude the diagnosis (as emphasized by the 2010 ACR preliminary diagnostic criteria) (",
"      <a class=\"graphic graphic_table graphicRef81631 \" href=\"UTD.htm?26/19/26941\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link&amp;anchor=H13#H13\">",
"       \"Differential diagnosis of fibromyalgia\", section on 'Myofascial pain syndromes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8056?source=see_link\">",
"       \"Clinical manifestations and diagnosis of fibromyalgia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Severe, focal muscle pain should suggest the possibility of muscle infarction, compartment syndrome, or pyomyositis",
"     </li>",
"     <li>",
"      Delayed relaxation of reflexes, slowed speech, dry skin, hoarse voice or other signs of hypothyroidism",
"     </li>",
"     <li>",
"      Depressed or flattened affect (as an indication of depression or as associated with a somatization disorder)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;For mild symptoms, watchful waiting without laboratory evaluation may be appropriate, as symptoms often resolve on their own with time. However, for more significant symptoms (eg, severe pain or muscle weakness), selected laboratory studies may be quite helpful in ruling in or ruling out conditions that remain in the differential diagnosis after a detailed history and physical examination.",
"   </p>",
"   <p>",
"    As an initial assessment, complete blood count, urinalysis, and measures of renal and liver function are appropriate for most patients with significant myalgia. Depending upon the specific symptoms and physical findings, measures of serum calcium, albumin, phosphate, TSH, CK, and 25-hydroxyvitamin D may be appropriate to assess.",
"   </p>",
"   <p>",
"    The following tests may also prove helpful in certain clinical situations (",
"    <a class=\"graphic graphic_table graphicRef60716 \" href=\"UTD.htm?6/54/7021\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood cultures and serologic testing for infectious agents (such as parvovirus and viral hepatitis)",
"     </li>",
"     <li>",
"      ESR, CRP &mdash; These may be helpful to identify the presence of systemic inflammation, as with infection and systemic rheumatic disease (especially PMR and inflammatory myopathy). On the other hand, a normal ESR is the expected finding in patients with fibromyalgia.",
"      <br/>",
"      <br/>",
"      However, caution must be taken in interpreting these test results as elevations in the ESR and CRP are not specific. In addition, normal or unimpressive results rarely rule out a particular cause of myalgia.",
"     </li>",
"     <li>",
"      Autoantibodies, such as antinuclear antibodies (ANA) for suspected systemic lupus erythematosus, anti-neutrophilic cytoplasmic antibodies (ANCA) for suspected ANCA-associated vasculitis, as well as rheumatoid factor (RF) and anti-cyclic citrullinated peptide (Anti-CCP) antibodies for suspected rheumatoid arthritis, should be limited to those patients for whom there is at least a moderate pre-test probability of disease. Widespread testing with these autoantibody tests for all patients with myalgia is likely to produce an unacceptably high rate of false-positive results. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=see_link\">",
"       \"Measurement and clinical significance of antinuclear antibodies\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/47/33528?source=see_link\">",
"       \"Clinically useful biologic markers in the diagnosis and assessment of outcome in rheumatoid arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Testing of cortisol production, such as morning serum cortisol or adrenocorticotropic hormone (ACTH) stimulation test, are helpful to diagnose or rule out adrenal insufficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other studies",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging &mdash; Radiographs, MRI, and other imaging tests are not routinely necessary in the evaluation of myalgia. Utility is limited to assessment of erosive arthritis (rheumatoid arthritis and others), fracture, inflammatory muscle disease, or localized muscle disease (pyomyositis, muscle infarction).",
"     </li>",
"     <li>",
"      Neurophysiology studies &mdash; Electromyogram (EMG) with nerve conduction studies (NCS) may be helpful to support the diagnosis of inflammatory or metabolic myopathy, as well as a neuropathic process.",
"     </li>",
"     <li>",
"      Tissue sampling (eg, aspiration or biopsy) &mdash; Most patients with myalgia will not require tissue sampling. However, it may be diagnostic for patients with suspected abscess, inflammatory myopathy, vasculitis, or systemic lupus erythematosus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no established guidelines or expert consensus regarding how best to treat myalgia. Features of the history, physical examination, and selective testing may prove particularly useful to identify the etiology that will guide management.",
"   </p>",
"   <p>",
"    If medication-induced myalgia is suspected, a trial off the medication is warranted, though only after balancing the clinical improvement gained from such a trial with the risks of stopping the drug. It may take weeks or even months, however, to get a clear sense of whether myalgia was related to a medication [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2424/abstract/34\">",
"     34",
"    </a>",
"    ]. A notable exception is polymyalgia rheumatica (PMR), a condition in which a rapid and dramatic improvement within a few days of low-dose corticosteroid treatment is typical. In fact, this prompt response to treatment can help confirm the diagnosis.",
"   </p>",
"   <p>",
"    When the cause cannot be readily identified, patients should be closely observed and treated symptomatically. In the absence of specific contraindications, empiric treatment may include heat, rest,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , non-steroidal anti-inflammatory drugs,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    muscle relaxants.",
"   </p>",
"   <p>",
"    Indications for referral include suspicion of a particular condition for which specialty care is warranted (such as referral to a rheumatologist for suspected PMR) or severe, functionally-limiting symptoms, especially if they are worsening or persistent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/9/15506?source=see_link\">",
"       \"Patient information: Nocturnal (nighttime) leg cramps (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The etiology of myalgia can be divided into conditions causing diffuse or localized symptoms (",
"      <a class=\"graphic graphic_table graphicRef60716 \" href=\"UTD.htm?6/54/7021\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef61398 \" href=\"UTD.htm?9/21/9563\">",
"       table 2",
"      </a>",
"      ). Conditions leading to diffuse myalgias include systemic rheumatic disease, fibromyalgia, infection, medication use, metabolic derangements, hypothyroidism, and psychiatric causes. Conditions leading to localized myalgia include strenuous activity, soft tissue disease, pyomyositis, myofascial pain syndrome, muscle infarction, and compartment syndrome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt diagnosis and treatment are required for bacterial infections, especially endocarditis and impending sepsis, which may present with diffuse myalgia as well as fever, chills, and arthralgia. Rhabdomyolysis can present with diffuse myalgias, as well as renal failure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      compartment syndrome in severe cases. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Serious conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical history should include mode of onset, location of pain, muscle weakness, associated symptoms, medication use, and any previous trauma. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination should include an assessment of focal muscle pain or inflammation, muscle weakness, and examination of findings associated with other medical conditions. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For mild symptoms, watchful waiting without laboratory evaluation may be appropriate, as symptoms often resolve on their own. However, for more significant symptoms including severe pain or muscle weakness, selected laboratory studies may be quite helpful in ruling in or ruling out disease.",
"     </li>",
"     <li>",
"      As an initial assessment, a complete blood count, urinalysis, and measures of renal and liver function are appropriate for most patients with significant myalgia. Other specific testing will depend on the history and physical examination findings. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of myalgia usually depends on the underlying cause. When the cause cannot be readily identified, patients should be closely observed and treated symptomatically. In the absence of specific contraindications, empiric treatment may include heat, rest,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      , non-steroidal anti-inflammatory drugs,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      muscle relaxants. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/1\">",
"      Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/2\">",
"      Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006; 73:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/3\">",
"      Archard LC, Bowles NE, Behan PO, et al. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med 1988; 81:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/4\">",
"      Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008; 83:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/5\">",
"      Gonz&aacute;lez-Juanatey C, Gonz&aacute;lez-Gay MA, Llorca J, et al. Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study. Medicine (Baltimore) 2001; 80:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/6\">",
"      Misra UK, Kalita J, Maurya PK, et al. Dengue-associated transient muscle dysfunction: clinical, electromyography and histopathological changes. Infection 2012; 40:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/7\">",
"      Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/8\">",
"      Pease CT, Haugeberg G, Morgan AW, et al. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation. J Rheumatol 2005; 32:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/9\">",
"      Meeus M, Nijs J, Meirleir KD. Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J Pain 2007; 11:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/10\">",
"      Siddiqi SA, Thompson PD. How do you treat patients with myalgia who take statins? Curr Atheroscler Rep 2009; 11:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/11\">",
"      Jacobson TA. Toward \"pain-free\" statin prescribing: clinical algorithm for diagnosis and management of myalgia. Mayo Clin Proc 2008; 83:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/12\">",
"      Eisele S, Garbe E, Zeitz M, et al. Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature. Int J Clin Pharmacol Ther 2009; 47:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/13\">",
"      Lambrinoudaki I, Vlachou S, Galapi F, et al. Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging 2008; 3:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/14\">",
"      Yamamoto Y, Iwase H. Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer. Int J Clin Oncol 2008; 13:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/15\">",
"      Conte P, Frassoldati A. Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective. Breast J 2007; 13:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/16\">",
"      Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997; 58 Suppl 7:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/17\">",
"      Testa M, Navazio FM, Neugebauer J. Recognition, diagnosis, and treatment of mitochondrial myopathies in endurance athletes. Curr Sports Med Rep 2005; 4:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/18\">",
"      DiMauro S, Gurgel-Giannetti J. The expanding phenotype of mitochondrial myopathy. Curr Opin Neurol 2005; 18:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/19\">",
"      Lyman D. Undiagnosed vitamin D deficiency in the hospitalized patient. Am Fam Physician 2005; 71:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/20\">",
"      Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/21\">",
"      Fain O. Musculoskeletal manifestations of scurvy. Joint Bone Spine 2005; 72:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/22\">",
"      Muratori P, Granito A, Pappas G, et al. Autoimmune liver disease 2007. Mol Aspects Med 2008; 29:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/23\">",
"      Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/24\">",
"      Bazzichi L, Rossi A, Giuliano T, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 2007; 26:2115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/25\">",
"      Shapiro MS, Trebich C, Shilo L, Shenkman L. Myalgias and muscle contractures as the presenting signs of Addison's disease. Postgrad Med J 1988; 64:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/26\">",
"      Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology 2000; 33:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/27\">",
"      Vaccarino AL, Sills TL, Evans KR, Kalali AH. Multiple pain complaints in patients with major depressive disorder. Psychosom Med 2009; 71:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/28\">",
"      Alvarez-Nemegyei J, Canoso JJ. Evidence-Based Soft Tissue Rheumatology IV: Anserine Bursitis. J Clin Rheumatol 2004; 10:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/29\">",
"      Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans): current perspective. Postgrad Med J 2004; 80:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/30\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1997. A 54-year-old diabetic woman with pain and swelling of the leg. N Engl J Med 1997; 337:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/31\">",
"      Bennett R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 2007; 21:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/32\">",
"      Naderi AS, Farsian FN, Palmer BF. Diabetic muscle necrosis. J Diabetes Complications 2008; 22:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/33\">",
"      Mammen AL, Amato AA. Statin myopathy: a review of recent progress. Curr Opin Rheumatol 2010; 22:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2424/abstract/34\">",
"      Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med 2011; 78:393.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2751 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.65.66-4367187BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2424=[""].join("\n");
var outline_f2_23_2424=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diffuse myalgias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Localized myalgias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Serious conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Muscle symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Associated symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Muscle examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - General physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2751\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2751|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/54/7021\" title=\"table 1\">",
"      Diff dx diffuse myalgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/21/9563\" title=\"table 2\">",
"      Diff dx localized myalgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9950\" title=\"table 3\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/19/26941\" title=\"table 4\">",
"      Fibromyalgia diagnostic criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=related_link\">",
"      Acute compartment syndrome of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=related_link\">",
"      Approach to the metabolic myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26694?source=related_link\">",
"      Approach to the patient with muscle weakness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14041?source=related_link\">",
"      Bursitis: An overview of clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30825?source=related_link\">",
"      Clinical features and diagnosis of chronic fatigue syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=related_link\">",
"      Clinical features of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8056?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromyalgia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=related_link\">",
"      Clinical manifestations and diagnosis of polymyalgia rheumatica",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/47/33528?source=related_link\">",
"      Clinically useful biologic markers in the diagnosis and assessment of outcome in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=related_link\">",
"      Diabetic muscle infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=related_link\">",
"      Differential diagnosis of fibromyalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6856?source=related_link\">",
"      Drug-induced myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29093?source=related_link\">",
"      Hypothyroid myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=related_link\">",
"      Measurement and clinical significance of antinuclear antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14137?source=related_link\">",
"      Myopathies of systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4711?source=related_link\">",
"      Nocturnal leg cramps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42472?source=related_link\">",
"      Overview of soft tissue rheumatic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/9/15506?source=related_link\">",
"      Patient information: Nocturnal (nighttime) leg cramps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=related_link\">",
"      Pyomyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=related_link\">",
"      Statin myopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_23_2425="Pathogenesis perinatal arterial ischemic stroke";
var content_f2_23_2425=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of perinatal arterial ischemic stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DIC: disseminated intravascular coagulation; ECMO: extracorporeal membrane oxygenation; PFO: patent foramen ovale; PHACES: Posterior fossa brain malformations, Hemangiomas, Arterial anomalies, Cardiac anomalies/coarctation of the aorta, Eye abnormalities/endocrine abnormalities, Sternal cleft, supraumbilical raphe, or both.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Ichord, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2425=[""].join("\n");
var outline_f2_23_2425=null;
var title_f2_23_2426="The Reed-Sternberg cell and the pathogenesis of Hodgkin lymphoma";
var content_f2_23_2426=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The Reed-Sternberg cell and the pathogenesis of Hodgkin lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Jon C Aster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/23/2426/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/23/2426/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hodgkin lymphoma (HL, formerly called Hodgkin's disease) is a neoplasm characterized by the presence of clonal malignant",
"    <span class=\"nowrap\">",
"     Hodgkin/Reed-Sternberg",
"    </span>",
"    (HRS) cells (",
"    <a class=\"graphic graphic_picture graphicRef63379 \" href=\"UTD.htm?41/18/42276\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef77200 \" href=\"UTD.htm?27/58/28578\">",
"     picture 2",
"    </a>",
"    ) in a reactive cellular background comprised of variable numbers of granulocytes, plasma cells, and lymphocytes. Historically, HRS cells have been enigmatic and difficult to study, as they often constitute less than 1 percent of the cells in involved tissues. The central pathogenic issues in HL are: the origin of HRS cells, the identity of the events underlying the transformation of HRS cells, and the nature of the signals that produce the intense, characteristic tissue response.",
"   </p>",
"   <p>",
"    Our understanding of the origin of HRS cells has taken a quantum leap forward, based on elegant molecular studies that relied on single cell micromanipulation of HRS cells, coupled with amplification of RNA and genomic DNA by the polymerase chain reaction (PCR). These techniques have established a B cell origin for HRS cells in the vast majority of cases of HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], and have led to the identification of recurrent molecular abnormalities in HRS cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3-6\">",
"     3-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     Hodgkin/Reed-Sternberg",
"    </span>",
"    cell and the pathobiology of classical HL will be reviewed here. The role of Epstein-Barr virus infection in the development of HL is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3703?source=see_link&amp;anchor=H4#H4\">",
"     \"The role of Epstein-Barr virus in Hodgkin lymphoma\", section on 'Association with infectious mononucleosis and EBV'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSICAL VERSUS NON-CLASSICAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;One complication when discussing the nature of HRS cells is heterogeneity within the diagnostic category of HL. HL is currently divided into two broad groups [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Classical HL, which includes the nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depletion subtypes.",
"     </li>",
"     <li>",
"      \"Non-classical\" HL, which includes only the uncommon nodular lymphocyte predominant subtype that comprises about 5 percent of HLs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The distinction between these groups is based on differences in the morphology and phenotype of the HRS cells (",
"    <a class=\"graphic graphic_table graphicRef57079 \" href=\"UTD.htm?17/23/17788\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In nodular lymphocyte predominant HL, the prevalent tumor cell is the \"lymphocytic and histiocytic\" (L&amp;H) HRS variant, which often has a polypoid nuclear contour resembling a popcorn kernel (",
"    <a class=\"graphic graphic_picture graphicRef63097 \" href=\"UTD.htm?1/5/1111\">",
"     picture 3",
"    </a>",
"    ); classic HRS cells with multiple nuclear lobes and large, inclusion-like nucleoli are rare or absent. The L&amp;H variants of the nodular lymphocyte predominant subtype express B cell markers, grow within expanded networks of follicular dendritic cells, have productive immunoglobulin gene rearrangements, and show evidence of ongoing somatic hypermutation of immunoglobulin genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/8-11\">",
"     8-11",
"    </a>",
"    ], features that resemble normal germinal center B cells and some of their malignant counterparts, such as follicular lymphoma cells. Retention of the lymphocyte predominant subtype within the HL category is based on the frequent presence of rare cells resembling classical HRS cells, the predominance of background reactive cells, and certain clinical features (such as response to therapy) that are more typical of HL than non-Hodgkin lymphomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33432?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, the HRS cells of classical forms of HL have been much more mysterious, and are still incompletely understood; these cells are the focus of this review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CELLULAR ORIGIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The HRS cells of classical HL fail to exhibit phenotypes typical of any normal cell. Routine stains for leukocyte common antigen (LCA), T cell, and B cell markers as usually negative, although the B cell marker CD20 can be detected on some HRS cells in a significant subset of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/12\">",
"     12",
"    </a>",
"    ]. CD15, the diagnostic marker that is most specific among lymphomas for classic HRS cells, is normally expressed on granulocytes. The other most useful diagnostic marker, CD30, is not lineage specific; with sensitive staining methods, expression of T cell markers may be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A clearer picture of the ontogeny of HRS cells has emerged from analysis of rearranged antigen receptor genes isolated from single cells. Within B lymphoid cells, the most lineage-specific molecular events involve rearrangement and mutation of the immunoglobulin genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"     1",
"    </a>",
"    ]. Most patients with nodular sclerosis HL, the most common classical HL subtype, have a clonal rearrangement of the V, D, and J segments of the immunoglobulin (Ig) heavy chain locus in the HRS cells, a feature characteristic of mature B lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"     1",
"    </a>",
"    ]. Even more tellingly, sequence analysis of the rearranged VDJ regions has revealed a high load of somatic mutations, usually resulting in nonfunctional Ig variable regions [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/11,14,15\">",
"     11,14,15",
"    </a>",
"    ]. Somatic hypermutation of Ig genes appears to be restricted normally to germinal center B cells within the follicles of secondary lymphoid organs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/16\">",
"     16",
"    </a>",
"    ], strongly suggesting that the HRS cells of classical HL usually arise from germinal center or post-germinal center B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1,14,15,17\">",
"     1,14,15,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further evidence linking HRS cells to germinal center B cells comes from the evaluation of rare patients with both HL and a non-Hodgkin lymphoma (NHL) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/18,19\">",
"     18,19",
"    </a>",
"    ] or chronic lymphocytic leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/20\">",
"     20",
"    </a>",
"    ]. In these patients, the HRS cells and the NHL cells are often clonally related, as evidenced by identical VDJ rearrangements at the Ig heavy chain locus and certain shared somatic mutations within the VDJ region. In addition, the HRS and NHL cells sometimes accumulate specific somatic mutations that are not shared by the other cell type. These findings suggest that the initial transforming event occurred in a germinal center B cell that was the precursor of both the NHL and HRS cells. This event must have been followed by acquisition of distinct sets of secondary molecular lesions responsible for the divergent phenotypes of the two diseases.",
"   </p>",
"   <p>",
"    Some reports suggest that classic HRS cells can be of T cell origin, but such cases are rare. Even among cases where T cell markers are expressed on HRS cells, the tumor cells usually have clonal somatically mutated IgG rearrangements, a finding indicative of a B cell origin. The few cases (estimated to be 1 to 2 percent of classical HL) that have clonal rearrangements of T cell receptor genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/21\">",
"     21",
"    </a>",
"    ] have not been shown to be clinically distinct, but the numbers available for analysis are very small.",
"   </p>",
"   <p>",
"    Despite the clear molecular evidence in most cases of classical HL for a germinal center origin, HRS cells characteristically lose the phenotypic features of germinal center B cells. Although in up to 33 percent of cases of classical HL the HRS cells express the B cell marker CD20 (which has been suggested on the basis of some [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/22\">",
"     22",
"    </a>",
"    ], but not other [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/23\">",
"     23",
"    </a>",
"    ], retrospective studies to be a marker of poorer outcome), most cases fail to express markers that define germinal center B cells, such as the transcriptional repressor BCL-6 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/24\">",
"     24",
"    </a>",
"    ]. HRS cells do not show evidence of ongoing somatic hypermutation of their immunoglobulin genes after the initial transforming event [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"     1",
"    </a>",
"    ], and in fact usually fail to transcribe RNA for immunoglobulin.",
"   </p>",
"   <p>",
"    The peculiar absence of immunoglobulin gene expression in HRS cells appears to be due to impaired activation of the immunoglobulin promoters and enhancers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/14,15,25\">",
"     14,15,25",
"    </a>",
"    ] stemming from the lack of expression of the B cell transcription factors OCT2, BOB-1, and PU.1 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], accompanied by epigenetic silencing of IgH promoters [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/28\">",
"     28",
"    </a>",
"    ]. Proteins that are involved in signaling downstream of the IgH receptor, such as BLNK, as well as other B-cell specific genes, are also down-regulated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is now some insight into the basis for this dramatic change in gene and protein expression pattern, which is fundamental to understanding how HRS cells are created [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"     1",
"    </a>",
"    ]. HRS cells continue to express PAX5, EBF, and E2A transcription factors that act as master regulators of B cell development, implying that the activity of these factors must be interfered with in some way. It is now recognized that HRS cells commonly mis-express Id2, a factor that is not expressed in normal B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Id2 antagonizes the function of E2A and possibly PAX5 as well, providing a plausible explanation for the failure of HRS cells to express most B cell-specific genes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISMS OF TUMORIGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One mechanism that is firmly linked to the growth and survival of classical HRS cells is activation of the nuclear factor kappa B (NF-kB) transcription factor-signaling pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/33\">",
"     33",
"    </a>",
"    ]. NF-kB encompasses a family of proteins consisting of homodimers and heterodimers of gene products related to the v-rel oncoprotein. NF-kB activation plays an important role in many normal immune responses, including those involving B cells, and has been implicated in many forms of human neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Most resting cells do not have nuclear NF-kB because one or more inhibitory proteins belonging to the I kappa B (IkB) family sequester NF-kB in the cytoplasm. However, a number of cellular stimuli lead to the phosphorylation, ubiquitination, and subsequent degradation of IkB, which permits NF-kB factors to travel to the nucleus and activate the transcription of target genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two major types of NF-kB heterodimers are found in normal mature B cells,",
"    <span class=\"nowrap\">",
"     NF-kB1/c-REL",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     NF-kB1/REL-A",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Both the c-REL and REL-A heterodimers are sensitive to inhibition by IkBa [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/36\">",
"     36",
"    </a>",
"    ]. The few HRS cell lines derived from classical HLs have elevated nuclear",
"    <span class=\"nowrap\">",
"     NF-kB1/c-REL",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     NF-kB1/REL-A",
"    </span>",
"    levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/38\">",
"     38",
"    </a>",
"    ], a finding consistent with a general disturbance in the regulation of NF-kB activation. Despite the structural similarities of the various NF-kB family members, c-REL is unique in its ability to promote lymphocyte transformation and its nuclear accumulation likely contributes to HRS cell transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Activation of nuclear factor kappa B",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first evidence for a role of NF-kB in HL came from the demonstration of constitutive NF-kB DNA binding activity in the nucleus in several HL cell lines and in primary HRS cells from one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/38\">",
"     38",
"    </a>",
"    ]. This constitutive nuclear activity can both prevent apoptosis and promote cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/34\">",
"     34",
"    </a>",
"    ]. There are at least three mechanisms by which increased NF-kB activity might occur:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mutation or loss of IkB or other negative regulators of NFkB",
"     </li>",
"     <li>",
"      Constitutive activity of kinases that target IkB for degradation",
"     </li>",
"     <li>",
"      Modification of NF-kB resulting in insensitivity to inhibition by IkB",
"     </li>",
"     <li>",
"      Amplification of the REL oncogene (which encodes NF-kB) secondary to chromosomal gains involving the short arm of chromosome 2 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A mutation of the IkB alpha (IkBa) gene has been documented in the HRS cells and cell lines from some patients with HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. In two cell lines, for example, one allele of IkBa was deleted and the other allele had a deletion or point mutation, resulting in a truncated IkBa protein lacking the C-terminus that is presumably not able to inhibit NF-kB DNA binding activity and prevent translocation into the nucleus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These cell lines were established from treated patients late in the course of their disease. The next step was to determine if IkBa alterations were clonal events that could be identified in the HRS cells of untreated patients. In a total of 19 patients studied in three reports, five had truncating mutations of IkBa on at least one allele [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. In one such patient, all HRS cells that were removed from a lymph node biopsy via micromanipulation contained two different mutant IkBa alleles, each resulting in truncation of the C-terminus of the protein [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the majority of classical HLs, the HRS cells lack mutations of IkBa. Thus, most tumors apparently have wild type IkBa alleles and express normal IkBa protein. Some HL cell lines have constitutive nuclear",
"    <span class=\"nowrap\">",
"     NF-kB1/relA",
"    </span>",
"    DNA binding complexes despite having wild-type IkBa alleles. This may be due, at least in part, to constitutive activity of IkB kinases, resulting in rapid degradation of IkBa [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/42\">",
"     42",
"    </a>",
"    ]. Cytokines secreted by these cell lines also may contribute by triggering NF-kB activation, a factor that may also be important in vivo, as discussed further below. More recently, the analysis of laser-microdissected HRS cells has detected loss of function mutations (ie, either deletions or frameshift mutations) in the TNFAIP3 gene in 70 percent of EBV negative classical HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/43\">",
"     43",
"    </a>",
"    ]. The TNFAIP3 protein (also known as A20) is also commonly involved by loss-of-function mutations in mediastinal B cell lymphoma, an entity with a number of molecular similarities to classical HL.",
"   </p>",
"   <p>",
"    Another important contributor to NF-kB activation is Epstein-Barr virus (EBV) infection. EBV is present in the HRS cell in about 40 percent of cases of the lymphocyte-rich subtype; in about 70 percent of cases of mixed cellularity HL, which is more frequent in children and older adults, and an even higher fraction of the lymphocyte depletion subtype, which is most often seen in HIV+ patients. It is uncommon in the nodular sclerosis subtype. EBV+ HRS cells typically express the EBV gene LMP-1, which encodes a transmembrane protein that behaves like a constitutively active TNF receptor. LMP-1 activates NF-kB by promoting IkBa turnover [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/44\">",
"     44",
"    </a>",
"    ]. A detailed discussion of the possible role of EBV in the pathogenesis of HL is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3703?source=see_link\">",
"     \"The role of Epstein-Barr virus in Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Three TNF family receptor-ligand pairs have the potential to activate NF-kB in HRS cells. CD40, a member of the TNF receptor superfamily, is virtually always expressed on HRS cells; it may be engaged by CD40 ligand on the surrounding T and B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. CD40 activation of NF-kB is mediated by proteolysis of TNF receptor-associated factors; these factors appear to regulate",
"    <span class=\"nowrap\">",
"     CD40/NF-kB-mediated",
"    </span>",
"    control of the immune response in HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition, TNF produced by the HRS cell may act in an autocrine fashion via TNF receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/48\">",
"     48",
"    </a>",
"    ], and CD30 on the HRS cell may be crosslinked by CD30 ligand on either the HRS cell or on surrounding cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, some data suggest that overexpression of CD30 per se is sufficient to activate TRAF2 and TRAF5 dependent signals that lead to NF-kB activation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Consequences of constitutive NF-kB activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene expression analyses have shown that many NF-kB target genes appear to be highly expressed in primary HRS cells and HRS cell lines. As an example, NF-kB activates the IkBalpha gene, resulting in a negative feedback loop that reduces NF-kB signaling [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. In the majority of patients with classical HL, 10 to 90 percent of the HRS cells express high levels of IkBalpha [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3\">",
"     3",
"    </a>",
"    ]. Other NF-kB target genes expressed in HRS cells include intercellular adhesion molecule (ICAM-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-6, and TNF. Some of these cytokines may have effects on the surrounding non-neoplastic leukocytes that form the characteristic background of classical HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=see_link\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of NF-kB activation was demonstrated in a study in which HL cell lines were manipulated to over-express a dominant negative version of IkBa that could not be degraded [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/56\">",
"     56",
"    </a>",
"    ]. These cell lines had reduced nuclear NF-kB, decreased proliferation rates, an enhanced apoptotic response to the removal of serum from the culture medium, and reduced ability to form tumors in immunodeficient mice [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The antiapoptotic effects of NF-kB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/34,57\">",
"     34,57",
"    </a>",
"    ] may be of particular importance. As noted above, HRS cells contain nonfunctional Ig genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/14,15\">",
"     14,15",
"    </a>",
"    ] that are derived from germinal center B cells. These cells, which should have been negatively selected as a result of the crippling mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"     1",
"    </a>",
"    ], may be rescued from apoptosis by the associated NF-kB activation.",
"   </p>",
"   <p>",
"    These observations suggest that therapies aimed at the NF-kB system might be of benefit in patients with classical HL. However, an important limitation of this approach is the variability in the mechanisms by which NF-kB can be activated. An interesting observation in this regard derives from a population-based case-control study in which the regular use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , an anti-inflammatory agent known to inhibit activation of NF-kB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/58\">",
"     58",
"    </a>",
"    ], significantly decreased the risk of developing HL (odds ratio 0.60, 95% CI 0.42-0.85) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/59\">",
"     59",
"    </a>",
"    ]. Further, a proteosome inhibitor drug, PS-341, that prevents NF-kB activation through several mechanisms has been shown to cause classical HL cell lines to undergo growth arrest and apoptosis, events that were accompanied by diminished levels of nuclear NF-kB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/60\">",
"     60",
"    </a>",
"    ] and activation of death pathway components.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Interleukin-13 signaling pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cytokine IL-13 is expressed in HRS cell lines and by HRS cells in tissues involved by classical HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/61\">",
"     61",
"    </a>",
"    ]. The IL-13 receptor is also frequently expressed by HRS cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/62\">",
"     62",
"    </a>",
"    ], suggesting the existence of an",
"    <span class=\"nowrap\">",
"     IL-13/IL-13",
"    </span>",
"    receptor autocrine signaling loop [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/63\">",
"     63",
"    </a>",
"    ]. The receptors for both IL-13 and IL-4 have two signaling chains in common and may therefore activate overlapping downstream targets [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The HRS cell lines also differentially expressed the",
"    <span class=\"nowrap\">",
"     E4BP4/NF-IL3",
"    </span>",
"    gene [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/61\">",
"     61",
"    </a>",
"    ], which encodes a transcription factor that prevents apoptosis upon withdrawal of IL-3 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/65\">",
"     65",
"    </a>",
"    ]. Since this gene is regulated by IL-4 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/66,67\">",
"     66,67",
"    </a>",
"    ], its expression in HRS cells may reflect autocrine signaling by IL-13.",
"   </p>",
"   <p>",
"    Direct evidence suggesting a pathogenetic role of IL-13 comes from the in vitro observation that neutralizing antibodies to IL-13 produce dose-dependent inhibition of proliferation in a HRS cell line [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/61\">",
"     61",
"    </a>",
"    ]. In some cases, there could be a relationship between IL-13 and NF-kB activation. IL-13 normally inhibits NF-kB by activating IkBa transcription [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. However, this effect could be minimized in HRS cells that have mutations in the IkBa gene [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/3-5\">",
"     3-5",
"    </a>",
"    ] or by constitutive degradation of IkB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/42\">",
"     42",
"    </a>",
"    ]. In this setting, other effects of IL-13 may predominate. As an example, the IL-13 and IL-4 activate JAK kinases and stimulate the transcription factor, STAT6 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/70,71\">",
"     70,71",
"    </a>",
"    ], which can interact physically with NF-kB on certain promoters. Complexes of these transcription factors may synergistically activate some target genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/72-74\">",
"     72-74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been suggested that IL-13 may be responsible for the occasional development of minimal change disease in patients with Hodgkin lymphoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34601?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology, clinical features, and diagnosis of minimal change disease in adults\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     NOTCH signaling pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;The NOTCH signaling pathway regulates normal T cell development and has been implicated in controlling the development of some mature B cell subsets. HRS cell lines express the NOTCH1 receptor and grow at an increased rate when exposed to NOTCH ligands [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. Staining of tissues has also shown classical HRS cells express NOTCH1 and are surrounded by lymphocytes expressing the NOTCH ligand JAGGED1, suggesting that NOTCH1 signaling likely occurs in vivo as well. Because NOTCH1 activates T cell programs of gene expression at the expense of B cell programs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/77\">",
"     77",
"    </a>",
"    ], it is possible that NOTCH1 signals could be involved in masking the identity of HRS cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genomic instability",
"    </span>",
"    &nbsp;&mdash;&nbsp;HRS cells, unlike the tumor cells of B cell non-Hodgkin lymphomas, seem to lack recurrent chromosomal translocations involving oncogenes. However, standard and molecular cytogenetic analyses have shown that HRS cell lines and primary HRS cells are aneuploid and have many chromosomal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/78,79\">",
"     78,79",
"    </a>",
"    ], several of which are sufficiently common or unusual to merit mention. The uniform presence of widespread genomic instability undoubtedly contributes to the bizarre nuclear appearance of HRS cells and seems very likely to promote HRS cell transformation and tumor progression; its basis, however, is currently unknown.",
"   </p>",
"   <p>",
"    One manifestation of genomic instability is gene amplification. Already discussed is the amplification of c-REL on chromosome 2p, which likely contributes to NF-kB activation in some cases. HRS cells often demonstrate abnormalities in the p53 protein, but only rarely have mutations in the p53 gene. It has been proposed that amplification of the MDM2 gene, which encodes a protein that regulates p53, could be a more common basis for p53 dysregulation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/80\">",
"     80",
"    </a>",
"    ]. Another recurrent gene amplification that is most commonly associated with the nodular sclerosis subtype of classical Hodgkin lymphoma involves chromosome 9p band 24.1 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/81\">",
"     81",
"    </a>",
"    ]. This amplicon contains JAK2, a gene encoding a kinase that activates signal transducer and activator of transcription (STAT) proteins, which could contribute to the activation of STAT3 that has been reported in HRS cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/82\">",
"     82",
"    </a>",
"    ]. The same amplicon also includes the genes PD-1L and PD-2L, which encode ligands for the PD-1 and PD-2 receptors. These ligands are expressed on HRS cells and are believed to contribute to T cell immunosuppression in patients with nodular sclerosis CHL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/83\">",
"     83",
"    </a>",
"    ]. A curious aberration is the frequent presence of amplifications involving the ribosomal RNA genes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Allelotyping of microdissected HRS cells has revealed widespread loss of heterozygosity throughout the genome, with losses being particularly prevalent in the regions of chromosome 6p25 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MECHANISMS OF TISSUE REACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, autocrine or paracrine signaling loops likely drive the proliferation and survival of HRS cells. Of equal importance are factors elaborated by HRS cells that regulate the host response. Most of the tumor mass in patients with HL is comprised of reactive inflammatory cells, and the interplay between these cells and HRS cells likely controls both local tumor growth and systemic features of HL, including immune abnormalities (eg, hypergammaglobulinemia, anergy), anemia, and leukocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    They do so by elaborating a variety of cytokines, chemokines, and surface ligands that influence specific aspects of the host response. Since there are no experimental models of HL, data linking various factors to specific types of tissue responses are largely correlative. However, based on known roles in other contexts, certain interactions seem likely to be pathogenically important. The role of NF-kB activation in HRS cells in the expression of these cytokines remains to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cytokine responses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given that cytokines produced by HRS cells and surrounding reactive cells are thought to contribute to the pathogenesis of HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/63\">",
"     63",
"    </a>",
"    ], circulating cytokine levels might be of prognostic value. This issue was addressed in a prospective GELA study correlating pretreatment plasma levels of various cytokines with treatment outcome in 519 consecutive patients with a first diagnosis of classical HL [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/86\">",
"     86",
"    </a>",
"    ]. A cytokine prognostic index was devised, with one point being given for each of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum IL1-RA level &gt;668",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"     </li>",
"     <li>",
"      Serum IL-6 level &gt;30",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"     </li>",
"     <li>",
"      Serum soluble CD30 level &gt;80",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subjects with scores of zero, one, two, or three had five-year event-free survivals of 92, 85, 75, and 15 percent, respectively. These results require prospective validation in other studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     T cell response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissues involved by classical HL typically demonstrate the accumulation of predominantly of CD4+ T cells, which have several potential functions. Activated CD4+ TH2 cells, which are involved in immune reactions characterized by eosinophilia, plasmacytosis, and fibrosis, likely collaborate with factors produced directly by HRS cells to elicit tissue reaction. IL-13 produce by HRS cells may promote T helper cell differentiation to the TH2 phenotype directly [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/87\">",
"     87",
"    </a>",
"    ], and activate the expression of the macrophage derived chemokine (MDC) gene (also called CCL22) in HRS cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. HRS cells also express the chemokine TARC, and both MDC and TARC bind the CCR4 receptor on TH2 T cells and thereby generate signals which enhance homing of TH2 cells to tissue sites where HRS cells lurk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Humans possess an important class of negative regulatory T cells (Tregs) that expressCD4, high levels of CD25, and the transcription factor FOXP3 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. HRS cells express high levels of Galectin-1, a small heavily glycosylated secreted polypeptide that promotes the differentiation of CD4 positive T cells to the TH2 and Treg fates at the expense of the TH1 fate [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/94\">",
"     94",
"    </a>",
"    ]. Together with the other factors noted above, these effectors may explain the systemic immune alterations that are commonly noted in classical HL patients. These include enhanced TH2 responses and anergy to immune challenges that induce TH1 responses. It has been proposed that neutralizing antibodies against galectin-1 might correct some of these immune defects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;HRS cells produce IL-5 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/95\">",
"     95",
"    </a>",
"    ], and the chemokine CCL28, and also synthesize factors, such as TNF, that induce tissue fibroblasts to make eotaxin (CCL11) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. All of these factors are chemoattractants that recruit eosinophils and produce tissue eosinophilia. IL-5 can also increase marrow production of eosinophils through pro-growth and survival effects on eosinophilic precursors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue fibrosis, a feature most characteristic of the nodular sclerosis subtype of classical HL, has been linked to production of TGFb and basic fibroblast growth factor by HRS cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/98,99\">",
"     98,99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Plasmacytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;HRS cells elaborate the chemokine CCL28, and as mentioned above, a number of other factors that promote accumulation and growth of TH2 cells, which augment plasma cell development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fever and leukocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;TNF and other inflammatory cytokines released from HRS cells may contribute to fever and other features of chronic inflammation, such as anemia and elevation of the erythrocyte sedimentation rate. A discussion of the effect of IL-6 can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H5#H5\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'Hepcidin'",
"    </a>",
"    .) HRS cells also release GM-CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/100\">",
"     100",
"    </a>",
"    ], which may increase marrow production of leukocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other dysregulated genes and proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genomic-scale gene expression profiling using DNA microarrays has contributed to a much more complete understanding of gene expression programs that characterize HL cell lines and other forms of human cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/66,81,101-103\">",
"     66,81,101-103",
"    </a>",
"    ]. This technology, which currently uses \"gene chips\" containing most known human genes, simultaneously quantifies the expression of tens of thousands of genes in parallel, producing a \"snap-shot\" of the \"transcriptosome\" of cancer cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39674?source=see_link\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In an earlier approach using DNA microarrays containing 950 genes, the gene expression in two HL cell lines [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/61\">",
"     61",
"    </a>",
"    ] was compared with that in a lymphoblastoid B cell line transformed with EBV. Since the LMP1 protein of EBV would be expected to activate NF-kB target genes in the lymphoblastoid cell line, the expression of some NF-kB target genes in the HL cell lines may have been missed. In this assay, genes that might contribute to the pathogenesis of classical HL would be expressed in the HRS cell lines but not those in the EBV-transformed lymphoblastoid cell line. Several such genes, such as that for IL-13, were identified.",
"   </p>",
"   <p>",
"    Increased expression by HRS cells of proteins in the programmed cell death pathway might be related to overall clinical prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. In one study, the presence of high numbers of active caspase-3-positive HRS cells was associated with higher rates of complete remission and overall survival [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other expression profiling data have highlighted a surprising degree of similarity between the profiles of classical HL cell lines and mediastinal large B cell lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/107,108\">",
"     107,108",
"    </a>",
"    ]. Of interest, like classical HL, mediastinal large B cell lymphoma often occurs in young adults and is characterized by constitutive activation of NFkB [",
"    <a class=\"abstract\" href=\"UTD.htm?2/23/2426/abstract/109\">",
"     109",
"    </a>",
"    ]. Occasional patients have both tumors, either metachronously or synchronously, further suggesting a close pathogenic relationship.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14589362\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hodgkin lymphoma is a neoplasm characterized by relatively small numbers of clonal malignant",
"      <span class=\"nowrap\">",
"       Hodgkin/Reed-Sternberg",
"      </span>",
"      (HRS) cells in an abundant reactive cellular background comprised of variable numbers of granulocytes, plasma cells, macrophages, and lymphocytes.",
"     </li>",
"     <li>",
"      The malignant HRS cells are derived from germinal center B cells, but have characteristically lost the phenotypic features of these cells. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cellular origin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The growth and survival of classical HRS cells are closely tied to the activation of the nuclear factor kappa B (NF-kB) transcription factor-signaling pathway. The constitutive nuclear activity of NF-kB can both prevent apoptosis and promote cell proliferation. EBV, which is found in the tumor cells of a significant minority of cases, expresses viral proteins such as LMP1 that lead to NF-kB activation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Activation of nuclear factor kappa B'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Consequences of constitutive NF-kB activation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other pathways that appear to be involved in the pathogenesis of classical Hodgkin lymphoma include the interleukin-13 signaling pathway and NOTCH signaling pathway. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Interleukin-13 signaling pathway'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'NOTCH signaling pathway'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although no specific genetic abnormalities are diagnostic of classical Hodgkin lymphoma, there is widespread genomic instability with gene amplification. Many cases demonstrate amplification of genes, such as c-REL and JAK2, which contribute to the activation of NF-kB and STAT3. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Genomic instability'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Interactions between HRS cells and the surrounding reactive inflammatory cells likely controls both local tumor growth and systemic features of HL, including immune abnormalities (eg, hypergammaglobulinemia, anergy), anemia, and leukocytosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Mechanisms of tissue reaction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/1\">",
"      K&uuml;ppers R, Schwering I, Br&auml;uninger A, et al. Biology of Hodgkin's lymphoma. Ann Oncol 2002; 13 Suppl 1:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/2\">",
"      Re D, Thomas RK, Behringer K, Diehl V. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood 2005; 105:4553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/3\">",
"      Emmerich F, Meiser M, Hummel M, et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94:3129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/4\">",
"      Cabannes E, Khan G, Aillet F, et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999; 18:3063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/5\">",
"      Jungnickel B, Staratschek-Jox A, Br&auml;uninger A, et al. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/6\">",
"      Emmerich F, Theurich S, Hummel M, et al. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol 2003; 201:413.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/8\">",
"      Braeuninger A, K&uuml;ppers R, Strickler JG, et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 1997; 94:9337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/9\">",
"      Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997; 337:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/10\">",
"      Ohno T, Stribley JA, Wu G, et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 1997; 337:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/11\">",
"      Liso A, Capello D, Marafioti T, et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 2006; 108:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/12\">",
"      Tzankov A, Zimpfer A, Pehrs AC, et al. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003; 16:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/13\">",
"      Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol 1988; 130:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/14\">",
"      Marafioti T, Hummel M, Foss HD, et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/15\">",
"      Kanzler H, K&uuml;ppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/16\">",
"      Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature 1991; 354:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/17\">",
"      Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol 2004; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/18\">",
"      Marafioti T, Hummel M, Anagnostopoulos I, et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999; 17:3804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/19\">",
"      Br&auml;uninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999; 340:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/20\">",
"      Ohno T, Smir BN, Weisenburger DD, et al. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with \"Hodgkin's transformation\". Blood 1998; 91:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/21\">",
"      Seitz V, Hummel M, Marafioti T, et al. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 2000; 95:3020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/22\">",
"      Portlock CS, Donnelly GB, Qin J, et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol 2004; 125:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/23\">",
"      Rassidakis GZ, Medeiros LJ, Viviani S, et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol 2002; 20:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/24\">",
"      Falini B, Bigerna B, Pasqualucci L, et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 1996; 87:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/25\">",
"      Theil J, Laumen H, Marafioti T, et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001; 97:3191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/26\">",
"      Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/27\">",
"      Jundt F, Kley K, Anagnostopoulos I, et al. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 2002; 99:3060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/28\">",
"      Ushmorov A, Ritz O, Hummel M, et al. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 2004; 104:3326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/29\">",
"      Marafioti T, Pozzobon M, Hansmann ML, et al. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood 2004; 103:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/30\">",
"      Ushmorov A, Leith&auml;user F, Sakk O, et al. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 2006; 107:2493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/31\">",
"      Mathas S, Janz M, Hummel F, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/32\">",
"      Renn&eacute; C, Martin-Subero JI, Eickernj&auml;ger M, et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 2006; 169:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/33\">",
"      Jost PJ, Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007; 109:2700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/34\">",
"      Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/35\">",
"      Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004; 119:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/36\">",
"      Liou HC, Sha WC, Scott ML, Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 1994; 14:5349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/37\">",
"      Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci U S A 1994; 91:5056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/38\">",
"      Bargou RC, Leng C, Krappmann D, et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87:4340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/39\">",
"      Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 2004; 23:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/40\">",
"      Joos S, Menz CK, Wrobel G, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/41\">",
"      Mart&iacute;n-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99:1474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/42\">",
"      Krappmann D, Emmerich F, Kordes U, et al. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 1999; 18:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/43\">",
"      Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009; 206:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/44\">",
"      Sylla BS, Hung SC, Davidson DM, et al. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc Natl Acad Sci U S A 1998; 95:10106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/45\">",
"      Carbone A, Gloghini A, Gruss HJ, Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/46\">",
"      Clodi K, Asgari Z, Younes M, et al. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance. Cancer 2002; 94:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/47\">",
"      Annunziata CM, Safiran YJ, Irving SG, et al. Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor. Blood 2000; 96:2841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/48\">",
"      Messineo C, Jamerson MH, Hunter E, et al. Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation. Blood 1998; 91:2443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/49\">",
"      Gruss HJ, Ulrich D, Dower SK, et al. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Blood 1996; 87:2443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/50\">",
"      Molin D, Fischer M, Xiang Z, et al. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 2001; 114:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/51\">",
"      Horie R, Watanabe T, Morishita Y, et al. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene 2002; 21:2493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/52\">",
"      Horie R, Watanabe T, Ito K, et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol 2002; 160:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/53\">",
"      Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993; 259:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/54\">",
"      Scott ML, Fujita T, Liou HC, et al. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev 1993; 7:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/55\">",
"      Buri C, K&ouml;rner M, Sch&auml;rli P, et al. CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease. Blood 2001; 97:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/56\">",
"      Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100:2961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/57\">",
"      Wu M, Lee H, Bellas RE, et al. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15:4682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/58\">",
"      Costanzo A, Moretti F, Burgio VL, et al. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003; 195:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/59\">",
"      Chang ET, Zheng T, Weir EG, et al. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst 2004; 96:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/60\">",
"      Zheng B, Georgakis GV, Li Y, et al. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 2004; 10:3207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/61\">",
"      Kapp U, Yeh WC, Patterson B, et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 1999; 189:1939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/62\">",
"      Skinnider BF, Elia AJ, Gascoyne RD, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2001; 97:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/63\">",
"      Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002; 99:4283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/64\">",
"      Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/65\">",
"      Ikushima S, Inukai T, Inaba T, et al. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A 1997; 94:2609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/66\">",
"      Alizadeh A, Eisen M, Botstein D, et al. Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol 1998; 18:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/67\">",
"      Chu CC, Paul WE. Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis. Mol Immunol 1998; 35:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/68\">",
"      Manna SK, Aggarwal BB. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J Immunol 1998; 161:2863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/69\">",
"      Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997; 100:2443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/70\">",
"      Takeda K, Kamanaka M, Tanaka T, et al. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 1996; 157:3220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/71\">",
"      Skinnider BF, Elia AJ, Gascoyne RD, et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002; 99:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/72\">",
"      Iciek LA, Delphin SA, Stavnezer J. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction. J Immunol 1997; 158:4769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/73\">",
"      Shen CH, Stavnezer J. Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. Mol Cell Biol 1998; 18:3395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/74\">",
"      Messner B, St&uuml;tz AM, Albrecht B, et al. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J Immunol 1997; 159:3330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/75\">",
"      Jundt F, Anagnostopoulos I, F&ouml;rster R, et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99:3398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/76\">",
"      Schwarzer R, D&ouml;rken B, Jundt F. Notch is an essential upstream regulator of NF-&kappa;B and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia 2012; 26:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/77\">",
"      Pui JC, Allman D, Xu L, et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/78\">",
"      Weber-Matthiesen K, Deerberg J, Poetsch M, et al. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/79\">",
"      Deerberg-Wittram J, Weber-Matthiesen K, Schlegelberger B. Cytogenetics and molecular cytogenetics in Hodgkin's disease. Ann Oncol 1996; 7 Suppl 4:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/80\">",
"      K&uuml;pper M, Joos S, von Bonin F, et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol 2001; 112:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/81\">",
"      Steidl C, Telenius A, Shah SP, et al. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 2010; 116:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/82\">",
"      Mart&iacute;n-Subero JI, Knippschild U, Harder L, et al. Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma? Leukemia 2003; 17:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/83\">",
"      Green MR, Monti S, Rodig SJ, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010; 116:3268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/84\">",
"      Re D, Starostik P, Massoudi N, et al. Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells. Cancer Res 2003; 63:2606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/85\">",
"      Alvaro T, Lejeune M, Garc&iacute;a JF, et al. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells. Clin Cancer Res 2008; 14:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/86\">",
"      Casasnovas RO, Mounier N, Brice P, et al. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007; 25:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/87\">",
"      McKenzie GJ, Fallon PG, Emson CL, et al. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/88\">",
"      Cossman J, Annunziata CM, Barash S, et al. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999; 94:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/89\">",
"      Niens M, Visser L, Nolte IM, et al. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol 2008; 140:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/90\">",
"      Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998; 161:5027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/91\">",
"      Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/92\">",
"      Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol 2004; 16:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/93\">",
"      Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/94\">",
"      Juszczynski P, Ouyang J, Monti S, et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A 2007; 104:13134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/95\">",
"      Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/96\">",
"      Hanamoto H, Nakayama T, Miyazato H, et al. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells. Am J Pathol 2004; 164:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/97\">",
"      Jundt F, Anagnostopoulos I, Bommert K, et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999; 94:2065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/98\">",
"      Kadin ME, Agnarsson BA, Ellingsworth LR, Newcom SR. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol 1990; 136:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/99\">",
"      Hsu SM, Lin J, Xie SS, et al. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hum Pathol 1993; 24:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/100\">",
"      Gause A, Keymis S, Scholz R, et al. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease. Lymphokine Cytokine Res 1992; 11:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/101\">",
"      Staudt LM, Brown PO. Genomic views of the immune system*. Annu Rev Immunol 2000; 18:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/102\">",
"      K&uuml;ppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/103\">",
"      Scott DW, Chan FC, Hong F, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol 2013; 31:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/104\">",
"      Garc&iacute;a JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003; 101:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/105\">",
"      Montalb&aacute;n C, Garc&iacute;a JF, Abraira V, et al. Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group. J Clin Oncol 2004; 22:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/106\">",
"      Dukers DF, Meijer CJ, ten Berge RL, et al. High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome. Blood 2002; 100:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/107\">",
"      Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/108\">",
"      Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102:3871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/23/2426/abstract/109\">",
"      Rodig SJ, Savage KJ, LaCasce AS, et al. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma. Am J Surg Pathol 2007; 31:106.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4698 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2426=[""].join("\n");
var outline_f2_23_2426=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14589362\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSICAL VERSUS NON-CLASSICAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CELLULAR ORIGIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISMS OF TUMORIGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Activation of nuclear factor kappa B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Consequences of constitutive NF-kB activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Interleukin-13 signaling pathway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      NOTCH signaling pathway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genomic instability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MECHANISMS OF TISSUE REACTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cytokine responses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      T cell response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Plasmacytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fever and leukocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other dysregulated genes and proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14589362\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4698\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4698|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/18/42276\" title=\"picture 1\">",
"      Reed Sternberg cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/58/28578\" title=\"picture 2\">",
"      Reed Sternberg variants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/5/1111\" title=\"picture 3\">",
"      L H Reed Sternberg cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4698|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/23/17788\" title=\"table 1\">",
"      Hodgkin immunophenotype",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33432?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=related_link\">",
"      Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34601?source=related_link\">",
"      Etiology, clinical features, and diagnosis of minimal change disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39674?source=related_link\">",
"      Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3703?source=related_link\">",
"      The role of Epstein-Barr virus in Hodgkin lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_23_2427="Two by two table";
var content_f2_23_2427=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73504&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The two-by-two table",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disease present, gold standard",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disease absent, gold standard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test result positive",
"       </td>",
"       <td>",
"        True positives",
"       </td>",
"       <td>",
"        False positives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test result negative",
"       </td>",
"       <td>",
"        False negatives",
"       </td>",
"       <td>",
"        True negatives",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Sensitivity: true positives/(true positives + false negatives); Specificity: true negatives/(false positives + true negatives).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2427=[""].join("\n");
var outline_f2_23_2427=null;
var title_f2_23_2428="Diagnostic criteria for AMR reject of renal allograft";
var content_f2_23_2428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F82577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F82577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for antibody-mediated rejection of renal allograft",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acute AMR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophil/lymphocyte margination (capillaritis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombosis/necrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C4d+ in peritubular capillaries (PTC)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Circulating anti-donor antibodies (DSA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cell mediated rejection*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ATN*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Chronic AMR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        1. Histologic evidence of chronic damage (2/4 required)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        - Tubulointerstitial fibrosis/atrophy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        - Arterial intimal thickening without elastosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        - GBM/TBM duplication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. C4d+ in PTC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. DSA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Suspicious for AMR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C4d+ in PTC with capillaritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No DSA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No histopathological findings",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    At least three criteria of those listed in the table are required for diagnosis of acute AMR.",
"    <br>",
"     ATN may be the earliest feature of AMR.",
"     <div class=\"footnotes\">",
"      * These may accompany AMR but are not specific AMR features.",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced from: Liapis H, Koch MJ, Mengel M. Kidney. In: Pathology of Solid Organ Transplantation, 1st ed, Liapis H, Wang HL (Eds), Springer, New York 2011, with kind permission from Springer Science + Business Media B.V.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2428=[""].join("\n");
var outline_f2_23_2428=null;
var title_f2_23_2429="Medicare coverage of medical equipment and prosthetic items";
var content_f2_23_2429=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F86415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F86415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medicare coverage of durable medical equipment and prosthetic and orthotic items",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        What Medicare covers",
"       </td>",
"       <td class=\"subtitle1\">",
"        What the patient pays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Durable medical equipment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Air fluidized beds",
"       </td>",
"       <td rowspan=\"18\">",
"        The patient pays 20 percent of the Medicare-approved amount after paying Medicare Part B deductible for the year. Medicare pays the other 80 percent. The Medicare-approved amount is the lower of the actual charge for the item or the fee Medicare sets for the item. However, the amount the patient pays may vary because Medicare pays for different kinds of durable medical equipment in different ways. Some equipment may be able to be rented or purchased.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blood glucose monitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bone growth (or osteogenesis) stimulators",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Canes (except white canes for the blind)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bedside commode",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Crutches",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Home oxygen equipment and supplies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hospital beds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infusion pumps and some medicines used in them",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphedema pumps/pneumatic compression devices",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nebulizers and some medicines used in them",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Patient lifts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Scooters and power wheelchairs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Traction equipment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Transcutaneous electronic nerve stimulators (TENS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ventilators or respiratory assist devices",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Walkers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wheelchairs (manual and power)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Prosthetic&nbsp;and orthotic items",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arm, leg, back, and neck braces",
"       </td>",
"       <td rowspan=\"6\">",
"        Patient pays 20 percent of the Medicare-approved amount after paying Medicare Part B deductible for the year. Medicare pays the other 80 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Artificial limbs and eyes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breast prostheses (including a surgical brassiere) after a mastectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ostomy supplies for people who have had a colostomy, ileostomy, or urinary ostomy (per physician order)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prosthetic devices needed to replace an internal body part or function (eg, Foley urinary catheter)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Therapeutic shoes or inserts for people with diabetes who have severe diabetic foot disease (prescribed by the doctor treating the diabetes or a podiatrist, and provided by doctor or other qualified individual such as a podiatrist)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Medicare Coverage for Durable Medical Equipment and Other Devices. Medicare Website. Available at:&nbsp;",
"     <a href=\"file://www.medicare.gov/publications/pubs/pdf/11045.pdf\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"      file://www.medicare.gov/publications/pubs/pdf/11045.pdf",
"     </a>",
"     (Accessed January 28, 2012).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2429=[""].join("\n");
var outline_f2_23_2429=null;
var title_f2_23_2430="Contents: Genetics basic science";
var content_f2_23_2430=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Genetics basic science",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Genetics basic science",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Basic principles of genetics",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/38/21097\">",
"           Basic principles of genetic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/27/28087\">",
"           Genomic disorders: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/44/43717\">",
"           Glossary of genetic terms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/46/43750\">",
"           Non-Mendelian inheritance patterns of monogenic diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/56/35718\">",
"           Overview of Mendelian inheritance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/63/5112\">",
"           Overview of genetic variation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/42/9897\">",
"           Overview of stem cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/44/10950\">",
"           Principles of complex trait genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/27/17846\">",
"           Principles of molecular genetics",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disease-specific genetics",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/49/22293\">",
"           Peptide hormone signal transduction and regulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/36/8777\">",
"           Personalized medicine",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic counseling and testing",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/1/24602\">",
"           Genetic counseling and testing",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Methodologic tools",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/55/28536\">",
"           Cytogenetic and molecular genetic diagnostic tools",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/38/3689\">",
"           Genetic association studies: Principles and applications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/47/23287\">",
"           Genomics and model systems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/4/11335\">",
"           Mendelian randomization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/51/31544\">",
"           Mouse genetics: Breeding strategies and genetic engineering",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/54/13159\">",
"           Polymerase chain reaction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39799\">",
"           Tools for genetics and genomics: Gene expression",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pharmacogenetics",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/32/22026\">",
"           Overview of pharmacogenomics",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-D4BF8B6C39-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f2_23_2430=[""].join("\n");
var outline_f2_23_2430=null;
var title_f2_23_2431="Brown dog tick";
var content_f2_23_2431=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    An adult female rhipicephalus sanguineus (brown dog tick)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 223px; height: 225px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Champman, AS, Bakken, JS, Folk, SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever, Ehrlichoioses, and Anaplasmosis-United States: A practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_23_2431=[""].join("\n");
var outline_f2_23_2431=null;
